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Abs absorbance 
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ABSTRACT 
Protein O-mannosylation is an essential, conserved and abundant post-translational 
modification in the eukaryotic secretory pathway. Protein O-mannosylation is initiated at the 
endoplasmic reticulum (ER) by the covalent addition of single mannoses to serine and 
threonine residues of target polypeptides. This reaction is catalyzed by members of the 
evolutionarily conserved protein mannosyltransferase family (PMT). In the model organism 
Saccaromyces Cerevisiae, among its different biological roles, protein O-mannosylation has 
been described to target both unfolded and irreversibly misfolded proteins. The recently 
named unfolded protein O-mannosylation (UPOM) pathway is hypothesized to function as a 
fail-safe mechanism to prevent ineffective folding attempts for polypeptides that did not 
achieve the native conformation within certain time window. However, although UPOM has 
been described to target multiple misfolded model proteins, the mechanism by which the 
PMT machinery discriminates misfolded polypeptides is unknown. In fact, the question of 
whether UPOM is a physiologically relevant mechanism contributing to maintain 
homeostasis in the ER remains unanswered. 
In this current work, it is shown: I) The relevance of the Pmt1-Pmt2 complex as necessary to 
maintain ER homeostasis being integrated in the unfolded protein response (UPR). II) Aiming 
to unravel the UPOM machinery, the genes PGI1 (phosphoglucose isomerase) and BFR1 
(Brefeldin A resistance) were found as necessary for efficient UPOM. On one hand, the 
characterization of PGI1 highlighted a direct link between O-mannosylation, cytosolic sugar 
metabolism, and ER stress. On the other hand, the RNA binding protein (RBP) Bfr1 was found 
to modulate the translational state of PMT mRNAs among many other ORFs, mainly coding 
for proteins localizing to the secretory pathway, suggesting a role as a local translational 
control factor. III) Aiming to address the physiological relevance of UPOM in the ER protein 
quality control system, the impact of O-mannosylation on the stability of a subset of PMT 
target proteins was investigated. Both, protein stabilization and de-stabilization effects were 
presented. The prevalence of either effect was largely dependent on the nature of the 
O-mannosylation substrate. In line with this, Pmt1 is shown to be necessary for the 
degradation of the beta-1,6 synthase Kre6 when mislocalized in the vacuole. 
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ZUSAMMENFASSUNG 
Die Protein-O-Mannosylierung ist eine essentielle, konservierte und häufig auftretende, 
post-translationale Modifikation im eukaryotischen sekretorischen Transportweg. Die 
Protein-O-Mannosylierung beginnt im Endoplasmischen Retikulum (ER) durch die kovalente 
Bindung einer einzelnen Mannose an Serin- oder Threoninreste von Zielpolypeptiden. 
Katalysiert wird diese Reaktion von der evolutionär konservierten Protein-O-
Mannosyltransferase (PMT) Familie. Im Modellorganismus, der Bäckerhefe Saccaromyces 
Cerevisiae, spielt die Protein-O-Mannosylierung vielfältige, wichtige biologische Rollen und 
es konnte gezeigt werden, dass sowohl ungefaltete als auch irreversibel fehlgefaltete 
Proteine modifiziert werden. Vor kurzem wurde die sogenannte Ungefaltete Protein-
O-Mannosylierung (UPOM) eingeführt, von welcher vermutet wird, dass Sie als fehlerfreier 
Mechanismus zur Vermeidung unnützer Faltungszyklen von Polypeptiden dient, welche nicht 
innerhalb eines festen Zeitfensters korrekt gefaltet werden. Obwohl die Protein-
O-Mannosylierung für mehrere fehlgefaltete Modellproteine beschrieben wurde, ist der 
Mechanismus, durch welchen die PMTs diese erkennen, noch unverstanden. Genauso 
unbeantwortet ist die Frage ob die UPOM als physiologisch relevanter Prozess zur 
Homöostase des ER beiträgt. 
Diese Arbeit zeigt erstens: Die Notwendigkeit des Pmt1-Pmt2-Komplexes für die Intergration 
der ER Homöostase in die ungefaltete Proteinantwort (UPR). Zweitens: Die Gene PGI1 
(phosphoglucose isomerase) und BFR1 (Brefeldin A resistance) wurden als notwendige Gene 
der UPOM Maschinerie identifiziert. Einerseits, konnte durch die Untersuchung von PGI1 
eine direkte Verbindung von Protein-O-Mannosylierung zum zytosolischen 
Zuckermetabolismus und ER Stress Signalwegen hergestellt werden. Andererseits, wurde das 
RNA-Bindeprotein Bfr1 als Modulator des translationalen Stadiums von PMT mRNAs aus den 
einzelnen offenen Leserahmen, welche hauptsächlich für Proteine des sekretorischen Wegs 
kodieren, identifiziert. Dies legt für Bfr1 eine Rolle als lokaler Translationskontrollfaktor 
nahe. Drittens, wurde der Einflusses der UPOM auf das ER Qualitätskontrollsystem anhand 
von Stabilitätsuntersuchung von PMT Zielproteinen physiologisch untersucht. Sowohl 
protein-stabilisierende als auch -destabilisierende Effekte konnten festgestellt werden. Der 
vorherrschende Effekt hing dabei größtenteils von der Natur des Zielproteins ab. 
Übereinstimmend mit diesen Beobachtungen konnte hier gezeigt werden, dass Pmt1 
notwendig für den Abbau der fälschlich vakuolar lokalisierten beta-1,6 synthase Kre6 ist. 
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PUBLISHED DATA AND CONTRIBUTION BY CO-WORKERS  
This section summarizes published data, contributions of co-workers and experiments 
performed in collaboration with other groups shown in this current work. Yet, this 
information can be found in the corresponding description of methods as well as at the 
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hindered to do so. The bachelor student Sven Klassa performed the spotting assay showed in 
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homeostasis”, submitted to the Ruprecht-Karls-University (Heidelberg faculty of Biosciences) 
in 2017. The bachelor student Karen Schriever performed the microscopy experiment shown 
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The ER-GFP screening was performed by Lihi Gal in the frame of a collaboration with the 
group of Prof. Maya Schuldiner (Weizmann Institute of Science, Rehovot, Israel). 
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1 INTRODUCTION 
 
Homeostasis is commonly referred to as the process by which physical and chemical 
conditions within the internal environment of the body are maintained within tolerable 
ranges even when the external environment changes. It was first used as a term in 
physiology by Walter Bradford Cannon in 1926 (Cannon, 1926) and since then it has been 
applied to describe the equilibrium existing not only at the organismal level but in all 
physiological systems.  
The different components of the cell are no exception and have developed multiple 
mechanisms to maintain homeostatic conditions within organelles, contributing thus to 
optimize the cell’s physiological functions. Within the cell, the endoplasmic reticulum (ER) is 
a central cellular hub for the production of secretory proteins. Approximately one-third of 
the human proteome including both soluble and membrane proteins is translated, 
translocated and sorted to the ER (reviewed in X. Chen et al., 2010). Protein homeostasis in 
the ER is achieved by the interplay between different mechanisms that ensure both, correct 
protein folding and maturation, including the addition of post-translational modifications, 
and minimize the impact of adverse conditions either caused internally or as a consequence 
of the cellular environment. Adverse conditions impacting negatively on ER protein 
homeostasis are commonly referred to as ER stress. ER stress pictures an altered 
physiological scenario in which the cell is challenged to activate multiple responses at many 
layers in an attempt to restore protein homeostasis (reviewed in C. Xu et al., 2005). In this 
current work protein O-mannosylation is explored as one of the many tools used by the cell 
to maintain protein homeostasis in terms of the interplay with other ER stress cellular 
responses, the different factors that orchestrate it, and its potential physiological role in 
affecting protein stability. 
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1.1 Protein glycosylation 
 
The covalent addition of carbohydrates to proteins is not only decisive for the protein’s 
molecular function but establishes a fundamental process concomitant with the existence 
of all living organisms. First discovered in the 60s (Johansen et al., 1961), protein 
glycosylation is found as the most abundant and heterogeneous post-translational protein 
modification across life domains. 
Protein glycosylation has been linked to countless aspects of the protein function. These 
include structural function, contribution to protein stability, determinant for cell-cell and 
cell-matrix interaction, cell recognition by microorganisms and antibodies and the 
modulation of the interaction of peptides with their cognate ligands or receptors (reviewed 
in Varki, 1993). One relevant facet of protein glycosylation is the existence of congenital 
disorders of glycosylation (CDGs) in humans, inherited systemic diseases that appear linked 
to the malfunction of different steps of the protein glycosylation pathways. While 
impairment of protein glycosylation results in embryonic lethality, CDGs appear associated 
with mutations affecting the glycosylation pathways at different steps of the glycoprotein 
synthesis and/or maturation. CDGs are diverse and generally classified according to the 
gene affected in each case and they normally have in common systemic symptoms caused 
by abnormal development of the brain and defects of the nerve‐, liver‐, stomach‐, and 
intestinal systems (reviewed in Varki, 1993; Grunewald et al., 2002; Lehle et al., 2006). 
 
The vast complexity of protein glycosylation is reflected by the fact that carbohydrate-
protein linkages have been described for most of the functional groups occurring on peptide 
chains and multiple commonly occurring sugars, establishing an enormous number of 
possible functional combinations of linear and branched oligosaccharides of distinct length 
and composition (reviewed in Spiro, 2002). Protein glycosylation is generally classified 
according to the type of glycopeptide linkage in N-glycosylation, O-glycosylation, 
C-mannosylation, phophoglycosylation and glycosylfosfatidylinositol (GPI linkage) (reviewed 
in Spiro, 2002; Lehle et al., 2006). The different types of protein glycosylation largely diverge 
in prevalence across and within biological kingdoms (reviewed in Dell et al., 2010). In 
general, glycans present in higher eukaryotes are richer in diversity and complexity than 
what found in unicellular organisms (Zielinska et al., 2012), representing another layer of 
 
  
11 
specialization of the cell and expanding the versatility of the organism’s proteome 
(reviewed in Lis & Sharon, 1993; Spiro, 2002; Dell et al., 2010). In baker’s yeast, with the 
exception of glypiation, protein N-glycosylation, and protein O-mannosylation as the only 
type of O-glycosylation are present. This, together with the high degree of conservation of 
the biosynthetic pathways of O-and N-glycans has qualified Saccharomyces cerevisiae as a 
suitable model organism to study protein glycosylation, not only in terms of the molecular 
mechanism of the glycoprotein biosynthesis and the function of glycans but also to the 
characterization of different CDG subtypes (reviewed in Lehle et al., 2006). With the focus 
of this current work put on protein O-glycosylation, it is worth to mention that it is precisely 
the finding and characterization of the protein O-mannosylation machinery in yeast (Strahl-
Bolsinger et al., 1993, Lussier et al., 1995) what set the basis for the discovery of the 
conserved pathways in higher eukaryotes (Jurado et al., 1999; Willer et al., 2002; Beltran-
Valero de Bernabe et al., 2002). 
1.2 Protein glycosylation in Saccharomyces cerevisiae 
 
Protein N-glycosylation, O-mannosylation and the formation of the GPI anchor (with regard 
to the sugar added to the GPI precursor) are initiated at the ER by the covalent transfer of 
the core sugar structures from the sugar donor dolichol phosphate (Dol-P) and 
dolichylpyrophosphate (Dol-PP) to synthesized polypeptides. Dolichol belongs to the family 
of poly-isoprenoid lipids comprised of a linear structure of fifteen core isoprene units in 
yeast (Adair & Cafmeyer, 1987). The Dol-P and Dol-PP-linked sugars are synthesized at the 
cytosolic side of the ER and flipped into the lumen by a yet unknown mechanism to serve as 
a platform providing sugars for each glycosylation pathway. 
One of the yeast compartments primarily found to accumulate glycoproteins is the cell wall, 
where they comprise approximately 30-50 % of its mass (reviewed in Klis et al., 2006). For 
some extensively modified glycoproteins, glycans contribute up to 95% of their total 
molecular mass (Ballou, 1990). Based on prediction it has been initially estimated that 20-
50% of the yeast proteome could undergo glycosylation (Apweiler et al., 1999). Discovery-
based glycoproteomic studies have been able to identify and map about 270 N-glycoproteins 
(Zielinska et al., 2012), and 512 O-mannoproteins (Neubert et al., 2016). The glycoproteins 
identified in these two studies represent 20-30% of the yeast secretome and this number is 
still expected to increase as long as glycoproteomic approaches increase in resolution. 
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1.2.1 Protein N-glycosylation 
 
Biosynthesis of N-glycoproteins is initiated at the cytosolic side of the ER membrane by the 
formation of an initial lipid-linked oligosaccharide (LLO). Noteworthy, these steps are shared 
by all eukaryotes as well as the core structure of the glycan transferred to synthesized pro-
teins. Dolichylpyrophosphate core oligosaccharide is assembled by the coordinated function 
of enzymes of the ER-glycosyltransferase ALG family. In the cytosol, sugar substrates used 
for the first steps of the lipid-linked oligosaccharide are derived from the primary metabo-
lism as the nucleotide activated sugars UDP-GlcNAc and GDP-Man. The Alg7 transfers an 
initial N-acetylglucosamine phosphate residue. A second N-acetylglucosamine is added by 
the Alg13-Alg14 complex (Rine et al., 1983; Bickel et al., 2005). The sugar chain is subse-
quently elongated by the addition of five mannose residues in a stepwise manner by Alg1, 
Alg2, and Alg11, resulting in the formation of Man5GlcNAc2-P-P-Dol (Couto et al., 1984; 
Cipollo et al., 2001; O'Reilly et al., 2006; Kampf et al., 2009), which flips into the ER lumen by 
a yet unknown mechanism for further processing. In the ER lumen, four mannose and three 
glucose residues are transferred in a stepwise manner by the glycosyltransferases Alg3, Alg9, 
Alg12 and Alg6, Alg8 and Alg10 (Stagljar et al., 1994; Aebi et al., 1996; Reiss et al., 1996; 
Burda & Aebi, 1998; Burda et al., 1999; Frank & Aebi, 2005), resulting in the final LLO. ER 
luminal glycosyltransferases use Dol-P-Mannose and Dol-P-Glucose as substrate donors, 
which are assembled in the cytosol from GDP-mannose and UPD-glucose in a reaction cata-
lyzed by Dpm1 (See 1.2.2) and Alg5 (Heesen et al., 1994), respectively, and translocated 
across the membrane similar to the LLO precursor. The final LLO is used as a sugar donor by 
the oligosaccharyltransferase (OST) complex, which transfers the core N-glycan to Asn resi-
due of the sequon Asn-X-Ser/Thr of synthesized polypeptides, being X any amino acid except 
proline (Aebi, 2013). Recent studies showed a preference for Asn-X-Thr sites over Asn-X-Ser 
(Zielinska et al., 2012). 
The OST complex in yeast is a heteroligomeric protein complex comprised of eight trans-
membrane proteins: The four essential subunits Stt3, Ost1, Ost2 and Wbp1 assemble with 
Ost4, Ost5 and either Ost3 or Ost6, resulting in two different OST complex isoforms that 
have different polypeptide substrate specificity (Schwarz et al., 2005; Kelleher & Gilmore, 
2006; Spirig et al., 2005; Schulz & Aebi, 2009). Based on phylogenetic and structural studies 
it is assumed that the Stt3 subunit carries the catalytic active site (Izquierdo et al., 2009; 
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Hese et al., 2009; Nasab et al., 2008; Bai et al., 2018). However, the specific function of other 
members of the OST complex is not yet understood. 
One important feature of the OST complex is that it is found associated to the translocon 
complex (Shibatani et al., 2005) and structural studies in yeast and bacteria suggest that 
N-glycosylation might precede or compete with folding of target polypeptides (Lizak et al., 
2011; Bai et al., 2018). 
Once correctly folded (see 1.3), the resulting glycoprotein is packaged into trafficking vesi-
cles to the Golgi apparatus, where the glycans undergo further processing. For heavily glyco-
sylated proteins like invertase, up to 200 mannose residues are added on the core N-glycans 
during the journey of the glycoprotein throughout the Golgi (Ballou, 1990). Elongation steps 
at the Golgi also work in a step-wise manner by the interplay of different mannosyltranfer-
ases: Och1 initiates an α-1,6-polymannose chain, which is elongated and branched by the 
coordinated function of members of the MNN9, MNN10, KTR, and MNN1 mannosyltranfer-
ase families. Some of the N-glycan branches also receive a phosphomannose (reviewed in 
Aebi, 2013; Dean, 1999). 
In yeast, the function of N-glycans has been linked to key biological processes such as cell 
wall biogenesis (Lesage & Bussey, 2006), intracellular transport (Nagai et al., 1997) or pro-
tein folding and quality control (McCracken & Brodsky, 1996). Quality control of 
N-glycoproteins is one of the most studied aspects of N-glycosylation in yeast and likely the 
most relevant for this current work due to the potential similarities with O-mannosylation. 
The function of N-glycans in protein quality control is developed in 1.3.1. 
 
1.2.2 Protein O-mannosylation 
 
Protein O-mannosylation is a vital protein post-translational modification firstly discovered 
in the late 60s with the analysis of the glycan composition of the yeast cell wall (Sentandreu 
& Northcote, 1968). The sugar donor for O-mannosylation is Dol-P-Man, which in analogy to 
other lipid-based sugar donor precursors is synthesized at the cytosolic side of the ER mem-
brane (Babczinski & Tanner, 1973). Dol-P-Man is generated from Dol-P by the addition of a 
single mannose residue from GDP-Man derived from the primary metabolism. This reaction 
is catalyzed by dolichol phosphate mannose synthase (Dpm1) (Haselbeck, 1989), an essential 
mannosyltranferase that in yeast functions as a single ER transmembrane protein (Orlean et 
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al., 1988). Once assembled, Dol-P-Man flips across the ER membrane by a yet unknown 
mechanism and serves as a crossroad between O-mannosylation, N-glycosylation, and glypi-
ation, providing single mannoses as a substrate for the different glycosylation machinery in 
the ER lumen (Rush & Waechter, 1995; reviewed in Schenk et al., 2001). 
O-mannosylation is initiated at the luminal side of the ER, where members of the protein 
mannosyltransferase (PMT) family catalyze the transfer of single mannoses in α- anomeric 
configuration to the hydroxyl group of Ser or Thr residues of target polypeptides via α- man-
nosidic linkage (Bause & Lehle, 1979). 
Knowledge on O-mannosylation in vivo substrates was for long restricted to cell wall and 
plasma membrane proteins and found only on regions enriched with high Ser and Thr con-
tent (Cappellaro et al., 1991; M. H. Chen et al., 1995; Mrsa et al., 1999; Shimoi et al., 1998; 
Ecker et al., 2003). Based on this assumption, about 20% of proteins targeted to the ER by a 
signal peptide were predicted to be O-mannosylated (Gonzalez et al., 2012). A different pic-
ture is provided by in vitro acceptor peptides, where also modest Ser/Thr stretches were 
shown to be O-mannosylated (Weston et al., 1993; Strahl lab, unpublished). However, a re-
cent proteomic study from our group showed that the prevalence of O-mannosylation in the 
secretory pathway is broader than initially excepted (Neubert et al., 2016). 293 secretory 
proteins were found to be O-mannosylated in more than 2000 unique glycosites. This prote-
omic study also provided evidence of structural features of O-mannosylation protein targets: 
preference for unstructured regions and β-strands, preference for Thr over Ser sites and 
depletion of O-mannosylation in proximity to N-glycosylation sites. Nevertheless, the exist-
ence of a defined target sequon in analogy to N-glycosylation has been so far elusive. 
Among the O-mannosylation targets, there is significant enrichment of cell wall and plasma 
membrane proteins, but also proteins in the ER and Golgi. These O-mannoproteins fulfill 
diverse functions in glycosylation, trafficking, and protein quality control, indicating that the 
function of O-glycans in yeast is not solely structural as initially thought and might contribute 
to multiple key processes in the secretory pathway. This hypothesis is further supported by 
genomic and transcriptomic studies of the cell response upon defects in O-mannosylation 
where crosstalk between O-mannosylation and processes such as N-glycosylation, for-
mation, and remodeling of the GPI anchor, the unfolded protein response, the mating re-
sponse, and the cell wall integrity pathway have been presented (Arroyo et al., 2011; 
Zatorska et al., 2017). 
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 The protein mannosyltransferase (PMT) family 
1.2.2.1
 
Topologically, PMTs are large polytopic integral ER membrane proteins comprised of eleven 
transmembrane domains, ten hydrophilic loops, a cytosolic N-terminal and a luminal 
C-terminal domain (Figure 1.1,Bai et al., 2019)  
 
Figure 1.1. (A) Topology of Pmt1 according to Bai et al., 2019. The 
conserved D-E catalytic site in loop 1 and three MIR domains in loop 
7 are indicated. Pmt1 has three N-glycosylation sites (Y). (B) Protein 
O-mannosylation in the ER. Dol-P-man is assembled in the cytosol 
by Dmp1 and flips across the ER membrane. Members of the PMT 
family catalyze the transfer of single mannose residues from the 
sugar donor Dol-P-Man to Ser/Thr residues of target polypeptides. –
D, -E; aspartic and Glutamic acid. 
 
 
 
Among the hydrophilic loops that face the ER lumen, the loop 1 contains a conserved aspar-
tic and glutamic acid motif that is required for substrate binding and catalytic activity, sug-
gesting that is part of the catalytic active site (Lommel et al., 2011). In the significantly larger 
loop 7, three MIR (Mannosyltransferase - Inositol trisphosphate receptor - Ryanodine recep-
tor) motives are also required for PMT activity although they do not interfere with the en-
gagement of PMTs with target substrates (Figure 1.1; Girrbach et al., 2000; Lommel et al., 
2011). 
The PMT family includes at least 6 isoforms in yeast named PMT1-6 (Immervoll et al., 1995; 
Lussier et al., 1995; Strahl-Bolsinger & Scheinost, 1999), thought to be originated by genomic 
duplication during evolution. PMTs are conserved in fungi, animals and some bacteria and 
archaea (Lommel & Strahl, 2009). So far, no PMT-like protein has been identified in plants. 
Phylogenetic analyses of the PMT family have classified the different PMT isoforms into 
three subfamilies: PMT1, PMT2, and PMT4 (Figure 1.2; Girrbach et al., 2000; Willer et al., 
2002). The PMT1 subfamily includes Pmt1 and Pmt5; the PMT2 subfamily Pmt2, Pmt5 and 
Pmt6; and Pmt4 is the only member of the PMT4 subfamily. Redundancy within the different 
PMT subfamilies is present in some fungi like Candida albicans (Lommel & Strahl, 2009) 
whereas only one member per subfamily exists in other yeast species and filamentous fungi 
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(Goto, 2007; Olson et al., 2007; Kriangkripipat & Momany, 2009). The PMT1 subfamily is so 
far fungi-specific whereas in animals only unique members of the PMT2 (POMT2) and PMT4 
(POMT1) subfamilies are present (Jurado et al., 1999; Willer et al., 2002; Lommel & Strahl, 
2009). 
 
Figure 1.2. Phylogeny within the PMT family. 
ClustalW-based analysis of PMT protein sequenc-
es (J. D. Thompson et al., 1994). Af, A. fumigatus; 
Cg, C. glutamicum; Dm, D. melanogaster; Dr, Dan-
io rerio; Gg, Gallus gallus; Hs, Homo sapiens; Mm, 
Mus musculus; Mt, M. tuberculosis; Sc, S. cere-
visiae; Sp, S. pombe. Taken from (Lommel & 
Strahl, 2009). 
 
 
 
 
PMTs work forming protein complexes that include members from different PMT subfami-
lies and/or within the same family. In yeast members of the PMT1 subfamily (Pmt1 and 
Pmt5) form heteromeric complexes with members of the PMT2 subfamily (Pmt2 and Pmt3) 
whereas Pmt4 is shown to form homomeric complexes. 
Preferentially the Pmt1-Pmt2 and Pmt3-Pmt5 complexes coexist with the Pmt4-Pmt4 com-
plex. However, upon the deletion of their cognate partners, Pmt1-Pmt3 and Pmt2-Pmt5 in-
teractions have been demonstrated (Girrbach & Strahl, 2003). The formation of these com-
plexes has been shown to be necessary for full in vitro activity (Tanner et al., 1995) and there 
is no direct evidence of functional PMT monomers.  
Similar to the OST complex, there is evidence of O-mannosylation working co-translationally 
at least to some extent: First, radioactively labeled mannose is found in the polysome frac-
tion of the cell (Larriba et al., 1976); and second, direct interaction with the Sec61 translocon 
has been proven both in vivo and in vitro (Loibl et al., 2014). This, however, cannot be gen-
erally extended to all scenarios since when translocation has been already completed, pro-
longed and inefficient folding of proteins seems to be a trigger for the so-called unfolded 
protein O-mannosylation (see 1.4.2; C. Xu et al., 2013).  
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As mentioned above, O-mannosylation is a vital process. Combined deletion of PMT1, PMT2 
and PMT4 results in cell death, however single deletion of any member of the PMT family 
does not show phenotypes besides the formation of cell clumps likely linked to defects in 
the cell wall composition. Combination of several deletions is also viable although results in 
a thermosensitive phenotype (pmt1pmt4, pmt2pmt3, pmt1pmt2pmt3, pmt1pmt3pmt4) or 
growth only upon osmotic stabilization (pmt2pmt3, pmt2pmt4, pmt1pmt2pmt3) (Immervoll 
et al., 1995; Gentzsch & Tanner, 1996). The Pmt3-5 complex is thought to have overlapping 
functions with the Pmt1-Pmt2 complex (Girrbach & Strahl, 2003), however a clear effect of 
its deletion on O-mannosylated proteins analyzed in vivo has been milder, only present in 
combination with deletion of Pmt1/Pmt2 or even not observable at all (Gentzsch & Tanner, 
1997; Proszynski et al., 2004; Petkova et al., 2012). No physical interaction with other Pmts 
has been shown for Pmt6 (Girrbach & Strahl, 2003). Taken together this led to the assump-
tion that Pmt3, Pmt5, and Pmt6 are minor contributors to the overall O-mannose glycopro-
teome. In line with this, there is no phenotype associated with pmt356Δ, which is indistin-
guishable from wild type at least under the conditions tested (M. Loibl, unpublished data). 
Still, dissection of the O-mannose glycoproteome into each PMT member’s contribution re-
mains to be addressed. 
1.3 The ER quality control of secretory proteins 
 
Rapidly after synthesis, proteins undergo a folding process in which polypeptides adopt a 
3D-dimensional structure necessary to perform their function. The functional structure of a 
protein is referred to as the native conformation, and it is achieved by the interplay of the 
thermodynamic context and local folding factors that work independently in the cytosol, the 
ER and mitochondria (reviewed in Hartl & Martin, 1995). 
In the ER a set of members of the Hsp70 chaperone family (Kar2 and Lhs1) and Hsp40 co-
chaperones (Jem1 and Scj1), the nucleotide-exchange factor Sil1, lectin-like proteins such as 
Cne1 and thiol oxidoreductases (Eps1, Eug1, Mpd1, Mpd2, and Pdi1) assist folding of poly-
peptides (reviewed in Thibault & Ng, 2012) while and after they are translocated into the 
lumen (Whitley et al., 1996; reviewed in Fedorov & Baldwin, 1997; and Kowarik et al., 2002). 
All these factors bind or interact with newly synthesized proteins keeping them soluble, pre-
venting aggregation, ensuring the formation of correct disulfide bonds and stabilizing other-
wise unstable structures that would result in incorrect folding. This process requires high 
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fidelity since incorrect folding results in most cases in loss of protein function, linked to 
severe diseases such as Alzheimer’s or Parkinson's disease (reviewed in Selkoe, 2003). The 
diverse mechanisms in charge of assisting and monitoring protein folding as well as 
removing those secretory proteins that irreversibly fail to achieve the native conformation 
are referred to as ER protein quality control (ERQC) mechanisms. 
1.3.1 The endoplasmic reticulum associated degradation (ERAD) pathway  
 
ERAD refers to a molecular pathway occurring in the ER that monitors the correct folding of 
secretory proteins and targets them to proteasomal degradation when misfolding defects 
are detected (reviewed in (Ismail & Ng, 2006; Thibault & Ng, 2012). The initial step of ERAD 
is the recognition and discrimination among different classes of proteins based on their 
folding state: First, proteins within the folding cycle are protected from premature 
degradation (Zhang et al., 2017); second, properly folded proteins are normally packaged 
into coat complex protein II (COPII) vesicles to the Golgi based on sequence-based export 
signals or kept in the ER when they bear ER retention signals (reviewed in Dancourt & 
Barlowe, 2010); finally, misfolded proteins are prevented from further trafficking and 
eventually degraded.  In the third case, after recognition misfolded proteins are targeted to 
the ER membrane where retro-translocation in the cytosol occurs through a still unknown 
membrane channel with the aid of the Cdc48p AAA-ATPase complex. At the cytosolic side of 
the ER membrane, E2 ubiquitin-conjugating enzymes and E3 ligases mark misfolded proteins 
with ubiquitin, which determines the final degradation by the 26S proteasome (reviewed in 
Thibault & Ng, 2012). 
In yeast, two main protein complexes define the ERAD system and are named based on the 
E3 ligase integrated into each complex: Hrd1 and Doa10. Each complex acts on different 
classes of misfolded protein grouped according to the topological domain of the protein that 
presents the misfolded region. Soluble proteins and transmembrane proteins presenting 
luminal misfolded regions are targeted to the so-called ERAD-L, associated with the function 
of the Hrd1 complex. Hrd1 is also responsible for the disposal of membrane proteins with 
aberrant transmembrane domains as part of the ERAD-M pathway. Finally, membrane 
proteins presenting lesions in their cytosolic domains are targeted to the ERAD-C pathway, 
represented by the Doa10 complex (Carvalho et al., 2010).  
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The biochemical reconstitution of both ERAD complexes showed a large overlapping in 
components as well as some unique features (Gauss et al., 2006; Denic et al., 2006; Carvalho 
et al., 2006). As part of the complex, the Doa10 E3 ligase interacts with the E2 dimer 
Ubc7/Cue1 and Cdc48 and its cofactors Npl1 and Ufd1 which get recruited by the bridging 
factor Ubx2. The Hrd1 complex also includes Cdc48-Npl1-Ufd1 but is in general much more 
diverse. Hrd3, Der1, Usa1, and Yos9 (see below) define the core components assembled with 
Hrd1 for ERAD-L. On the other hand, for ERAD-M only Hrd1 and Hrd3 seem to be required. 
The molecular basis of the substrate recognition is clearer for the Hrd1 complex. As 
developed in 1.4.1, the lectin Yos9 is responsible for the recognition of aberrant 
N-glycoproteins (Cormier et al., 2005) and it interacts with Kar2 and Hrd3, also capable of 
binding misfolded proteins (S. I. Nishikawa et al., 2001; Gauss et al., 2006; Denic et al., 2006) 
likely constituting the luminal core that monitors folding and recognizes misfolded proteins. 
How the Doa10 complex selects ERAD-C substrates is still unknown. 
1.3.2 Post-ER quality control 
 
ER Quality control mechanisms are able to distinguish those proteins that are correctly 
folded and should generally move on the secretory pathway from those that did not 
complete the folding cycle yet, retaining them in the ER and potentially sending them for 
degradation. What are the determinants to make the decision are not entirely clear, 
although the prolonged engagement with chaperones or the presence of yet hydrophobic 
segments seem to favor ER retention and eventual degradation, whereas the display of 
folded ER export signals favors trafficking to the Golgi apparatus via COPII vesicles (reviewed 
in M. C. S. Lee et al., 2004; Dancourt & Barlowe, 2010). Although way less characterized, 
there are exceptions to these rules since some misfolded proteins are able to escape the ER 
quality control mechanisms towards the Golgi apparatus (Vashist et al., 2001; Kincaid & 
Cooper, 2007; reviewed in Dancourt & Barlowe, 2009; Wang & Ng, 2010) and in some cases 
be diverted to the vacuole for degradation (Spear & Ng, 2003; Coughlan et al., 2004). 
Vacuolar degradation has been also described for protein aggregates that reach the vacuole 
by the autophagy pathway (S. I. Nishikawa et al., 2001; Ishida & Nagata, 2009). This 
alternative pathway to remove aberrant proteins is referred to as post-ER quality control 
and is suggested to assist the ER quality control mechanisms when these get saturated 
(Spear & Ng, 2003). However, the mechanisms underlying the sorting of misfolded proteins 
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for vacuolar turnover and its occasional prevalence over ERAD is not characterized in detail 
yet. 
1.3.3 The unfolded protein response (UPR) 
 
In the context of ER protein homeostasis, the different protein quality control mechanisms 
coordinate each other to ensure precise and efficient protein production. 
Generally, ER stress causes an unbalance between the folding requirements and the capacity 
of the ER quality control mechanisms, thereby resulting in the accumulation of misfolded 
proteins. In this scenario, eukaryotic cells have evolved a compensatory mechanism to adapt 
the protein folding capacity of the ER to an increasing demand for folding factors named the 
unfolded protein response (UPR). Adaptation to stress is achieved by transcriptional 
upregulation of ER-chaperones, glycosyltransferases, genes involved in lipid biosynthesis and 
the ERAD machinery (Travers et al., 2000). In metazoans, the UPR also drives selective mRNA 
degradation and translational attenuation (Harding et al., 1999; Hollien & Weissman, 2006). 
In yeast, the activation of the UPR is solely driven by the type I transmembrane protein Ire1, 
which is the only member of the UPR conserved in all eukaryotes. Upon sensing of ER stress, 
Ire1 oligomerizes on its N-terminal luminal domain and undergoes trans-
autophosphorylation through its cytosolic kinase domain (Kimata et al., 2007; Korennykh et 
al., 2009; Pincus et al., 2010). Upon activation, the cytosolic ribonuclease domain of Ire1 
cleaves the intron of HAC1 mRNA in an unconventional splicing reaction (Cox et al., 1993; 
Mori et al., 1993; Cox & Walter, 1996). HAC1 mRNA exons are then ligated by a tRNA ligase 
and final mRNA is translated into a bZIP transcription factor that upregulates the expression 
quality control-related genes (Sidrauski et al., 1996; Travers et al., 2000). 
Oligomerization of Ire1 in high-order clusters has been shown to be necessary for full RNase 
activity (Korennykh et al., 2009; Li et al., 2010). The first step of Ire1 oligomerization is 
thought to be the formation of dimers that assemble into high-order oligomers by the 
nucleotide-binding domain of the kinase (K. P. K. Lee et al., 2008; Korennykh et al., 2009). 
Phosphorylation seems to directly affect Ire1 deactivation (Rubio et al., 2011), which is 
important since the maintenance of the UPR for prolonged time compromises cell viability 
(Chawla et al., 2011). 
Ire1’s sensing of unfolded proteins was though for a long time to rely on the binding of the 
Hsp70 chaperone Kar2 which dissociates in the presence of unfolded proteins, facilitating 
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Ire1 oligomerization and activation (Dorner et al., 1992; Kohno et al., 1993; Shamu et al., 
1994). More recently, a second mechanism based on the crystal structure of the luminal 
domain of Ire1 proposed that Ire1 has the capacity to bind unfolded peptides by the 
formation of a ligand-binding groove (Credle et al., 2005). Further studies have shown that 
the luminal domain of Ire1 is actually dispensable for Ire1 activation (Oikawa et al., 2007) 
and direct evidence of interaction with unfolded proteins in vivo and in vitro have been 
shown  (Kimata et al., 2007). Similar to Kar2, Ire1 interacts preferentially with regions 
containing basic and hydrophobic residues. This is the case of CPY*, a misfolded protein 
model shown to interact with Ire1 even when Ire1 carries mutations that prevent 
oligomerization (Gardner & Walter, 2011; Promlek et al., 2011). 
Today it is accepted that direct interaction with unfolded proteins is the main driving force 
for Ire1 oligomerization and activation. Kar2 association to Ire1 is however thought to 
stabilize inactive Ire1 monomers, preventing hypersensitivity to modest stress levels and 
buffering its function (Kimata et al., 2004; Pincus et al., 2010). 
In general, conditions that result in the stabilization of high-order Ire1 oligomers are thought 
to contribute to Ire1 activation. This is the case of altered lipid composition of the ER 
membrane (Promlek et al., 2011), suggested to decrease membrane protein diffusion. Also, 
ligand binding to Ire1’s cytosolic domain has been shown to activate the UPR by stabilization 
of Ire1 dimers (Wiseman et al., 2010).  
1.4 Protein quality control meets protein glycosylation 
1.4.1 Quality control of N-glycoproteins 
 
After the transfer of the core N-glycan to the target protein in the ER lumen, glucosidases 
Gls1 and Gls2 trim terminal glucose residues of the A- branch of the glycan as a checkpoint 
for protein degradation (Hammond et al., 1994; Hitt & Wolf, 2004). This step has been well 
characterized in mammals and referees as the calnexin cycle, where trimming of terminal 
glucoses works as a determinant for prolonged cycles of folding and are terminated by re-
glucosylation (Trombetta & Helenius, 2000; Solda et al., 2007). In baker’s yeast, however, 
the role of calnexin is yet not well understood (McCracken & Brodsky, 1996).  
In S. cerevisiae after folding of the glycoprotein is accomplished, subsequent trimming of a 
terminal mannose from B- and C-branches of the core N-glycan by the mannosidases Mns1 
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and Htm1 define a protein degradation signal recognized by the lectin Yos9 (Jakob et al., 
1998; Quan et al., 2008). Discriminating between the signal for protein degradation on 
terminal mannoses from those that are displayed during the synthesis of the core glycan is 
likely accomplished by the interplay of other folding factors such as Kar2 and Pdi1. This 
assumption is based on the fact that α-1,6-linked mannose is not solely recruiting Htm1 and 
also unfolded segments on the protein need to be exposed (Clerc et al., 2009; Gauss et al., 
2011). In terms of protein quality control, the different reactions that precede Htm1 
recruitment define a time frame in which the polypeptide undergoes folding. In this context, 
the resulting structure of the core N-glycan functions as a timer thought to determine when 
the folding cycle of proteins must cease, and the defective protein must undergo ERAD. 
1.4.2 The so-called unfolded protein O-mannosylation (UPOM) 
 
In the last two decades, protein O-mannosylation has been suggested to play a role in 
folding or quality control of secretory proteins in an increasing number of studies. The 
branch of O-mannosylation that targets misfolded proteins during or as part of their quality 
control has been recently named unfolded protein O-mannosylation (UPOM) (C. Xu et al., 
2013).  
The term UPOM is based on the analysis of misfolded model proteins, either artificial 
recombinant constructs or truncations of endogenous proteins that are not targets of this 
modification in their native state. The first study reporting this phenomenon was published 
in 2001 by the Römisch group using a mutated version of the yeast pheromone precursor 
pre pro-alpha-factor Δgpαf (Harty et al., 2001). Δgpαf lacks N-glycosylation acceptor sites of 
the native pre pro-alpha-factor (Mayinger & Meyer, 1993) and is consequently misfolded 
and targeted for ERAD (McCracken & Brodsky, 1996). Harty and colleagues showed that 
Δgpαf is O-mannosylated by Pmt2 after synthesis in vitro and in vivo. Based on in vitro 
experiments using yeast microsomes they determined that this type of O-mannosylation is a 
slow process, suggesting that it might occur post-translationally as a result of prolonged 
exposure of the substrate to PMTs (Harty et al., 2001). Following this first study, several 
misfolded protein models of diverse nature and topology have been shown to receive 
O-mannosylation by the Pmt1-Pmt2 complex (Vashist et al., 2001; Coughlan et al., 2004; 
Nakatsukasa et al., 2004; Hirayama et al., 2008; S. Y. Li et al., 2012; Rubenstein et al., 2012; 
C. Xu et al., 2013). However, the molecular basis of this modification is far from being clear.  
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For some model protein UPOM was shown to reduce their engagement with the ER 
chaperone Kar2 (Nakatsukasa et al., 2004; C. Xu et al., 2013), suggesting that 
O-mannosylation might work as a fail-safe mechanism to relieve the workload for ER 
chaperones and irreversibly mark either irreversibly misfolded proteins (Nakatsukasa et al., 
2004) or proteins that fold very inefficiently (C. Xu et al., 2013).  
Of particular relevance is the case of ER-GFP, the latest discovered UPOM target to date. GFP 
was long known to fold poorly when targeted to the ER of either yeast or mammalian cells 
(Jain et al., 2001; D. G. Huang & Shusta, 2006). Xu and colleagues found out that ER-GFP 
becomes a target of the Pmt1-Pmt2 complex as a consequence of its poor folding kinetics in 
the oxidative environment of the ER (Aronson et al., 2011; C. Xu et al., 2013). In contrast, the 
kinetically engineered version of GFP, sfGFP or as referred to in this and the current work, 
ER-GFPfast, is able to skip O-mannosylation. When genetically deleting PMT1 and/or PMT2, 
ER-GFP becomes folding competent, suggesting that UPOM prevents futile folding (and 
worthless investment of resources) of slow folding proteins that could otherwise overwhelm 
the ER folding capacity. Thus, UPOM targets ER-GFP depending on its folding state and 
provides a time window in which proteins are able to fold before being irreversibly excluded 
from the folding cycle. This hypothesis seems to be conceptually similar to what shown for 
the quality control of N-glycoproteins, where trimming of terminal mannoses from the core 
N-glycan by Htm1 recruits ERAD components for effective degradation (Gauss et al., 2011; 
see 1.4.1).  
On the contrary, UPOM does appear to be directly coupled to any specific degradation 
pathway and the final fate of proteins that undergo UPOM is diverse. On one hand, UPOM is 
shown to be a determinant for ERAD of several misfolded protein models. This is the case of 
KHN, the ER-targeted simian virus 5 haemagglutinin neuraminidase (KHN) (Vashist et al., 
2001), a pro-region-deleted derivative of Rhizopus niveus aspartic proteinase-I (Δpro) 
(Nakatsukasa et al., 2004) or the A-chain of Shiga-like toxin (S. Li et al., 2012). One common 
feature of the ERAD targets that receive O-mannosylation for their degradation is their 
capacity to form aggregates in the absence of Pmt1 or Pmt2. It is accepted that the addition 
of O-glycans to these misfolded protein models increases their solubility and therefore 
facilitates their recognition and extraction from the ER by the ERAD pathway (S. Nishikawa et 
al., 2001; Vashist et al., 2001; Nakatsukasa et al., 2004). The effect of O-mannosylation 
promoting ERAD of misfolded proteins is, however, not a common feature of all 
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O-mannosylated ERAD substrates. Some misfolded models receive O-mannosylation 
presumably during their quality control without their degradation efficiency being affected 
when O-mannosylation is compromised. This is the case for models such as the before 
mentioned N-glycosylation mutant of the pre pro-alpha-factor (Harty et al., 2001; 
Nakatsukasa et al., 2004) or the ER membrane protein Sec62 appended with the Deg1 
degron (Rubenstein et al., 2012) or ER-GFP (C. Xu et al., 2013). On the other hand, the 
deletion of Pmt1 or Pmt2 has been reported to influence the O-mannosylation of different 
misfolded versions of the GPI-anchored protein Gas1, redirecting them from ERAD to post-
ER degradation at the vacuole (Hirayama et al., 2008). 
1.4.3 The impact of O-glycans on protein stability 
 
Besides its role in contributing to the degradation of some misfolded protein models, 
O-mannosylation is also known to play an opposing role in maintaining the stability of bona 
fide proteins. Abrogating O-mannosylation by both the Pmt1-Pmt2, and the Pmt4-Pmt4 
complex impacts on the maturation and severely reduces the stability of the plasma 
membrane sensors of the cell wall integrity: Wsc1, Wsc2, Mid2, and Mtl1 (Lommel et al., 
2004; De La Torre Ruiz et al., 2012). This, in turn, results in impaired sensing of cell wall 
defects and activation of the cell wall integrity pathway. A similar effect is observed in the 
human pathogen Candida albicans for Sec20, an ER membrane protein that functions as a 
tSNARE component in retrograde vesicle traffic and displays maturation defects and 
decreased stability upon perturbation of O-mannosylation (Ernst et al., 2004). Another 
example is Axl2, a glycoprotein necessary for yeast axial budding shown to require Pmt4-
dependent O-mannosylation for correct maturation. In the absence of PMT4, Axl2 is shown 
to be unstable and incorrectly localized to the vacuole (Roemer et al., 1996; Sanders et al., 
1999). 
 
1.4.4 State of the art: the many gaps in UPOM  
 
One of the many aspects that remain elusive is how the Pmt1-Pmt2 complex targets 
misfolded proteins. During UPOM, the Pmt1-Pmt2 complex is able to select and discriminate 
proteins bearing unfolded segments from those that are properly folded. It is plausible that 
  
25 
such a mechanism could involve additional factors recruiting potential UPOM targets to the 
Pmt1-Pmt2 complex. Analysis of Pmt1 and Pmt2 interactome by mass spectrometry (Goder 
& Melero, 2011) yielded potential candidates to fulfill this function such as members of the 
p24 family, the oxidoreductases Ero1 and Pdi1 and even the central E3 ligase of ERAD Hrd1. 
Additional clues on potential interactors between the Pmt1-Pmt2 complex and misfolded 
proteins are provided by the sequence of PMTs itself. PMTs include three MIR motifs that 
share homology with SDF2-type proteins (stromal cell-derived factor 2), poorly characterized 
ER proteins present in mammals and plants that are known to interact with Hsp40 ER 
chaperones (Meunier et al., 2002). Therefore, in analogy to SDF2, PMTs might interact via 
loop7 with members of the Hsp40 chaperone family to recruit substrates for UPOM. 
In contrast, in the case of ER-GFP UPOM seems to respond to a timing mechanism in which 
prevalence in the folding cycle works as a determinant for recruitment to the Pmt1-Pmt2 
complex (C. Xu et al., 2013). In a scenario where the Pmt1-Pmt2 complex works as a timer, 
additional factors are not strictly needed since only abnormally prolonged exposure of 
unfolded moieties would be sufficient to trigger UPOM. By extension, also other more 
drastically misfolded models that have been described could enter and exit the folding cycle 
based on the Pmt1-Pmt2 timing mechanism.  
Besides potential interactors, another aspect that remains to be answered is how UPOM is 
regulated. Previous high throughput studies have shown that O-mannosylation is integrated 
in the UPR (Travers et al., 2000; Promlek et al., 2011) and therefore it is likely that proteins 
involved in the ER stress response are tightly linked to UPOM. That is the case of HAC1 and 
the described lethality when deleted together with major PMTs (Arroyo et al., 2011). 
Likewise, upon treatment with the N-glycosylation inhibitor tunicamycin, many proteins 
receive O-glycans (Harty et al., 2001), indicating that ER stress favors UPOM of proteins that 
would not receive O-glycans otherwise. Is it then valid to assume that UPOM is only 
physiologically relevant upon ER stress when UPR is meant to restore ER homeostasis? 
Although it is not trivial to answer these questions, large scale analysis of both the 
transcriptome and the sensitivity to the PMT-specific inhibitor R3A-5a have shown signaling 
pathways such as cell wall integrity (CWI) pathway, filamentous growth or the mating 
cascade to be activated to compensate PMT loss or reduction in activity (Arroyo et al., 2011; 
Zatorska et al., 2017). Even though these studies did not discriminate UPOM from 
O-mannosylation in general, they set the basis to speculate about PMTs contributing to the 
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ER quality control not only in the context of the ER stress. It is, therefore, a major purpose of 
this study to unravel which components function next to the Pmt1-Pmt2 complex in the so-
called UPOM, both being part of the molecular mechanism and orchestrating it perhaps as 
part of a regulon. 
 
To date, the existence of proteins that receive O-mannosylation during ER protein quality 
control is restricted to misfolded protein models, where damage is artificially introduced to 
trigger the activation of the different mechanisms that cope with the stress generated. The 
question of whether O-mannosylation targets endogenous proteins and facilitates their 
turnover, being or not, part of a quality control mechanism remains unanswered. One 
limitation that arises when studying O-mannosylation in the context of protein quality 
control is the presence of opposing effects in protein stability (detailed in 1.4.2 and 1.4.3). 
Besides the potential role of this modification facilitating protein turnover, O-mannosylation 
is necessary for maturation of secretory proteins and deletion of the corresponding PMTs is 
shown to cause protein destabilization (Sanders et al., 1999; Lommel et al., 2004). 
Moreover, the effect of the high degree of redundancy and substrate specificity among the 
different O-mannosyl transferases limits the study of protein stability to specific 
physiological processes and down to individual proteins. Therefore, it is a goal of the current 
work to obtain a broader view of the consequences of O-mannosylation defects in protein 
stability by taking advantage of more systematic approaches. 
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2 MATERIALS 
2.1 Microorganisms 
2.1.1 Escherichia coli strains 
Strain Genotype Reference 
DH5α [F– φ80lacZΔM15 Δ(lacZYA-argF)U169] recA1 
endA1 hsdR17(rK
–, mK
+) phoA supE44 λ– thi-1 
gyrA96 relA1 
(Bethesda 
Laboratories, 1986) 
XL1-Blue recA1 endA1 gyrA96 thi-1  hsdR17 supE44 relA1 
lac [F´ proAB lacIqZΔM15 Tn10 (Tetr)] 
(Bullock et al., 1987) 
 
2.1.2 Saccharomyces cerevisiae strains 
Yeast strains directly derived from genetic libraries appear underlined. 
Strain Genotype Reference 
BY4741 
MATa met15-Δ0 his3-Δ1 leu2-Δ0 ura3-
Δ0 
(Brachmann et al., 
1998) 
SEY6210 
MAT lys2-801  his3-200  leu2-3,112  
trp1-901 ura3-52  suc2-9 
(Robinson et al., 
1988) 
MLY213 BY4741 except pmt1Δ 
M. Loibl 
(unpublished) 
MLY214 BY4741 except pmt2Δ 
M. Loibl 
(unpublished) 
MLY216 BY4741 except pmt4Δ 
M. Loibl 
(unpublished) 
MLY231 BY4741 except pmt356Δ 
M. Loibl 
(unpublished) 
MLY235 BY4741 except pmt1356Δ 
M. Loibl 
(unpublished) 
MLY241 BY4741 except pmt4356Δ 
M. Loibl 
(unpublished) 
JCY001 BY4741 except ade8::4xUPRE-GFP This study 
JCY002 MLY213 except ade8::4xUPRE-GFP This study 
JCY003 MLY214 except ade8::4xUPRE-GFP This study 
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JCY004 MLY216 except ade8::4xUPRE-GFP This study 
JCY005 MLY231 except ade8::4xUPRE-GFP This study 
JCY006 MLY235 except ade8::4xUPRE-GFP This study 
JCY007 MLY241 except ade8::4xUPRE-GFP This study 
YMS721 
MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
can1Δ::STE2pr-spHIS5 lyp1::STE3pr-
LEU2 
(Papic et al., 2013) 
JEY05 YMS721 hoΔ:: ER-GFPf-URA3 
Jakob Engel 
(unpublished) 
JEY06 YMS721 hoΔ:: ER-GFP-URA3 
Jakob Engel 
(unpublished) 
JCY010 JEY06 except pmt1Δ::KanMX4 This study 
JCY011 JEY06 except pmt2Δ::KanMX4 This study 
JCY012 JEY06 except pmt4Δ::KanMX4 This study 
pep4Δ BY4741 except pep4Δ::KanMX4 Euroscarf  
spf1Δ BY4741 except spf1Δ::KanMX4 Euroscarf  
pmt1Δ BY4741 except pmt1Δ::KanMX4 Euroscarf  
pmt2Δ BY4741 except pmt2Δ::KanMX4 Euroscarf  
ost3Δ BY4741 except pmt2Δ::KanMX4 Euroscarf  
bfr1Δ BY4741 except bfr1Δ::KanMX4 Euroscarf  
pop2Δ BY4741 except pop2Δ::KanMX4 Euroscarf  
psa1-DAmP ER-GFP JEY06 except psa1Δ::psa1-DAmP This study 
pgi1-DAmP ER-GFP JEY06 except pgi1Δ::pgi1-DAmP This study 
bfr1Δ ER-GFP JEY06 except bfr1Δ::KanMX4 This study 
spf1Δ ER-GFP JEY06 except spf1Δ::KanMX4 This study 
JCY015 BY4741 except psa1Δ::psa1-DAmP This study 
JCY014 BY4741 except pgi1Δ::pgi1-DAmP This study 
JCY016 JEY06 except bfr1Δ::KanMX4 This study 
JCY017 BY4741 except bfr1Δ::BFR1-3xHA This study 
JCY033 MLY214 except pgi1Δ::pgi1-DAmP This study 
MLY014 
SEY6210 except PMT2-GAGA-HA3-
kanMX6 
M. Loibl 
(unpublished) 
MLY098 
MLY74 except klTRP1-PGAL1-UBI4-R-
PMT2 
M. Loibl 
(unpublished) 
JCY034 MLY098 except bfr1Δ::URA3 This study 
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MLY201 BY4741 except pmt1Δ::KANMX6 
M. Loibl 
(unpublished) 
MLY202 BY4741 except pmt2Δ::KANMX6 
M. Loibl 
(unpublished) 
MLY204 BY4741 except pmt4Δ::KANMX6 
M. Loibl 
(unpublished) 
YMaM330 
MATα can1Δ::STE2pr-SpHIS5 
lyp1Δ::STE3pr-LEU2 his3Δ1 
leu2Δ0::GAL1pr-I-SCEI-natNT2 ura3Δ0 
(Khmelinskii et al., 
2014) 
WT Kre6-tFT YMaM330 except KRE6::mCherry-sfGFP 
(Khmelinskii et al., 
2014) 
EZY91 WT Kre6-tFT except pmt1Δ::KANMX6 
This study (Castells-
Ballester et al., 2018) 
WT Vrg4-tFT YMaM330 except VRG4::mCherry-sfGFP 
(Khmelinskii et al., 
2014) 
EYZ96 WT Vrg4-tFT except pmt1Δ::KANMX6 
This study (Castells-
Ballester et al., 2018) 
WT Axl2-tFT YMaM330 except AXL2::mCherry-sfGFP 
(Khmelinskii et al., 
2014) 
EZY107 WT Axl2-tFT except pmt4Δ 
This study (Castells-
Ballester et al., 2018) 
WT YNL058C-tFT 
YMaM330 except YNL058C::mCherry-
sfGFP 
(Khmelinskii et al., 
2014) 
EZY106 WT YNL058C-tFT except pmt2Δ 
This study (Castells-
Ballester et al., 2018) 
WT Mnn11-tFT 
YMaM330 except MNN11::mCherry-
sfGFP 
(Khmelinskii et al., 
2014) 
EZY109 WT Mnn11-tFT except pmt4Δ 
This study (Castells-
Ballester et al., 2018) 
MGY69 AXL2::HA (Sanders et al., 1999) 
MGY72 AXL2::HA except pmt4Δ (Sanders et al., 1999) 
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2.1.3 Sacharomyces cerevisiae genetic libraries 
 
Name Description Purpose Reference 
Yeast 
deletion 
library 
BY4741-based 
Single gene replacement with 
KanMX6 
ER-GFP screen. 
Automated crossing 
with JEY06 
(Giaever et al., 
2002) 
DAmP 
library 
BY4741-based 
3′UTR disruption by KanMX6 
insertion 
ER-GFP screen. 
Automated crossing 
with JEY06 
(Breslow et al., 
2008) 
Euroscarf 
BY4741-based 
Single gene replacement with 
KanMX6 
Hsp150-based re-
screen 
Euroscarf 
(Frankfurt, 
Germany) 
tFT library 
YMaM330-based 
N-terminal fusions of tFT 
tFT screen 
Automated crossing 
with MLY201, 
MLY202, and 
MLY204. 
(Khmelinskii et 
al., 2014) 
2.2 Plasmids 
 
Name Description Purpose Reference 
pPN001 
Ori, bla, URA3 
UPRE-GFP from pDEP017 via 
NotI/KpnI in pIS112 
Integration of 
ade8::4xUPRE-GFP 
 
P. Neubert 
(unpublished) 
pPN014 
Ori, CEN, PTDH3-ER-GFP-
3xFLAG-HDEL 
ER-GFP-3xFLAG 
purification 
P.Neubert 
(unpublished) 
pWX204 
ori, CEN, PTDH3-Kar2SS-ER-
GFPf-HDEL, URA3 
ER-GFPf expression 
(C. Xu et al., 
2013) 
pWX206 
ori, CEN, PTDH3-Kar2SS-ER -
GFP-HDEL, URA3 
ER-GFP expression 
(C. Xu et al., 
2013) 
pJC07 
ori, CEN, PTDH3-Kar2SS-ER -
GFPf, URA3 
HDEL removal by subcloning 
and reinsertion in pWX204 
via BamHI-XbaI 
ER-GFP expression This study 
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pJC08 
ori, CEN, PTDH3-Kar2SS-ER -
GFP, URA3 
HDEL removal by subcloning 
and reinsertion in pWX206 
via BamHI-XbaI 
ER-GFP expression This study 
pJC01 
ori, bla, 2µ, PMT2, LEU2 
PMT2 fragment from pVG76 
(Girrbach & Strahl, 2003) 
subcloned into pRS425 via 
SalI/PstI 
Template for pJC09 This study 
pJC02 
ori, bla, 2µ, PMT2, HIS3 
PMT2-3xHA fragment from 
pEZ43 subcloned into pRS423 
via SalI/SmaI 
Template for pJC10 This study 
pRS41N ori, CEN, natNT2 
Backbone for 
pJC09/10 
(Taxis & Knop, 
2006) 
pJC09 
ori, CEN, natNT2 
PMT2 fragment from pJC01 
subcloned into pRS41N via 
ApaI/SpeI 
Expression of PMT2 This study 
pJC10 
ori, CEN, natNT2 
PMT2-3xHA fragment from 
pJC02 subcloned into pRS41N 
via ApaI/SpeI 
Expression of PMT2-
3xHA 
This study 
pRS415 ori, bla, LEU2 Backbone for pJC16 
(Christianson et 
al., 1992) 
pJC16 
ori, CEN, PTDH3-Kar2SS-ER -
GFP-HDEL, LEU2 
PTDH3-Kar2SS-ER -GFP-HDEL 
subcloned from pWX206 into 
pRS416 via NotI/SalI 
ER-GFP expression This study 
pUG6 ori, bla, kanMX4 
template for loxP-
kanMX4-loxP 
cassette 
(Güldener et al., 
1996) 
pJH24 ori, bla, 2µ, URA3, kanMX6 
template for C-
terminal 3xHA 
tagging 
Hutzler (2008) 
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2.3 Oligonucleotides 
All oligonucleotides were purchased from Sigma-Aldrich Chemie (Munich, Germany) in dry 
form and dissolved in ddH2O to a final concentration of 100 μM. Stock solutions were diluted 
to a final 10 pmol/μl working concentration. 
2.3.1 RT-PCR oligonucleotides 
All oligonucleotides described in this list have Tm between 60 and 61 °C.  
 
Name Description Sequence (5’-3’) 
2262 ACT1 FW CCACCATGTTCCCAGGTATTGC 
2263 ACT1 REV GATAGAACCACCAATCCAGACGGAG 
2244 TAF10 FW ATATTCCAGGATCAGGTCTTCCGTAGC 
2245 TAF10 REV GTAGTCTTCTCATTCTGTTGATGTTGTTGTTG 
2246 TFC1 FW GCTGGCACTCATATCTTATCGTTTCACAATG 
2247 TFC1 TEV GAACCTGCTGTCAATACCGCCTGGAG 
2230 PMT1 FW AAATCGCAGTGGTTGTCTGGTTGG 
2231 PMT1 REV TAGTGGCGGCAGGTTGAGATTC 
2232 PMT2 FW GTACTGTTTCGACGCCGGTTTG 
2233 PMT2 REV AGTGCCATGAATCCGGCGTATAG 
2236 PMT4 FW AGTTGGCCCGGTAGTTTAAGTGG 
2237 PMT4 REV TGACTTGGAACCACCACCCAATG 
2264 HAC1u FW TGAACAAGAACACTAGCCCCA 
2272 HAC1u REV ACTCCCCCATCAGAGAACCAC 
2266 HAC1s FW AATTTGTTTGATGCGGTGGCCTC 
2267 HAC1s REV CCTGACTGCGCTTCTGGATTACG 
2290 KAR2 FW ACCGCCATTGCTGAAGACTTTG 
2291 KAR2 REV AGAACCATCAGCACCTCCGTAC 
2872 PGI1 FW GGAATATCAACTCTTTCGACCAATGG 
2873 PGI1 REV GTTGGTAGAAGCATCGTGGGTAGAA 
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2892 PSA1 FW GCAACTCCACCATCAAGAACCA 
2893 PSA1 REV ACAGTGACACCTTCCAAACGAC 
2930 BFR1 FW TACAAGAAGAAGAACCAACAGAAGAACACT 
2931 BFR1 REV TTCGGCCAAAGTAGCAATTAGTGTT 
2.3.2 Other oligonucleotides 
Sequences homologous to the indicated ORFs within oligos used for genomic modifications 
appear underlined. 
 
Name Description Sequence (5’-3’) 
2283 
Genotype 4xUPRE-GFP strains 
ADE8 5’ FW 
AGCAGCGCCTAACTACGACC 
2284 
Genotype 4xUPRE-GFP strains 
ADE8 5’ REV 
CTTGTTTGTCGTTATGGTTGGCCT 
2285 
Genotype 4xUPRE-GFP strains 
URA3 FW 
TAGAAGACGTTCAACTGTCGAGACC 
2286 
Genotype 4xUPRE-GFP strains 
URA3 REV 
CCATTTGGGCCTTCTGCTTCC 
2287 
Genotype 4xUPRE-GFP strains 
GFP FW 
CTTCTGCTTGTTGTTGCTGCTGT 
2288 
Genotype 4xUPRE-GFP strains 
GFP REV 
GAGAAAGCAAGGCACAACGCA 
2722 
Genotype KANMX6 genomic 
insertions REV 
CTGCAGCGAGGAGCCGTAAT 
2804 Genotype bfr1Δ Upstream 5’ GTAATTCGCATTTTATCTCGAACAT 
2805 Genotype bfr1Δ coding GTCTTTTGTCGTAAACACCTTGAGT 
2810 
BFR1 knockout via pUG6 as 
template for KanMX6 
substitution FW 
CCTCCTTTTATCAACGTAATAGCATATTTTCTA
ACAACACAGCCATTGCCCAGCTGAAGCTTCGT
ACGC 
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2811 
BFR1 knockout via pUG6 as 
template for KanMX6 
substitution REV 
AATTAAGTAATGAAGAAAGATCAGGAGAAAA
ATTTTTTTCTACTTCAGGTGCATAGGCCACTA
GTGGATCTG 
2822 
HDEL removal from 
pWXB204/206 to generate 
pJC07/08 FW 
AAGGATCCAAGAGTAGTCTCAAGGGAA 
2823 
HDEL removal from 
pWXB204/206 to generate 
pJC07/08 REV 
CGATCTAGAAAGCTTATTTGTATAGTTCATCC
ATGCCATGTGT 
2840 Genotype bfr1Δ coding FW ATGTCCTCCCAACAACACAAGTTCAA 
2841 Genotype bfr1Δ coding REV TTTCAGACTCTTCCTGTTCTTTCAATC 
2872 Genotype pgi1-DAmP FW GGAATATCAACTCTTTCGACCAATGG 
2873 Genotype pgi1-DAmP REV GTTGGTAGAAGCATCGTGGGTAGAA 
2874 Genotype pgi1-DAmP 3’ TATGTCCTTCGCGCACTGATTC 
2892 Genotype psa1-DAmP FW GCAACTCCACCATCAAGAACCA 
2893 Genotype psa1-DAmP REV ACAGTGACACCTTCCAAACGAC 
2894 Genotype psa1-DAmP 3’ CTCAGGCTACCACCAATAACACAG 
2885 
BFR1 3xHA genomic tag via 
pJH24 template FW 
AAGAAAAAAGATTGAAAGAACAGGAAGAGT
CTGAAAAAGATAAAGAAAATGGAGCAGGGG
CGGGTGCATACCCATACGATGTTCCTGACTAT
GC 
2886 
BFR1 3xHA genomic tag via 
pJH24 template FW 
TCAACCAAAGAAAAATTAAGTAATGAAGAAA
GATCAGGAGAAAAATTTTTCCCTCACTAAAG
GGAACAAAAGCT 
3102 
BFR1 knockout via pRS416 as 
template for URA3 substitution 
FW 
CCTCCTTTTATCAACGTAATAGCATATTTTCTA
ACAACACAGCCATTGCCACCACAGCTTTTCAA
TTCAATTCATCATTT 
3103 
BFR1 knockout via pRS416 as 
template for URA3 substitution 
REV 
AATTAAGTAATGAAGAAAGATCAGGAGAAAA
ATTTTTTTCTACTTCAGGTAACAACACTCAACC
CTATCTCGGTCTAT 
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2.4 Antibodies 
2.4.1 Primary antibodies 
 
Name Description Reference 
Pmt1 Rabbit, 1:2,500 (Strahl-Bolsinger & Tanner, 1991) 
Pmt2 Rabbit, 1:2,500 (Gentzsch et al., 1995) 
Pmt4 Rabbit, 1:250 (Girrbach & Strahl, 2003) 
Hsp150 Rabbit, 1:5,000 (Russo et al., 1992) 
Sec61 Rabbit, 1:2,500 (Stirling et al., 1992) 
HA Mouse, 1:10,000, 16B12 #MMS-101R; Covance (Princeton, NJ, USA) 
Gas1 Rabbit, 1:2,500 (Popolo et al., 1988) 
Wbp1 Rabbit, 1:2,500 (te Heesen et al., 1993) 
Kar2 Rabbit, 1:500 Strahl lab 
Ost3 Rabbit 1:1,000 Gift from M.Aebi 
G6PDH Rabbit, 1:5,000 
# A9521; Sigma-Aldrich Chemie (Munich, 
Germany) 
GFP Rabbit; 1:5,000 #13970; Abcam, Cambridge, UK 
GFP Rabbit; 1:2,500 
#A6455; Thermo Fisher Scientific (Waltham, 
MA, USA) 
Rpl5 Rabbit 1:7,000 Gift from E. Hurt 
Pgk1 Mouse, 1:10,000 #A6457; Mobitec (Gottingen, Germany) 
 
2.4.2 Secondary antibodies 
 
Name Description Reference 
mouseHRP Rabbit, 1:10,000, HRP conjugate #A9044, Sigma-Aldrich 
rabbitHRP Goat, 1:10,000, HRP conjugate #12-348, Sigma-Aldrich 
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2.5 Databases, web Services and Software 
2.5.1 Databases 
 
NCBI http://www.ncbi.nlm.nih.gov/ 
Uniprot https://www.uniprot.org/ 
SGD http://www.yeastgenome.org/ 
YEASTRACT (Teixeira et al., 2018) 
http://www.yeastract.com/ 
YETFASCO 1.02 (de Boer & Hughes, 2012) 
http://yetfasco.ccbr.utoronto.ca/ 
SPELL https://spell.yeastgenome.org 
DAVID https://david.ncifcrf.gov/ 
2.5.2 Web services 
 
ExPASy http://expasy.org/ 
TOPCONS http://topcons.cbr.su.se/ (Bernsel et al., 2009) 
2.5.3 Software 
 
DNA sequence analysis ApE – A plasmid Editor (by M. Wayne Davis) 
Image processing Adobe: Illustrator CS5, Photoshop CS4  
Image analysis ImageJ (Schneider et al., 2012) 
Western blot quantification Image Studio Lite 
RT-PCR analysis Rotor-Gene Q series software (Qiagen; Venlo, 
Netherlands) 
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2.6 Services 
 
Oligonucleotide synthesis Sigma-Aldrich (Steinheim, Germany) 
DNA sequencing eurofins mwg|operon (Hamburg, Germany) 
 
Flow cytometry Flow Cytometry & FACS Core Facility, ZMBH 
(Heidelberg University; Germany) 
 
  
38 
  
  
39 
3 METHODS 
3.1 Microbiology 
3.1.1 Cultivation of Escherichia coli 
 
Bacterial cultures were grown overnight at 37 °C in liquid LB medium with shaking at 200 
rpm or on LB plates containing 2% (w/v) agar. For selection, the medium was supplemented 
with 100 µg/mL ampicillin. 
For long-term storage, bacterial cells were grown in liquid LB medium supplemented with 
100 µg/mL ampicillin overnight at 37 °C. Cultures were supplemented with 20 % (v/v) 
glycerol, frozen in liquid nitrogen and stored at -80 °C. 
LB medium: 
1 % (w/v) Tryptone 
1 % (w/v) NaCl 
0.5 % (w/v) Yeast extract 
 
3.1.2 Cultivation of Saccharomyces cerevisiae 
 
Yeast cultures were routinely grown overnight in YPD/SD liquid medium with 200 rpm 
shaking or until complete growth on plates containing 2% (w/v) agar at 30 °C. The cell 
density of liquid cultures was determined as the optical density at 600 nm (OD600) using the 
spectrophotometer UltrospecTM 3100 pro (GE Healthcare, Munich, Germany). 
For general procedures yeast cells were grown to saturation in the corresponding medium, 
reinoculated in fresh medium, grown from 5h to 12h and harvested at mid-log phase (YPD: 
OD600 0.5 - 1.5; SD: OD600 0.4 - 1) by centrifugation (5 min at 3,000 gav).  
For short term storage yeast cells were kept as a saturated liquid culture and/or on agar 
plates with the corresponding medium at 4 °C up to 3 or 6 weeks, respectively. For long term 
storage yeast cells were grown overnight to saturation, supplemented with 20 % (v/v) 
glycerol, frozen in liquid nitrogen and stored at -80 °C.  
For auxotrophic selection, the corresponding amino acids were excluded from SD medium. 
For antibiotic-based selection, liquid cultures or agar-containing plates were supplemented 
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with either 400 µg/mL Geneticin (#11811-031, Invitrogen; Waltham, MA, USA) or 100 mg/L 
nourseothricin (#96736 -11-7, ClonNAT; Werner BioAgents, Jena-Cospeda, Germany). 
 
YPD medium  d.o. medium 
1 % (w/v) yeast extract  0.67 % (w/v) YNB 
2 % (w/v)  peptone  0.134 % (w/v) d.o. mix  
(-Ade/-His /Leu/Lys/Trp/Ura) 
(-His /Leu/Lys/Trp/Ura) 
2 % (w/v)  glucose  0.002 % (w/v) His/Trp/Ura/Ade 
   0.01 % (w/v) Leu 
   0.003 % (w/v) Lys 
   2 % (w/v) Glucose 
3.1.3 Spotting assay  
 
Cells were routinary grown to mid-log phase in the corresponding medium at 30 °C with 200 
rpm shaking, harvested by centrifugation 3 min at 3,000 gav and resuspended in 1 ml ddH2O. 
3 µL of initial concentration and of five serial tenfold dilutions were spotted on solid medium 
and grown in standard conditions. Solid medium plates containing chemicals when 
necessary were freshly prepared before the experiment. 
3.2 Molecular Biology 
3.2.1 Isolation of plasmid DNA from E. coli 
 
For plasmid verification, plasmid DNA was isolated from bacterial cultures by the Easy Prep 
protocol. In brief, 3 mL of overnight culture were pelleted by 1 min centrifugation at 20,000 
gav. The cells were resuspended in 40 µL of Easy Prep buffer and heated for 2 min at 95 °C. 
Next, the samples were chilled on ice for 2 min and centrifuged for 15 min at 20,000 gav. 2 to 
4 µL of obtained supernatant were used for plasmid verification by the corresponding 
restriction endonuclease reaction. 
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Easy Prep buffer: 
10 mM Tris-HCl pH 8.0 
1 mM EDTA pH 8.0 
15 % (w/v) Sucrose 
0.2 % (w/v) Lysozyme (#L6876, Sigma-Aldrich Chemie; Munich, Germany) 
0.02 % (w/v) RNase A (#A3832, AppliChem; Omaha, NE, USA) 
0.01 % (w/v) BSA (#A5611, Sigma-Aldrich Chemie; Munich, Germany) 
 
For either transformation or further cloning procedures, plasmid DNA was isolated with the 
GeneJET Miniprep Kit (#K0702, Thermo Fisher Scientific; Waltham, MA, USA) or 
NucleoBond® Xtra Midi (#740410, Macherey-Nagel; Düren, Germany) according to the 
manufacturer’s indications. 
3.2.2 Isolation of genomic DNA from S. cerevisiae for PCR-based applications 
 
Genomic DNA was retrieved from yeast cells following the method described in Looke et al., 
2011. In brief, a toothpick-tip amount of yeast cells scratched from the agar plate was 
resuspended in 100 µL of lysis solution, vigorously vortexed and incubated at 70 °C for 5 min. 
300 µL of ethanol was added and samples were vortexed and centrifuged 3 min at 15,000 
gav. Pellets were washed with 0.5 mL of 70 % ethanol, centrifuged 3 min at 15,000 gav and 
resuspended in 100 µL of TE buffer. Samples were incubated at RT for 5 min and centrifuged 
1 min at 15,000 gav to remove cell debris. The supernatant containing genomic DNA was 
transferred to a fresh tube and stored at 4 °C for short-term or -20 °C for long-term, 
respectively. 
 
Lysis solution:    TE buffer: 
200 mM LiOAc   10 mM       Tris-HCl pH 8.0 
1 % (w/v) SDS   1 mM       EDTA pH 8.0 
 
3.2.3 Isolation of total RNA from S. cerevisiae 
 
Cells were grown to mid-log phase in the corresponding selective medium at 30 °C with 200 
rpm shacking. Ice-cold NaN3 was added to a final concentration of 100 - 200 mM and 5 OD600 
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units were harvested by centrifugation 5 min at 3,000 gav. Total RNA was isolated using the 
Universal RNA Purification Kit (ROBOKLON GMBH, Berlin, Germany) according to the 
manufacturer’s indications.  
For spheroplast generation prior to cell lysis, lyticase (#L2524 Sigma-Aldrich Chemie; Munich, 
Germany) was added to the corresponding buffer. When indicated during the protocol, 
RNase-free DNase (#M6101, Promega; Madison, WI, USA) was added to the RNA binding 
columns and incubated at RT for 10 min. For representative sets of samples, total RNA 
integrity was checked by agarose gel electrophoresis. 
3.2.4 cDNA synthesis 
 
First-strand cDNA was prepared from 2 µg of total RNA template in 20 ml final volume by 
oligo(dT)18 amplification using the First Strand cDNA Kit (#K1622, Thermo Fisher Scientific, 
Bonn, Germany), and following the recommendations of the manufacturer. 
3.2.5 Determination of nucleic acid concentrations 
 
DNA and RNA concentrations were measured at 260 nm using the NanoDrop 2000 (Peqlab, 
Erlangen, Germany). 
 
3.2.6 Agarose gel electrophoresis 
 
DNA or total RNA were analyzed on 1 % agarose (#16500500, Thermo Fisher Scientific; 
Waltham, MA, USA) gels prepared in TBE buffer and containing ~0.2 µg/mL of ethidium 
bromide. The gel was run in TBE buffer at 8 V/cm until the desired separation was reached. 
When necessary, samples were mixed with DNA or RNA loading dye (#R0611, Thermo Fisher 
Scientific; Waltham, MA, USA; Strahl lab, respectively) prior to loading. GeneRuler DNA 
Ladder Mix (#SM0332, Thermo Fisher Scientific; Waltham, MA, USA) was used as a size 
reference. 
For cloning purposes, DNA fragments were purified from agarose gels using DNA the 
GeneJETTM Gel Extraction Kit from Fermentas (#K0692). 
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TBE buffer:      
90 mM Tris base    
90 mM Boric acid   
2 mM EDTA pH 8.0    
3.2.7 Polymerase chain reaction (PCR) 
 
PCR was performed using the thermocycler T3000 from Biometra (Göttingen, Germany).  
DreamTaq DNA Polymerase Green PCR Master Mix (#K1081, Thermo Fisher Scientific) was 
used for analytical PCR. All reactions were optimized according to oligonucleotide length and 
oligonucleotide Tm. As standard 20 µL reaction contained 10 ng of plasmid DNA or 1% (v/v) 
of gDNA prepared as described in 3.2.2. Primers were added to a final concentration of 0.5 
µM. 
Standard DreamTaq PCR program 
Step 
T 
[°C] 
Time N° of cycles 
Initial 
denaturation 
95 3 min - 
Denaturation 95 30 s 
30 
Annealing Tm 30 s 
Elongation 72 
15-30 
s/kb 
Final elongation 72 7 min - 
 
Phusion High-Fidelity DNA Polymerase (#F530, Thermo Fisher Scientific; Waltham, MA, USA) 
was used for preparative PCR to obtain DNA fragments for cloning or genomic manipulation. 
All reactions were optimized according to the following criteria: oligonucleotide length, 
oligonucleotide Tm, MgCl2 concentration and supplied buffer selection (HF or GC). As a 
standard 50 µL reaction contained 10 ng plasmid DNA or 50-100 ng genomic DNA, 1x 
concentrated HF/GC reaction buffer, 0.25 µM final concentration of each primer, 200 µM 
final concentration of each dNTP (#110012, Bioron; Ludwigshafen, Germany), 0.02 U/µL of 
Phusion High-Fidelity DNA Polymerase and 2mM MgCl2. 
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Standard Phusion PCR program 
Step T [°C] Time N° of cycles 
Initial 
denaturation 
98 3 min - 
Denaturation 98 30 s 
30 Annealing Tm 30 s 
Elongation 72 1 min/kb 
Final elongation 72 10 min - 
 
Two-step Phusion PCR program 
Step T [°C] Time N° of cycles 
Initial 
denaturation 
98 3 min - 
Denaturation 98 30 s 
5 Annealing Tm 30 s 
Elongation 72 1 min/kb 
Denaturation 98 30 s 
30-35 
Elongation 72 1 min/kb 
Final elongation 72 10 min 1 
 
3.2.8 DNA purification 
 
Purification of DNA fragments was performed using the GeneJET PCR purification Kit 
(#K0702, Thermo Fisher Scientific; Waltham, MA, USA), following the manufacturer’s 
instruction. 
3.2.9 Real-time Polymerase Chain Reaction (RT-PCR) 
 
Real-time qPCR assays were performed using the Rotor-Gene Q (Qiagen) PCR instrument. All 
reactions were performed using the qPCRBIO SYGreen Mix LO-ROX (#PB20.11, PCR 
Biosystems Ltd, London, UK). As a standard, 12.5 µL reaction contained 1x qPCRBIO SYGreen 
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Mix, 0.4 mM oligonucleotide pair and 1:20 dilution of cDNA template. As technical replicates 
as well as for determination of RT-PCR efficiency, 1:100 and 1:1000 cDNA dilutions were 
included. Only RT-PCR reactions with efficiencies ranging from 0.9 to 1.1 were considered.  
To quantify the abundance of HAC1u, oligos annealing on the HAC1 intron were designed 
(oligos 2264-2272, see 2.3.1). To quantify the abundance of HAC1s, oligo 2266 annealing 
upstream of the intron was used as the forward primer and oligo 2267, annealing on the 5’ 
of exon 1 and 3’ of exon 2 was used as the reverse primer. 
 
RT-PCR program 
Step T [°C] Time N° of cycles 
Initial 
denaturation 
95 
2 
min 
- 
Denaturation 95 5 s 
40 
Annealing 60 25 s 
Melt 
63 -> 95  
(+ 1 °C/step) 
10 
min 
- 
 
For calculation of either relative gene expression or fold-change in gene expression, both 
standard curve-based and 2-ΔΔCt methods were used, respectively, depending on the 
convenience of the output. Statistical analyses were based on three independent biological 
replicates: Two-tailed Student’s t-test on normalized expression values or one-tail Student’s 
t-test on log (2-ΔΔCt) were performed for relative gene expression or fold-change in gene 
expression, respectively. 
 
3.2.10 Molecular cloning procedures 
 
All DNA manipulations were performed according to Sambrook & Russel, 2001 and the 
manufacturer’s instructions. 
Endonuclease digestion was carried out with restriction enzymes purchased from either New 
England Biolabs (NEB, Frankfurt/Main, Germany) or Thermo Fisher Scientific (Fast digest 
endonucleases, Waltham, MA, USA) according to manufacturer’s instructions. When 
necessary, DNA fragments were dephosphorylated using FastAP Thermosensitive Alkaline 
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Phosphatase (#EF0651, Thermo Fisher Scientific; Waltham, MA, USA) following the 
manufacturer’s instructions. When necessary, the blunting of DNA overhangs was 
performed using T4 DNA Polymerase (#EP0061, Thermo Fisher Scientific; Waltham, MA, 
USA) according to the manufacturer’s instructions. Ligation of DNA fragments was 
performed using T4 DNA Ligase (#EL0011, Thermo Fisher Scientific; Waltham, MA, USA). A 
standard 10 µL reaction contained 2 - 3 U of T4 DNA Ligase. For ligation of cohesive or blunt 
overhangs, vector and insert were mixed in 1.3 or 1:1 molar ratio, respectively. The ligation 
reaction was routinely performed for either 1h at RT or overnight at 4 °C. 
3.2.11 Transformation of E. coli 
 
Chemically competent E. coli cells were prepared according to Inoue et al., 1990. 100 µl 
aliquots were frozen in liquid nitrogen and stored at -80 °C.  
For the transformation 100 µl aliquots were thawed and incubated for 10 min on ice.  
10 - 100 ng of purified DNA was added to the cells and incubated for 30 min on ice. Heat 
shock was performed at 42 °C for 60 – 90 seconds and samples were quickly transferred to 
ice. Once chilled, cells were recovered by adding 700 - 900 µL of LB medium and incubating 
for 30 min. After recovery cells were pelleted by centrifugation and plated on selective solid 
LB medium. For the transformation of DNA ligation products, 5 µl of ligation reaction mix 
was used. 
 
3.2.12 Transformation of S. cerevisiae genomic modification of S. cerevisiae 
 
All yeast transformations were performed in sterile conditions according to Gietz et al., 1995 
with some modifications. To generate yeast competent cells 10 ml overnight liquid culture 
was diluted to OD600 of 0.3 – 0.4 (approximately 50 ml) in the corresponding medium and 
grown for 3 – 6h at 30 °C with 200 rpm agitation. Cells equivalent to 0.5 - 1 OD600 were 
harvested by centrifugation 5 min at 1,500 – 3,000 gav, washed with TE buffer, resuspended 
in 1 ml LiAc/TE buffer and incubated 10 – 30 at RT. Next, cells were pelleted and 
resuspended in a final volume of 50µl LiAc/TE buffer. 
In parallel, DNA transformation mix was prepared by mixing transforming DNA (0.5 – 1 µg 
plasmid DNA or 5 – 10 µg of purified linear DNA) and 50 – 100 ng of salmon sperm DNA 
carrier (#201190, Agilent Technologies; Santa Clara, CA, USA) previously boiled for 5 min at 
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95 °C in a total of 10 µl TE buffer. DNA transformation mix was added to the competent 
yeast suspension together with 300 µl of LiAc/40%PEG-3350/TE and the solution was mixed 
by pipette action. Samples were incubated 30 min at 30 °C with agitation. Heat shock was 
performed for 15-20 min at 42 °C. Cells were collected by centrifugation 5 min at 3,000 gav 
washed with TE buffer and resuspended in 100 µl of either TE buffer or ddH2O. Cells were 
plated onto the appropriate selective solid medium in two serial 1:10 dilutions to facilitate 
the pickup of the future colonies. 
As an optional step to increase transformation efficiency, 44 µl of DMSO was added to the 
cell suspension and mixed by pipette action prior to the heat shock. 
For antibiotic-based selection, after the heat shock and before transferring them to selective 
medium, cells were recovered in YPD medium for 2 - 3h at 30 °C with agitation. 
 
TE-LiAc:  TE-LiAc-PEG: 
100 mM  LiAc 100 mM  LiAc 
10 mM  Tris-HCl pH 8.0 10 mM  Tris-HCl pH 8.0 
1 mM  EDTA pH 8.0 1 mM  EDTA pH 8.0 
 40 % (w/v)  PEG 3350 
 
3.2.13 Genomic modification of S. cerevisiae 
 
Yeast genomic modifications were performed based on homologous recombination 
(Longtine et al., 1998). Integrative cassettes for knockout, knockdown or for HA-genomic 
tagging were generated by Phusion PCR using pJUG6, genomic DNA or pJH24 as a template 
as described in 3.2.7. Oligonucleotides contained 50 – 60 bp 5’ and 3’ homologous 
sequences to the target genomic locus. PCR fragments were purified after agarose gel 
electrophoresis. For the generation of UPRE-GFP strains, the PN001 integrative vector was 
linearized via KpnI/NotI endonuclease digestion and purified as described in 3.2.8.  
The transformation of linear DNA fragments was performed as described in 3.2.12 and 
optimized for every single case.  
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3.3 Synthetic genetic array (SGA) procedures 
3.3.1 ER-GFP screening and data analyses 
 
These experiments were performed by Lihi Gal in the frame of a collaboration with the 
group of Prof. Maya Schuldiner (Weizmann Institute of Science, Rehovot, Israel). 
 
To create the collection of haploid strains containing the ER-GFP reporter on the background 
of all yeast mutants, the starting query strain JEY06 expressing ER-GFP was generated on the 
basis of an SGA compatible strain, YMS721 (Papic et al., 2013).  
The yeast deletion library (Giaever et al., 2002) and the DAmP library (Breslow et al., 2008) 
were crossed with the query strain JEY06 on 1536-colony format plates using a RoToR bench 
top colony arrayer (Singer Instruments, Somerset, UK) following SGA methodology described 
in (Cohen & Schuldiner, 2011) and (Tong & Boone, 2006). In brief, genetic libraries and JEY06 
were mated on YPD plates and the resulting diploids were selected for both deletion/DaMP 
libraries and ER-GFP markers; KanR and URA3, respectively. Sporulation was induced by 
transferring cells to nitrogen starvation media plates for 7 days. Haploid cells containing the 
desired mutations were selected by transferring cells to SD-plates with the above selections 
for both genetic alterations alongside the toxic amino acid derivatives canavanine and 
thialysine (Sigma-Aldrich) to select against remaining diploids, and lacking histidine to select 
for spores with an A mating type. 
The haploid collection carrying both the deletion/hypomorphic allele and ER-GFP was 
visualized using an automated microscopy setup described in Breker et al., 2013. In brief, 
cells were transferred from agar plates into 384-well polystyrene plates for growth in liquid 
media using the RoToR arrayer robot. Liquid cultures were grown in a LiCONiC incubator 
(LiCONiC instruments, Liechtenstein) overnight at 30 °C in SD medium. A JANUS liquid 
handler (PerkinElmer; Waltham, MA, USA) connected to the incubator was used to dilute the 
strains to an OD600 of ~0.2 into plates containing SD. Plates were incubated at 30 °C for 4 h. 
The cultures in the plates were then transferred by the liquid handler into glass-bottom 384-
well microscope plates (Matrical Bioscience; Spokane, WA, USA) coated with Concanavalin A 
(Sigma-Aldrich). After 20 minutes, wells were washed twice with SD-Riboflavin complete 
medium to remove non-adherent cells and to obtain a cell monolayer. The plates were then 
transferred to the ScanR automated inverted fluorescent microscope system (Olympus, 
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Shinjuku, Japan) using a robotic swap arm (Hamilton, Bonaduz, Switzerland). Images of cells 
in the 384-well plates were recorded in SD-Riboflavin complete medium at 24 °C at GFP 
(excitation at 490/20 nm, emission at 535/50 nm) channel using a 60x air lens (NA 0.9) and 
with an ORCA-ER charge-coupled device camera (Hamamatsu, Shizuoka, Japan). 
Analysis of ER-GFP intensity was performed using the Olympus ScanR analysis software. 
Images were preprocessed by background subtraction and segmentation was done with the 
brightfield images and a series of shape conditions were applied as filters. The median GFP 
intensity for each strain was measured from the remaining objects for each strain. Dead cells 
appear as high fluorescent outlier values and were removed with the ScanR software in an 
automated manner. Strains with an insufficient number of objects detected (<25) as well as 
contaminated strains were removed from the analyses. 
3.3.2 Tandem fluorescent protein timers screening and data analyses 
A subset of query strains from the tFT genetic library that were shown to be O-mannosylated 
(Neubert et al., 2016) were recorded to localize to the secretory pathway (by classification of 
translocation according to Ast et al., 2013 or inferred from high confidence/manual curated 
database annotations were selected from the library; App. Data 3) and crossed with MLY201 
(pmt1Δ), MLY202 (pmt2Δ) and MLY204 (pmt4Δ) on 1536-colony format plates using the 
ROTOR HDA pinning robot (Singer Instruments, Somerset, UK) following the SGA 
methodology described in Baryshnikova et al., 2010. In brief, both tFT queries and MLY201, 
MLY202, or MLY204 were mated, and the resulting diploids were selected, sporulated, and 
selected for haploids carrying both the tFT-tagged protein and the pmt deletion by 
sequential pinning followed by selection on appropriate media, as described in (Khmelinskii 
et al., 2014). Three technical replicates of each cross were arranged next to each other. 
Fluorescence intensities of the final colonies were measured after 24 h of growth on 
synthetic complete medium lacking leucine at 30 °C using Infinite M1000 Pro plate readers 
equipped with stackers for automated plate loading (Tecan, Männedorf, Switzerland) and 
custom temperature control chambers. Measurements in mCherry (587/10 nm excitation, 
610/10 nm emission, fixed detector gain) and sfGFP (488/10 nm excitation, 510/10 nm 
emission, fixed detector gain) channels were performed at 400 Hz frequency of the flash 
lamp, with ten flashes averaged for each measurement. 
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Failed crosses after haploid selection were excluded from the measurement based on colony 
size. For background correction, the fluorescence intensities of three negative control 
colonies arranged next to each sample were subtracted from the average of sample 
colonies. Fluorescence intensity measurements were log-transformed, and the data for each 
plate were normalized to the median fluorescence of a reference strain set that was present 
on every plate as described in Meurer et al., 2018. Changes in protein stability between wild-
type and mutant were estimated by subtracting the log-ratios of mCherry and sfGFP 
intensities, yielding a Δ-score. A moderated t-test implemented in the R package limma was 
used to compute p-values (R Development Core Team, 2017). Plots were generated using 
the ggplot2 (v2.2.1) package (Wickham, 2009). Data labels were introduced using functions 
of the ggrepel (v0.7.0) package (Slowikowski), and heatmaps were generated using the 
heatmap.2 function of the gplots (v3.0.1) package (Warnes). 
3.4 Protein Biochemistry 
3.4.1 Determination of protein concentrations 
 
Protein concentrations were measured with the DC protein assay (#500112, Bio-Rad; 
Hercules, CA, USA) in 96-well plate format according to the manufacturer’s instructions. BSA 
(#A5611, Sigma-Aldrich Chemie; Munich, Germany) was used for calibration. 
 
3.4.2 Preparation of total cell extracts and total membranes from S. cerevisiae 
To prepare total cell extracts, all procedures were performed on ice and/or at 4 °C. Cells 
were grown to mid-log phase in the corresponding selective medium at 30 °C with 200 rpm 
shacking. For end-point analyses or time-course experiments, ice-cold NaN3 was added to 
the culture to a final concentration of 100 - 200 mM. Cells equivalent to 10 or 20 OD600 were 
harvested by centrifugation 5 min at 3,000 gav, washed with ddH2O or breaking buffer and 
resuspended in 50 or 100 µl (for 10 and 20 OD600, respectively) of breaking buffer 
supplemented with protease inhibitors (1 mM PMSF, 1 mM benzamidine, 0.25 mM 1-chloro-
3-tosylamido-7-amino-2-heptanone, 50 μg/mL of l-1-tosylamido-2-phenylethyl chloromethyl 
ketone, 10 μg/mL of antipain, 1 μg/mL of leupeptin, and 1 μg/mL of pepstatin). Cell solution 
was transferred to a screw-cap tube and glass beads (ø 0.25 – 0.5 mm, #A553.1; Roth, 
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Karlsruhe, Germany) were added to reach 1 – 2 mm below the solution’s meninge. Cells 
were subjected to mechanic lysis using the Hybaid RiboLyser Homogenizer (Thermo 
Scientific, Bonn, Germany) in 4 rounds of 25 s at 4.5-speed level. After lysis, screw-cap tubes 
were punctuated with a needle and the suspension was transferred to a fresh tube by 
centrifugation 30 s – 1 min at 500 gav. To generate total cell extracts, cell debris was pelleted 
by centrifugation 5 min at 1,500 gav and supernatant was collected. To prepare total 
membranes, total cell extracts were centrifuged 1 h at 20,000 × gav. Membrane pellets were 
resuspended with the aid of a 0.3 mm syringe in an equivalent volume of membrane buffer 
supplemented with protease inhibitors (as described above). 
Breaking buffer:    Membrane buffer: 
50 mM Tris-HCl pH 7.4   20 mM  Tris-HCl pH 8.0 
5 mM MgCl2    10 mM  EDTA pH 8.0 
      15 % (v/v)  Glycerol 
3.4.3 Cycloheximide chase 
 
Cycloheximide chase experiments were performed as described in Tran & Brodsky, 2012. In 
brief, cells expressing the plasmid pJC08 were grown overnight in SD-URA medium at 30 °C 
to mid-log phase. Cells were initially sampled as time point zero, and cycloheximide was 
immediately added to a final concentration of 100 or 200 µM. Equal amounts of cells were 
sampled at the following time points: 15, 30, 60 and 120 min. After sampling, the chase was 
stopped at each time point by adding NaN3 to a final concentration of 20 mM, and cells were 
kept on ice until the last sample was collected. Total cell extracts were prepared from cells 
sampled at each time point as described in 3.4.2. 
 
3.4.4 Analysis of Hsp150 
 
Hsp150 analysis was performed as described in (Russo et al., 1992). In brief, yeast cells were 
grown to mid-log phase at 30 °C and 200 rpm shaking. Cells equivalent to 20 OD600 were 
harvested by centrifugation 5 min at 3,000 gav and resuspended in 100 µl of fresh YPD. Heat 
shock was performed for 1.5 h at 37 °C and cells were pelleted by centrifugation 5 min at 
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3,000 gav. 10 µl of the supernatant was transferred to a new tube and 5 µl of 3x Laemmli 
buffer was added prior to load in 8% SDS-PAGE (see 3.4.6). 
3.4.5 Immunoprecipitation of FLAG-tagged ER-GFP 
 
Cells expressing ER-GFP-3xFLAG (transformed with the plasmid pPN014) were grown in SD-
URA to mid-log phase at 30 °C and 200 rpm shaking. Cells equivalent to 20 OD600 were 
harvested by centrifugation 5 min at 3,000 gav. Total membrane preparation was performed 
as described in 3.4.2 with the following modifications: Centrifugation of total cell extracts to 
generate total membrane pellets was performed for 30 min at maximum speed (30,130 
gmax). Membrane pellets were resuspended in 200 µl of TBS buffer supplemented with 1 mM 
PMSF. For membrane solubilization, Triton X-100 was added to a final concentration of 1% 
(v/v) and samples were placed on a rotator mixer (#7-0045; Neolab, Heidelberg, Germany; 
Mode B4, 75rpm) for 10 min at RT. Next, to generate the immunoprecipitation input, 
samples were diluted 1:4 in TBS supplemented with 1mM PMSF (reaching a final Triton X-
100 concentration of 0.25% v/v) and centrifuged 15 min at 20,000 gav to remove 
insolubilized material. 
For immunoprecipitation, 100 µl of slurry anti-FLAG M2 magnetic beads (#M8823, Sigma-
Aldrich Chemie, Munich, Germany) were transferred to 2 ml low-binding tube (Sarstedt; 
Nümbrecht, Germany) and equilibrated with 3 x 5 min washing steps with 500 µl TBS 
supplemented with 0.25% Triton X-100 (v/v). Next, 100 µl of TBS 0.25% v/v Triton X-100 
supplemented with 1mM PMSF was added to the tube together with 200 µl 
immunoprecipitation input. The sample was incubated 4 h at 4 °C and the unbound fraction 
was collected. Beads were then washed three times using TBS 0.25% v/v Triton X-100 and 
the bound fraction was eluted by addition of FLAG peptide in TBS 0.25% v/v Triton X-100 to a 
final concentration 0.3 µg/µl and further incubation in the rotator mixer 1 h at 4 °C. ER-GFP 
presence in unbound and bound protein fractions was analyzed in 12% SDS-PAGE (see 3.4.6) 
followed by Western blot (see 3.4.7). 
TBS: 
150 mM NaCl 
50 mM  Tris-HCl pH 7.4 
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3.4.6 In vitro de-mannosylation of ER-GFP 
 
De-mannosylation of ER-GFP was carried out using (1-2,3,6)-mannosidase (#9025-42-7, 
Sigma-Aldrich Chemie; Munich, Germany) and the supplied buffer according to the 
manufacturer’s instructions. In brief, 10 or 20 µl of immunoprecipitated ER-GFP (see 3.4.4) 
was incubated overnight with 0.3 U of (1-2,3,6)-mannosidase at 37 °C. Mock treatment 
lacking (1-2,3,6)-mannosidase was performed in parallel. Both mock and enzyme-treated 
samples were analyzed in 12% SDS-PAGE followed by Western blot (see 3.4.6 and 3.4.7). 
3.4.7 SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was performed 
according to (Laemmli, 1970). In brief, protein fractions were denatured in the presence of 
Laemmli SDS-PAGE sample buffer for 10 min at 70 °C as standard with shaking at 1,000 rpm 
and separated on self-prepared 6 – 15 % glycine SDS polyacrylamide (PAA) gels. 
Electrophoresis was performed at 60 - 80 V for 30 min for the stacking gel and at 140 V for 
the resolving gel until complete run-off of the dye from Laemmli SDS-PAGE. 
 
Laemmli SDS-PAGE sample buffer: Running buffer: 
62.5 mM Tris-HCl pH 6.8 62.5 mM Tris-HCl pH 6.8 
10 % (v/v) Glycerol 10 % (v/v) Glycerol 
5 % (v/v) 2-Mercaptoethanol 5 % (v/v) 2-Mercaptoethanol 
2 % (w/v) SDS 2 % (w/v) SDS 
0.02 %(w/v)  bromophenol blue 0.02 %(w/v)  bromophenol blue 
 
 
   
4 % Stacking gel: 6 – 15 % Resolving gel:  
12.5 mM 37.5 mM Tris-HCl pH 6.8 
0.1 (w/v) 0.1 % (w/v) SDS 
4 % (w/v) 6 – 15 % (w/v) Acrylamide/Bis-acrylamide (37.5:1) 
0.1 % (w/v) 0.1 % (w/v) APS 
0.15 % (v/v) 0.1 % (v/v) TEMED 
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3.4.8 Colloidal Coomassie staining 
 
Coomassie staining of polyacrylamide gels was performed according to Kang et al., 2002. In 
brief, gels resulting from SDS-PAA electrophoresis were rinsed twice with ddH2O incubated 
overnight in Coomassie solution (5 % Al2SO43 · 18 H2O, 10 % EtOH, 0.02 % Coomassie-G250, 
2 % ortho-H2PO4). Gels were then destained in ddH2O until completion.  
 
3.4.9 Western blot/ immunoblot analysis 
 
Proteins were transferred from PAA gel to a nitrocellulose membrane (#RPN203D, GE 
Healthcare; Chicago, IL, USA) at 100 V for 60 min in transfer buffer including an ice-cold 
cooler. Transfer efficiency was monitored by the presence of the protein marker and 
confirmed by reversible ponceau staining. As standard, membranes were blocked with TBST 
(TBS with 0.1% Tween 20, see 3.4.5)– 5% milk powder buffer for 15 – 30 min at RT. 
The primary antibody was added in the corresponding dilution (see 2.4.1) to TBST – 5% milk 
powder and incubated either at RT for 1 – 2 h or overnight at 4 °C (depending on the 
convenience of the output). Membranes were then washed three times 10 – 15 min with 
TBST at RT and secondary antibodies were added and subsequently incubated 1 h at RT. 
Prior to detection, membranes were washed 2 – 3 times 10 min with TBST. 
Protein-antibody complexes were detected using ECL Prime Western Blotting Detection 
Reagent (#RPN2232, GE Healthcare; Chicago, IL, USA) and imager ImageQuant LAS 4000 (GE 
Healthcare; Chicago, IL, USA). 
 
Transfer buffer: Ponceau S solution: 
150 mM Glycine 3 % (w/v) TCA 
20 mM  Tris base 3 % (w/v) Sulfosalicylic acid 
20 % (v/v) Methanol  0.2 % (w/v) Ponceau S 
0.02 % (w/v) SDS  
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3.5 Cell biology 
3.5.1 Cell fractionation coupled to RNA preparation. 
 Cell fractionation by 1-step ultracentrifugation 
3.5.1.1
To fractionate cells into soluble and total membrane fraction the method described in 2.5.2 
was adapted to the purpose of extracting total mRNA from each fraction as described in 
Aronov et al., 2013 and Kraut-Cohen et al., 2013. Cells were grown to mid-log phase in the 
corresponding medium at 30 °C with 200 rpm shaking. Cycloheximide was added to the 
cultures to a final concentration of 100 µg/ml and cells were further grown for 15 min.  Cells 
equivalent to 20 OD600 were harvested by centrifugation 5 min at 3,000 gav, washed with ice-
cold SK buffer and incubated 5 min on ice. Cells were pelleted by centrifugation 3 min at 500 
gav, resuspended in 250 µl BRS buffer supplemented with protease inhibitors as described in 
2.5.2 and transferred to a screw-tap tube. Cell lysis was performed after adding glass beads 
(see 2.5.2) using the Hybaid RiboLyser Homogenizer in 5 rounds of 35 s at 4.5-speed level. 
After lysis, screw-cap tubes were punctuated with a needle and the suspension was 
transferred to a fresh tube by centrifugation 30 s – 1 min at 500 gav. To generate total cell 
extracts, cell debris was pelleted by centrifugation 10 min at 1,000 gav and supernatant was 
collected. 200 µl of total cell extracts were fractionated by ultracentrifugation (rotor TLA-
100.4, Beckman, Indianapolis, IN, USA) at 48,000 gav, resulting in the soluble fraction 
(supernatant) and membrane pellet. Next, membrane pellets were resuspended in 400 - 500 
µl BMRS buffer with the aid of a 0.3 mm syringe and ultracentrifugation was repeated using 
the same settings. Final membrane pellets were resuspended in 200 µl BMRS buffer. To 
confirm the successful separation of soluble and total membrane fractions, 1 µl of each was 
used for SDS-PAGE and immunodetection of Sec61 and G6PDH as described in 3.4.7 and 
3.4.9. Total RNA was prepared from 100 µl of each cell fractions using the Universal RNA 
Purification Kit (ROBOKLON GMBH, Berlin, Germany) according to manufacturer’s 
indications for purification of RNA from molecular biological reactions or from buffer 
solutions (Appendix 3 of the user’s manual) 
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BMRS buffer is prepared as BRS buffer except it contains80 U/ml Rnasin ribonuclease 
inhibitor. 
 Cell fractionation by sucrose step-gradient centrifugation 
3.5.1.2
 
This method is adapted from Aronov et al., 2013 and Kraut-Cohen et al., 2013. Cells were 
grown to mid-log phase in YPD at 30 °C with 200 rpm shaking. Cells equivalent to 300 OD600 
were harvested by centrifugation 5 min at 2,500 - 3,000 gav, washed with ice-cold SK buffer 
and incubated 5 min on ice. Cells were pelleted by centrifugation 5 min at 2,500 gav, 
resuspended in 1.2 ml lysis buffer supplemented with protease inhibitors as described in 
3.4.2, transferred to a screw-tap tube and lysed with the Hybaid RiboLyser Homogenizer in 4 
rounds of 45 s at 4.5-speed level. Total cell extracts were prepared as in 3.5.1.1. 
900 µl of total cell extracts were transferred to a fresh tube and diluted with lysis buffer 
supplemented with protease inhibitors to 2 ml final volume. 
In parallel, a discontinuous sucrose gradient was freshly prepared by adding 3 ml of 1.5 M 
and 1.2 M sucrose buffer layers on top of a 2 M sucrose cushion as shown in figure 4.29A. 
SK buffer: 
1.2 M Sorbitol 
0.1 M   KPO4 ph 7.5 
100 µg/ml
  
Cycloheximide (freshly added) 
BRS buffer: 
50 mM Tris-HCl ph 7.6 
150 mM NaCl 
250 mM  Sorbitol 
30 mM MgCl2 
200 U/ml Rnasin ribonuclease inhibitor (#N2511, Promega; Madison, WI, USA) 
(freshly added) 
100 µg/ml
  
Cycloheximide (freshly added) 
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Total cell extract was loaded on top of the gradient and centrifuged 2.5 h at 232,000 gmax in 
a TST14.41 swinging rotor. Gradients were then manually fractionated in 0.5 ml fractions. To 
analyze protein content on selected fractions they were diluted 1:4 in sucrose-base buffer 
(10mM Tris-HCl ph 7.5, 150 mM KCl 10mM MgCl2) and 5 µl were used for SDS-PAGE and 
immunodetection as described in 3.4.7 and 3.4.9. Total RNA was isolated from 300 µl of 
selected fractions as described in 2.6.1.1. 
 
Lysis buffer 
10 mM Tris-HCl ph 7.5 
0.25 M Sucrose 
30 mM MgCl2 
1 mM DTT 
200 U/ml RNasin ribonuclease inhibitor (#N2511, Promega; Madison, WI, USA) 
(freshly added) 
100 µg/ml Cycloheximide (freshly added) 
 
Sucrose buffer 
10 mM Tris-HCl ph 7.5 
X Sucrose 
150 mM KCl 
10 mM MgCl2 
 
X: Concentration of sucrose in each fraction is described in the text. 
3.5.2 Microscopy 
 
Cells were routinely grown to mid-log phase in the corresponding medium at 30 °C with 200 
rpm shaking. Microscopy was performed on standard glass plates adjusting the number of 
cells to the desired density. For end-point analyses, NaN3 was added to the culture prior to 
sampling to a final concentration of 10 mM. 
Yeast strains expressing UPRE-GFP or ER-GFP were viewed by using an LSM510-Meta 
confocal microscope (Carl Zeiss, Jena, Germany) with either ×100 or x40 PlanApochromat 
objective (numerical aperture 1.4). The fluorescence signal of GFP (excitation 488 nm, Ar 
laser) was detected by using a bandpass emission filter 505–530 nm. Single plane images 
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were taken using identical conditions per experiment and are presented without undergoing 
processing steps. 
Cells expressing tFT-fusion proteins were grown to the mid-log phase in synthetic complete 
medium. Prior to imaging, cells were treated with the vital dye 7-amino-4-
chloromethylcoumarin (CMAC, #C2110 Thermo Fischer) to a concentration of 10 µM to stain 
the lumen of yeast vacuoles. After 15 min incubation at 30 °C, cells were washed once and 
resuspended in fresh medium. Single plane images were acquired on a Delta Vision Elite 
system (Applied Precision, Issaquah, WA, USA) consisting of an inverted epifluorescence 
microscope (IX71; Olympus, Tokio, Japan) equipped with an LED light engine (SpectraX, 
Lumencor, Beaverton, OR, USA), 390/18-, 475/28- and 575/25-nm excitation and 435/48-, 
525/50- and 624/40-nm emission filters (Semrock, Rochester, NY, USA), a dual-band beam 
splitter 89021 (Chroma Technology, Bellows Falls, VT, USA), using either a 100× NA 1.4 
UPlanSApo or a 60× NA 1.42 Plan ApoN oil immersion objective (Olympus), an sCMOS 
camera (pco.edge 4.2, PCO), and a motorized stage contained in a temperature-controlled 
chamber. Image processing and quality control were performed using ImageJ. sfGFP, as well 
as mCherry images obtained for wild-type and corresponding pmtΔ mutant, were processed 
in the same manner. 
3.5.3 Flow cytometry 
 
Cells expressing ER-GFP or tFT-fusion proteins were grown to the mid-log phase in the 
corresponding medium at 30 °C. The fluorescence intensities of 20,000 cells were measured 
in the appropriate channel using the cell analyzer BD FACSCanto™ (BD Biosciences; 
Heidelberg, Germany), in collaboration with Flow Cytometry & FACS Core Facility (ZMBH, 
Heidelberg University; Heidelberg, Germany).  
For strains expressing ER-GFP background fluorescence was routinely measured by analyzing 
cells not expressing the fluorescent protein in parallel and subtracted the obtained values. 
To estimate the representativeness of the positive events over the whole population, 
fluorescence intensity was multiplied by the percentage of positive cells, obtaining an R 
value. R values of mutant strains were normalized to RWT and plotted as fold-change. One tail 
student’s t-test was applied to obtain the statistical significance of the changes in R. 
To define the age of a certain tFT-fusion protein, a first ratio mCherry/sfGFP was calculated 
for both wild-type and pmtΔ mutant based on the intensity of all measured events, and the 
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corresponding p-value was calculated using Student’s t-test and considering the null 
hypothesis as no showing difference between variances of each dataset. To address the 
impact of the deletion on protein age, a second ratio was calculated as 
WTmCherry/sfGFP/pmtΔmCherry/sfGFP. 
3.6 Ribosome profiling 
 
These experiments were performed by Ilgin Cotan in the frame of a collaboration with the 
group of Prof. Bern Bukau and Dr. Gunter Kramer (Zentrum für Molekulare Biologie, 
Heidelberg, Germany). 
3.6.1 Sample preparation 
 
Wild type and bfr1Δ cells were grown to mid-log phase at 30 °C and approximately 150 OD600 
units were harvested using rapid filtration and flash freezing in liquid nitrogen. Frozen cell 
pellets were mixed with 750 µl of frozen lysis buffer droplets and a metal ball in pre-chilled 
metal jars and lysed by mixer milling 2 min at 30 Hz (MM400 Retsch, Haan, Germany). Cell 
lysates were thawed in a water bath at 30 °C, transferred to low-binding tubes and RNA 
concentration was determined by Nanodrop. Lysates were next subjected to RNase I 
digestion (10U of RNase I per Abs260 unit) 30 min at 4 °C, reaction was stopped by adding 10 
µl of Superase-In Rnase inhibitor (#LSAM2694, Invitrogen) and lysates were cleared by 5 min 
centrifugation at 20,000 x gav. 
lysis buffer: 
20 mM Tris-HCl pH 8 
140 mM KCl 
10 mM MgCl2 
20% (v/v) NP-40 
100 µg/ml Cycloheximide 
1 x  EDTA-free protease inhibitor cocktail (Roche, Basel, Switzerland)   
0.02 U/µl DNase I (Roche, Basel, Switzerland)   
40µg/ml Bestatin 
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Total ribosomes were collected by sucrose cushion centrifugation. A maximum of 400 µl of 
cleared lysate was loaded onto 800 µl of sucrose cushion buffer in sucrose cushion tubes and 
centrifuged 90 min at 75,000 rpm and 4 °C in a TLA120-rotor (Beckman, Indianapolis, IN, 
USA). Pellets were resuspended in lysis buffer by continuous agitation at 4 °C and 
transferred to non-stick tubes. 
 
 
3.6.2 Ribosome-protected footprint mRNA extraction 
 
mRNA footprints were extracted from processed samples by phenol-chloroform extraction. 
In brief, ribosome pellets were top to a final volume of 700 µl with lysis buffer and mixed 
with 40 µl 20% (v/v) SDS to precipitate the protein content. 750 µl of pre-warmed (65 °C) 
acid phenol was added and samples were incubated 5 min at 65 °C and 1,400 rpm shaking, 
and chilled 5 min on ice. Next, samples centrifuged 2 min at 20,000 x gav and the aqueous 
phase was transferred to a new tube. 700 µl of hot phenol were again added and samples 
were incubated 5 min at room temperature with occasional vortexing. 600 µl of chloroform 
was added and mixed by vortexing. Samples were centrifuged 1 min at 20,000 x gav and the 
aqueous phase was transferred to a new tube. To precipitate nucleic acids, approximately 
650 µl of the sample was mixed with 1:9 equivalence volume of 3 M NaOAc pH 5.5, 1 
equivalence volume of isopropanol and 2 µl of Glycoblue, mixed by vortexing and chilled 
overnight at 80 °C. 
Sucrose cushion buffer: 
20 mM Tris-HCl pH 8 
140 mM KCl 
10 mM MgCl2 
100 µg/ml Cycloheximide 
1 x  EDTA-free protease inhibitor cocktail (Roche, Basel, Switzerland)   
25% (v/v) Sucrose  
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Next, RNA samples were centrifuged 2 h at 20,000 x gav and 4 °C and the pellet was washed 
with 750 µl ice-cold 70% ethanol. Centrifugation was repeated for 2 min and the pellet was 
dried for 2 min at 65 °C. Pellets were finally resuspended in 20 - 50 µl of 10 mM Tris-HCl ph 
7. RNA enrichment was verified by Bioanalyzer RNA Nano chip (Agilent) and total RNA 
concentration was determined by nanodrop after diluting RNA samples in water and 10 mM 
Tris-HCl ph 7, respectively. 
 
3.6.3 Deep sequencing library preparation 
 
The method for the analysis of total translatome in yeast is based on what described in 
Doring et al., 2017 with some modifications. RNA samples were heated at 80 °C for 2 min 
and 40-50 mg of RNA were loaded onto a 15% TBE-Urea polyacrylamide gels (Invitrogen) in 
1xTBE (Ambion) and run for 65 min at 200 V. Gels were stained for 20 min with SYBR gold 
(Invitrogen) and ribosome footprints were recovered from the gels by excising sections 
according to 21 to 33 nucleotide size. Gel pieces were placed into 0.5 mL gel breaker tubes 
and centrifuged for 3 min at 20,000 x gav. The remaining pieces were transferred to a fresh 
1.5 ml tube, resuspended with 10 mM Tris-HCl ph 7 and incubated 15 min at 70 °C in a 
thermomixer with maximum shaking. The gel slurry was then transferred to a Spin-X 
cellulose acetate column (#60702, Thermo Fisher Scientific; Waltham, MA, USA) and 
centrifuged 3 min at 20,000 x gav. Flow-through was transferred to a fresh pre-cooled 
nonstick tube on ice. Nucleic acid samples were precipitated as described previously (See 
3.6.2). Next, RNA samples were centrifuged 2 h at 20,000 x gav and 4 °C and the pellet was 
washed with 750 µl ice-cold 70% ethanol. Centrifugation was repeated for 2 min and the 
pellet was dried for 2 min at 65 °C. Pellets were finally resuspended in 15 µl of 10 mM Tris-
HCl ph 7 and transferred to a fresh nonstick tube. 
To dephosphorylate 3’ ends of ribosome footprints, a master mix was prepared containing 
2 µl 10 x T4 polynucleotide kinase buffer without ATP (NEB) and 1 µl murine RNase-Inhibitor 
per sample and 3 µl were added to each sample together with 2 µl truncated T4 
polynucleotide kinase (Frankfurt/Main, Germany). Samples were incubated 2 h at 37 °C and 
the enzyme was deactivated after the reaction by 10 min incubation at 75 °C. At this point, 
nucleic acids were again precipitated as previously indicated. 
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Samples were centrifuged 1 h at 20,000 x gav and 4 °C and RNA pellet was washed with 70% 
ethanol and resuspended in 15 µl of 10 mM Tris-HCl ph 7 and transferred to a fresh nonstick 
tube as previously indicated. At this point, RNA concentration was measured again by 
Bioanalyzer RNA Nano chip (Agilent) and by nanodrop after diluting RNA samples in water 
and 10 mM Tris-HCl ph 7, respectively. 
For 3’ L1 linker ligation, samples were diluted to a final RNA concentration of 10 pmol in 10 
µl of 10 mM Tris-HCl ph 7 and denatured 2 min at 80 °C. A master mix was prepared to 
contain 16 µl 50% sterile filtered PEG MW 8000, 4 µl DMSO, 4 µl 10x T4 RNA Ligase 2 buffer 
and 2 µl murine RNase-Inhibitor. The master mix was added to each sample together with 1 
µl truncated T4 RNA Ligase 2 (NEB, Frankfurt/Main, Germany). Ligation was carried out for 2 
h at 23 °C and nucleic acids were precipitated, RNA pellets washed with 70% ethanol as 
previously indicated and resuspended in 6 µl of 10 mM Tris-HCl ph 7. 
3’ –linked footprints were denatured at 80 °C for 2 min and purified on 10% TBE-Urea 
polyacrylamide gels (Invitrogen) in 1xTBE (Ambion) run for 50 min at 200 V. Gels were 
stained for 20 min with SYBR gold (Invitrogen) and 3’ –linked footprints were recovered from 
the gels by excising sections according to 64 nucleotide size (footprint + L1).  
Similar to the previous in-gel purification, gel pieces were placed into 0.5 mL gel breaker 
tubes and centrifuged for 5 min at 20,000 x gav. The remaining pieces were transferred to a 
fresh 1.5 ml tube, resuspended with 10 mM Tris-HCl ph 7 and incubated 15 min at 70 °C in a 
thermomixer with maximum shaking. The gel slurry was then transferred to a Spin-X 
cellulose acetate column (#60702, Thermo Fisher Scientific; Waltham, MA, USA) and 
centrifuged 3 min at 20,000 x gav. Flow-through was transferred to a fresh pre-cooled 
nonstick tube on ice. nucleic acids were precipitated, RNA pellets washed with 70% ethanol 
as previously indicated and resuspended in 6 µl of 10 mM Tris-HCl ph 7. 
To generate ssDNA, 3’ linked footprint fragments were reverse transcribed. A master mix 
containing 1 µl 10 mM dNTP mix, 1 µl 25 µM Linker L1’L20 and 1.5 µl DEPC H2O was 
prepared and added to the samples. Samples were incubated 5 min at 65 °C and 4 ml 5x FSB 
buffer (Invitrogen), 1 ml murine RNase inhibitor, 1 ml 0.1 M DTT and 1 ml Superscript III 
(#18080085, Invitrogen) was added. Reverse transcription was performed 30 min at 50 °C 
and the reaction was quenched by adding 2.3 ml 1 N NaOH and further incubating 15 min at 
95 °C. 
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Samples were denatured 2 min at 70C and run on a 10% TBE-Urea polyacrylamide gel for 70 
min at 200 V. Gels were stained as described before, desired bands were excised, and 
nucleic acids were extracted as mentioned earlier except that remaining gel pieces were 
mixed with 0.5 ml 10 mM Tris-HCl ph 8. Nucleic acids were precipitated by adding 1:16 
equivalence volume of 5 M NaCl and 1:500 equivalence volume of 0.5 M EDTA together with 
1 equivalence volume of isopropanol and 2 µl of Glycoblue. Precipitation was performed at -
20 °C overnight and pellets were washed with 70% ethanol and resuspended in 15 µl 10 mM 
Tris-HCl ph 8 as previously described. 
To Circularize ssDNA, a master mix containing 2 µl 10x CircLigase buffer, 1 µl 1 mM ATP, 1 µl 
50 mM MnCl2 was added to the samples together with 1 µl CircLigase
 (EPICENTRE). The 
reaction was carried out for 1h at 60 °C and the enzyme was deactivated by further 
incubation for 10 min at 80 °C. 1 µl of circularized ssDNA was used as a template for 4 
technical replicates of Phusion-based PCR using the following mix and PCR program: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
One tube was removed from the PCR reaction after cycles 7, 8, 9, 10. Samples were run on 
an 8% TBE polyacrylamide gel (Invitrogen, Waltham, MA, USA) in 1x TBE (Ambion) for 55 min 
at 180 V. Gels were stained as mentioned before, desired bands from each PCR reaction 
were excised and DNA was extracted as described before for the ssDNA samples. The size 
62.6 µl DEPC H20 
16.7 µl 5x HF buffer 
1.7 µl 10 mM dNTPs 
0.4 µl 100 mM barcoding primer 
0.4 µl 0.4 ml 100 mM PCR primer L1’ 
0.8 µl Phusion polymerase 
Step T [°C] Time 
N° of 
cycles 
Initial 
denaturation 
98 30 s - 
Denaturation 98 10 s 
10 Annealing 60 10 s 
Elongation 72 5 s 
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distribution of DNA fragments was determined by Bioanalyzer, concentration was 
determined by Qubit (#Q32852, Invitrogen) and samples were sequenced on a HiSeq 
(Illumina). 
Sequenced reads were processed as described previously using standard analysis tools 
(Bowtie2, Tophat2) and in-house generated python scripts adapted to S. cerevisiae. 
For metagene analyses, genes were normalized to their expression level by dividing the read 
density of each nucleotide by the average read density per nucleotide of the respective 
gene. For all normalized regions, reads from each gene were binned into the respective 
length and each bin was averaged. 
3.7 In silico analysis of PMT promoter motifs 
 
For PMT promoter analysis, 500 bp upstream of each ORF coding sequence was retrieved 
from the SGD database. The presence of transcription factor DNA binding motifs was 
analyzed using the YETFASCO tool (see materials). Based on the DNA motifs present, 
potential transcription factors were assigned to each ORF and plotted in a Venn diagram 
using Venny 2.1 (Oliveros, 2007-2015). 
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4 RESULTS 
4.1 The protein O-mannosyl transferase family is integrated in the ER 
folding stress response 
 
PMT proteins were firstly linked to protein folding stress using transcriptomic approaches 
(Travers et al., 2000). The following studies showed the presence of constitutive UPR 
activation in both pmt1Δ and pmt2Δ mutants (Jonikas et al., 2009) and synthetic lethality 
between PMTs and the UPR transcription factor HAC1 (Arroyo et al., 2011). In this context, 
the first aim of this work was to test the transcriptional link between PMTs and ER folding 
stress as well as to unravel the potential specificity of the different pmt mutants with respect 
to the constitutive activation of the UPR. 
4.1.1 PMT1 and PMT2 are specifically regulated by the UPR 
 
In order to approach the transcriptional regulation of the major members of the PMT family 
PMT1, PMT2 and PMT4 the presence of transcription factor binding motifs in the promoter 
region of these genes was investigated (Figure 4.1A). The promoter regions of the major 
PMTs PMT1, PMT2 and PMT4 were subtracted from the SGD database and searched for 
transcription factor binding motifs using the YETFASCO platform (detailed in 3.7). Unique 
and redundant binding motifs were associated with transcription factors based on sequence 
prediction. Results yielded a high number of transcription factors shared by all three 
members (69) and some overlap between, at least, two of the three (21, 8 and 19; PMT1-
PMT2, PMT2-PMT4, and PMT1-PMT4 respectively). Notably, the highest number of unique 
motifs that would indicate unique regulation of each PMT isoform is present in PMT4 
promoter (24; in comparison to 15 and 12 in PMT1 and PMT2, respectively). A valid 
interpretation of this observation is that the expression of the Pmt4 homomeric complex is 
regulated by additional transcription factors on top of a common PMT regulation. Prediction 
of a higher number of PMT4 unique transcription factors is consistent with published data 
(Figure App.1).  
In regard to ER stress, all PMT1, PMT2, and PMT4 are predicted to have Hac1 DNA binding 
motifs but in different numbers: 5, 3 and 1 motif for PMT1, PMT2, and PMT4, respectively. 
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Figure 4.1. (A) In silico analysis of potential transcription factors regulating PMT expression. Transcription 
factor binding DNA motifs in 500 bp upstream of PMT1, PMT2, and PMT4 were predicted by the YETFASCO 
database (see 3.7). (B) Relative mRNA levels of PMT1, PMT2, and PMT4 in response to DTT in wild type and 
hac1Δ (Euroscarf) cells. Wild type (BY4741) and hac1Δ (Euroscarf) cultures were treated with 2.2 mM DTT for 
60 min. cDNA was prepared from total mRNA according to 3.2.3 and 3.2.4 and RT-PCR was performed 
according to 3.2.9. Results show averages of mRNA abundance ± SD with respect to ACT1. For statistical 
significance, a two-tailed t-Student’s test was applied (n=3). 
 
To analyze the effect of UPR on each major PMT member, the quantification of all three 
transcripts in response to the folding stress agent DTT was performed in wild type and in 
hac1Δ cells, which are unable to activate the UPR (Figure 4.1B). Results show DTT treatment 
specifically upregulating the expression of PMT1 and PMT2 by approximately a factor of two 
in a HAC1 dependent manner. Therefore, in agreement with previous high throughput data 
(Travers et al., 2000), the Pmt1-Pmt2 heteromeric complex is a target of the UPR, whereas 
PMT4 expression is insensitive to ER stress, suggesting that the function of the Pmt4 
homomeric complex might be unconnected to the role of PMTs in protein quality control. 
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4.1.2 Absence of specific members of the PMT family triggers the UPR  
 
To further characterize the relation between the UPR and O-mannosylation, a RT-PCR-based 
method was established (see 3.2.9) to precisely quantify the level of UPR present in the cells 
by looking at the abundance of both unspliced (inactive, HAC1u) and spliced (active, HAC1s) 
forms of HAC1 mRNA (Cox & Walter, 1996). The abundance of KAR2 mRNA was also 
quantified as KAR2 is shown to be a major UPR target gene (Nikawa et al., 1996). 
 
 
Figure 4.2. Compromising O-
mannosylation activates the UPR. 
Fold- change in mRNA levels of 
HAC1
u
, HAC1
s
 and KAR2 upon either 
deletion of different members of the 
PMT family (A) or treatment with 10 
µM R3A-5a (B). Total RNA was 
extracted either from wild type 
(BY4741), MLY213 (pmt1Δ), MLY214 
(pmt2Δ), MLY16 (pmt4Δ), MLY231 
(pmt356Δ) and wild type (BY4741) 
treated with 2.2mM DTT for1h (A); or 
from wild type (BY4741) and hac1Δ 
(Euroscarf) cells mock or treated with 
10 µM R3A-5a (B); according to 3.2.3 
and 3.2.4. (A, B) Fold-change was 
calculated by averaged Cts with 
respect to ACT1. Errors bars show the 
confidence interval. For statistical 
significance, a one-tailed t-Student’s 
test was applied to log (2
-ΔΔCt
), n=3. 
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Results yielded an increase of 2 and 5-fold in the levels of HAC1s in pmt1Δ and pmt2Δ, 
respectively (Figure 4.2A). Together with this, the levels of KAR2 were also increased by ~2 
fold in both mutants, indicating a mild but constitutive UPR activation when PMT1 or PMT2 
is absent. Interestingly, no changes in the transcript level of HAC1s or KAR2 were observable 
when deleting PMT4 or in the strain pmt356Δ, where minor PMT members are deleted.  
As stated above, the deletion of PMTs together with HAC1 results in synthetic lethality 
(Arroyo et al., 2011). In order to validate that the increased level of KAR2 upon defective 
O-mannnosylation is HAC1-dependent wild type and hac1Δ cells were treated with the 
O-mannosylation inhibitor R3A-5a (Figure 4.2B). Consistent with what observed in pmt1Δ 
and pmt2Δ, chemical inhibition of O-mannosylation also results in an increased level of 
HAC1s and KAR2 transcripts in wild type cells (3.6 and 2 fold-change, respectively). On the 
contrary, levels were unaffected in hac1Δ cells confirming that the transcript upregulation 
observed in wild type is representative for UPR activation. 
As a second readout GFP under the control of a UPR responsive element (UPRE) was 
genomically integrated into different PMT deletion mutants (Figure 4.3A, left panel). In line 
with the transcript analysis, UPR activation in pmt1Δ and pmt2Δ was observed whereas 
upon deletion of other PMT members, GFP fluorescence levels were indistinguishable from 
wild type cells. In this second approach also the multiple deletion mutant pmt1356Δ and 
pmt4356Δ, which only keep the minimal set of PMTs for the cells to remain viable (Martin 
Loibl, unpublished data) were included. UPR activation was only observable in pmt1356Δ 
and not in pmt4356Δ indicating that only the Pmt1-Pmt2 heteromeric complex prevents UPR 
activation under standard conditions. As control for the capacity to activate the UPR of the 
mutants tested, the response to DTT of all the PMT mutants was also tested using the UPRE-
GFP reporter and no significant difference in GFP intensity was observed with respect to wild 
type cells (Figure 4.3, right panel). 
  
69 
 
Figure 4.3. Analysis of UPRE-GFP reporter in PMT deleted strains. JCY001 (wild type), JCY002 (pmt1Δ), JCY003 
(pmt2Δ), JCY004 (pmt4Δ), JCY005 (pmt356Δ), JCY006 (pmt1356Δ) and JCY007 (pmt4356Δ) were grown in YPD 
and imaged under standard conditions as detailed in 3.5.2 (left panel). JCY002 (pmt1Δ), JCY003 (pmt2Δ) and 
JCY006 (pmt1356Δ) show an increase in GFP intensity. The same strains were treated with 2.2Mm DTT for 1h 
(right panel). Scale bar 5 µM. 
 
In order to clearly rule out that PMTs interfere with the capacity of the ER to activate the 
UPR wild type and pmt2Δ cells were treated with DTT in a time-course experiment (Figure 
4.4). Under the conditions tested, maximum UPR activation was achieved after 15-30 min 
after the induction with DTT. After 60 min UPR decayed to a level close to the initial state. In 
particular, for HAC1s, increased levels (4.3 fold-change) of transcript remained even after 4h.  
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No striking changes were observed in the response to DTT upon the absence of PMT2 except 
for the increased basal and final levels of HAC1s and KAR2 in the assay, supporting the 
constitutive activation of the UPR in pmt2Δ observed in figure 4.2A and 4.3 and indicating no 
interference of Pmt2 with the UPR machinery.  
Taken all together, these results highlight the relevance of the Pmt1-Pmt2 complex during 
the response to ER folding stress. The basis of the relationship between the Pmt1-Pmt2 
complex and the UPR is bidirectional: Pmt1-Pmt2 is needed upon folding stress and causes 
folding stress when it is absent.  
  
Figure 4.4. Fold-change in mRNA levels of 
HAC1
u
, HAC1
s
 and KAR2 upon DTT 
treatment in a time course experiment. 
Wild type (BY4741) and MLY214 (pmt2Δ), 
were grown in YPD and treated with 
2.2mM DTT. At indicated time points, 
cultures were sampled and total RNA was 
extracted and cDNA prepared according to 
3.2.3 and 3.2.4. Fold-change was 
calculated by averaged Cts with respect to 
ACT1. Errors bars show the confidence 
interval. For statistical significance, a one 
tailed t-Student’s test was applied to log 
(2
-ΔΔCt
). n=3. 
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4.2 Searching for genes involved in the unfolded protein O-mannosylation 
(UPOM) 
 
O-mannosylation has emerged in the past years as a potential contributor to ER homeostasis 
and protein quality control with promising perspectives. As described in the introduction, 
the fate of many different unfolded protein models is determined by the presence of 
covalently attached O-glycans but yet, only certain PMTs define what has been named 
unfolded protein O-mannosylation (UPOM). Due to the high genetic redundancy of the PMT 
family and the fact that O-mannosylation was initially thought to have a structural function 
at the cell wall, UPOM components have remained out of the spotlight in the ER quality 
control field.  
When unraveling cell biological pathways and assigning novel protein functions, yeast 
genetics has proven its proficiency in multiple studies (Cohen & Schuldiner, 2011; Breker et 
al., 2013; Aviram et al., 2016; Geva et al., 2017). The availability of a vast diversity of yeast 
libraries as well as the accessibility for researchers to high-throughput methodologies 
facilitates to obtain a broad picture of a certain biological process. 
To unravel the role of O-mannosylation in ERQC, the relation between 
O-mannosyltransferases and ER folding stress was initially clarified. In this second part, yeast 
genetics were used as a tool to investigate what integrates the UPOM machinery. For this 
purpose, the efficiency of UPOM was characterized in a collection of gene deletion mutants, 
aiming to find genes that are crucial for this branch of the ER protein quality control. 
4.2.1 ER-GFP as a UPOM protein model 
 
ER-GFP has been shown as a target for the Pmt1-Pmt2 complex as a consequence of its 
inefficient folding ((C. Xu et al., 2013), detailed in 1.4.2). In contrast to other unfolded 
protein models previously used to study UPOM, the native conformation of GFP is 
fluorescent and therefore allows us to infer the degree of PMT contribution to the folding 
state of the protein by monitoring and quantifying fluorescence intensity. This peculiarity of 
ER-GFP over other UPOM targets described was encouraging to choose it as an 
O-mannosylation reporter in a fluorescence-based high-throughput genetic screen for 
unknown UPOM components.   
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 ER-GFP is O-mannosylated by the Pmt1-Pmt2 complex 
4.2.1.1
 
Taking advantage of ER-GFP as a UPOM model required additional characterization of the 
physiological effects of its expression as well as additional methods to examine its 
glycosylation state besides in vivo fluorescence intensity. Xu and colleagues (2013) showed 
that the absence of Pmt1 and/or Pmt2 results in hypoglycosylation of ER-GFP and thereby 
improves its folding competency. Comparable enhancement in folding efficiency was 
observed when analyzing ER-GFPfast (referred from now on as ER-GFPf) which skips UPOM 
due to its improved folding kinetics (C. Xu et al., 2013; C. Xu & Ng, 2015). ER targeting of GFP 
is driven by the N-terminal fusion of GFP to the Kar2 signal peptide. Additionally, in order to 
avoid bulk-flow of GFP along the secretory pathway, a C-terminal HDEL retention signal is 
added (This point is further developed in 4.2.1.3) 
A starting strain for the screen was generated by genomically integrating ER-GFP in the 
innoxious HO locus. Further, the major members of the PMT family were deleted to confirm 
the data published in C. Xu et al., 2013. Indeed, the deletion of PMT1 or PMT2 results in an 
increase in overall fluorescence of ER-GFP (Figure 4.5A). Consistent with this, a fraction of 
ER-GFP (represented by two smeary bands) was detected migrating slower in SDS-PAGE 
followed by western blot (Figure 4.5B, indicated with white arrow). This fraction of ER-GFP 
was absent in pmt1Δ and pmt2Δ mutants or in ER-GFPf, suggesting that it represents the 
fraction of ER-GFP that receives O-glycans and thereby increases its molecular mass. To 
confirm this hypothesis a C-terminally flag tagged version of ER-GFP was purified and 
subjected to α-mannosidase treatment in vitro, which cleaves terminal α-mannoses on 
glycans (Einhoff & Rudiger, 1988). Results show that the higher molecular mass fraction of 
ER-GFP collapses to the main 35 KDa band after α-mannosidase treatment (Figure 4.5C, 
indicated with black arrow), indicating that it corresponds to O-mannosylated ER-GFP. These 
results provided a qualitative straight forward method to analyze the glycosylation state of 
ER-GFP. 
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Figure 4.5. ER-GFP is O-mannosylated by the Pmt1-Pmt2 complex. (A) Microscopy of strains with the ER-GFP 
cassette genomically integrated (GFP appended with the Kar signal peptide and an HDEL retention sequence). 
JEY06 (wild type), JCY010 (pmt1Δ), JCY011 (pmt2Δ), JCY012 (pmt4Δ) and JEY05 (wild type expressing ER-GFPf as 
control) were grown in YPD and imaged under standard conditions (lower-left panel), scale bar 5 µM. The same 
strains were grown under identical conditions and analyzed by flow cytometry (lower-right panel). R values 
indicative of the cell population’s fluorescence intensity (see 3.5.3) are normalized to RWT and results are 
plotted as fold-change (n=3). (B) Total cell extracts were prepared from the same strains shown in (A). 20 µg of 
protein were resolved on a 12% PAA gel and subjected to Western blot analysis using anti-GFP antibody. An 
O-mannosylated fraction (white arrow) coexists with a less or non-modified fraction (black arrow) in wild type 
and pmt4Δ cells whereas is absent in pmt1Δ and pmt2Δ. (C) FLAG-tagged ER-GFP (upper panel) was expressed 
via plasmid pN014 in wild type cells and immunoprecipitated from total cell extracts according to 3.4.5. 
Purified ER-GFP-FLAG was subjected to (1-2,3,6)-mannosidase treatment (3.4.6) overnight at 37 °C, resolved 
on a 12% PAA gel and subjected to Western blot analysis using anti-GFP antibody. The O-mannosylated fraction 
(white arrow) collapses onto the main band (black arrow) after treatment. 
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 ER-GFP expression triggers the activation of the UPR 
4.2.1.2
 
ER-GFP is under the control of the TDH3 promoter which drives a strong protein 
overexpression. Previous studies have shown how overexpression of misfolded protein 
models results in ER stress and UPR activation (Umebayashi et al., 2001; Spear & Ng, 2003). 
Clarifying the effect of ER-GFP overexpression with respect to stress is particularly relevant 
since in an ER-stress scenario the levels of Pmt1 and Pmt2, as well as components of the ER 
folding machinery, are significantly increased (Travers et al., 2000, Figure 4.1B). 
The levels of UPR-related transcripts were measured in wild type cells overexpressing both, 
ER-GFPf and ER-GFP (Figure 4.6A). Consistent with prolonged time in achieving the native 
conformation, expression of ER-GFP yielded a very relevant increase for HAC1s and KAR2 (8 
and 4 fold-change, respectively). Although still statistically significant, expression of ER-GFPf 
only resulted in a mild increase of the same transcripts (1.5 and 1.2, respectively). The 
different impact of either version of ER-GFP on ER homeostasis is understandable taking into 
account that the requirement of folding factors for a protein that does not fold efficiently 
would be higher than for its folding competent counterpart. In line with the UPR activation 
observed at the transcript level, increased levels of HAC1s and KAR2 were correlated with 
increased protein abundance for Kar2, Pmt1, and Pmt2; whereas Pmt4 remained unaffected 
(Figure 4.6B).  
With respect to the use of ER-GFP as a UPOM reporter in a high throughput screen, these 
results picture a scenario where the ER suffers from folding stress and therefore 
components of the folding machinery, as well as the Pmt1-Pmt2 complex, are more 
abundant.  
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Figure 4.6. Impact of ER-GFP expression on the UPR. (A) Fold- change in mRNA levels of HAC1
u
, HAC1
s,
 and 
KAR2 upon ER-GFPf and ER-GFP expression. Total RNA was extracted (3.2.3) from wild type (BY4741), JEY05 
(ER-GFPf) and JEY06 (ER-GFP) grown in YPD, cDNA was prepared (3.2.4) and used as a template for RT-PCR. 
Fold-change is calculated by averaging Cts with respect to ACT1. Errors bars show the confidence interval. For 
statistical significance, a one-tailed t-Student’s test was applied to log (2
-ΔΔCt
), n=3. (B) Total cell extracts were 
prepared from the same strains. 20 µg of protein were resolved on a 12% PAA gel and subjected to Western 
blot analysis using the antibodies indicated. G6PDH served as loading control (n=2-3). 
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 ER-GFP can be targeted for vacuolar degradation 
4.2.1.3
 
Another important aspect to consider when working with ER-GFP as a model is to account 
for its stability. Most misfolded protein models studied to date are either recognized by the 
ERAD system, retro-translocated to the cytosol and degraded at the proteasome or sent to 
the vacuole for degradation (Nakatsukasa & Brodsky, 2008, Hong et al., 1996; Haynes et al., 
2002; Coughlan et al., 2004).  
ER-GFP is stable in the ER lumen (C. Xu & Ng, 2015), which in principle should rule out 
protein stability as a major contributor to its fluorescent intensity. However vacuolar 
turnover is still a scenario to consider. Soluble proteins functioning at the ER lumen require 
specific mechanisms to avoid their stochastic escape along the secretory pathway. These ER-
resident proteins are central contributors to ER homeostasis since most of them include 
chaperones, oxidoreductases, and proteins involved in lipid biogenesis. To avoid depletion of 
these proteins from the ER due to bulk flow, ER-resident proteins bear specific sequences, 
conserved in higher eukaryotes that function as signals for cargo receptors of the ER 
retrieval system along the secretory pathway. In yeast, the ER retrieval system is defined by 
the transmembrane receptor Erd2, which recognizes the canonical motif HDEL of ER-
residents and contributes to their retrograde transport into COPI-coated vesicles (reviewed 
in Perez-Linero & Muniz, 2015). 
When studying the O-mannosylation of ER-GFP, a canonical C-terminal HDEL sequence was 
included to prevent bulk flow interfering with the function of PMTs. The presence of the 
HDEL sequence, however, does not ensure the full efficiency of the retrieval system since it 
has been observed that some genes, including cargo receptors and others, are required for 
competent retrieval (Copic et al., 2009). In line with this, as shown in 4.2.1.2 the screen was 
performed under ER stress conditions which causes upregulation of chaperones such as 
Kar2, bearing an HDEL signal that might contribute to saturate the Erd2 receptor. These 
considerations were encouraging to study the effect of the HDEL signal on the stability of ER-
GFP. When including a C-terminal HDEL sequence in the ER-GFP construct, fluorescence 
microscopy indicates a clear ER and secretory pathway localization (Figure 4.5A). Consistent 
with this and with previous studies (C. Xu et al., 2013), this version of ER-GFP is stable in a 
cycloheximide chase experiment (Figure App. 2).  
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Figure 4.7. Analysis of non-retained ER-GFP. (A) Microscopy of strains expressing non-retained ER-GFP. Wild 
type (BY4741), MLY213 (pmt1Δ), MLY214 (pmt2Δ), MLY16 (pmt4Δ) transformed with pJC08 (ER-GFP) were 
grown in SD-URA and imaged under standard conditions. As a control, wild type (BY4741) was transformed 
with pJC07 (ER-GFPf) and analyzed in parallel. Given the strong difference in intensity, two different exposures 
were used for ER-GFP and ER-GFPf (200 and 90 ms, respectively). Scale bar 5 µM. (B, C) Western blot analysis of 
non-retained ER-GFP. Comparison between the ER-GFP construct (B, upper panel) analyzed in figure 4.5 and 
non-retained ER-GFP. Total cell extracts were prepared from wild type cells transformed with either pWXB206 
(ER-GFP) or pJC08 (non-retained ER-GFP) (B, lower panel) or from the same strains as in (A) (C). Equivalent to 
0.2 OD600 of protein were resolved on a 12% PAA gel and subjected to Western blot analysis using anti-GFP 
antibody. Black and gray arrows indicate the predominant protein fraction of ER-GFP and non-retained ER-GFP 
respectively. White arrow indicates the O-mannosylated ER-GFP fraction (n=2, representative results are 
shown). 
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On the contrary, expressing ER-GFP that lacks HDEL (referred to as non-retained ER-GFP) 
shows a central dotted pattern that suggests vacuolar localization (Figure 4.7A). Regarding 
the influence of O-mannosylation in the folding competency of ER-GFP, the presence of 
O-mannosylated protein fraction is shown by western blot for non-retained ER-GFP and an 
increase of fluorescence correlates with the absence of this higher molecular size fraction in 
pmt1Δ and pmt2Δ (Figure 4.7A and 4.7C). This indicates that despite non-retained ER-GFP 
does not localize to the ER, this has no major influence on the effect of O-mannosylation on 
its folding state. 
To test the vacuolar localization, non-retained ER-GFP was expressed in a pep4Δ mutant, 
where vacuolar degradation is deficient. Similar to pmt1Δ or pmt2Δ, the deletion of PEP4 
resulted in an increase of fluorescence of ER-GFP (Figure 4.7A). 
When analyzing the O-mannosylation state, Pep4 did not have any observable influence in 
the presence of a modified protein fraction. This suggests that the folding competency of ER-
GFP is not enhanced in pep4Δ but the observed increase in fluorescence might be the result 
of protein stabilization. To test this hypothesis a cycloheximide chase experiment was 
performed in wild type and pep4Δ expressing non-retained GFP (Figure 4.8). In contrast to 
the ER-retained counterpart, non-retained GFP is efficiently degraded in wild type and 
degradation is largely prevented in pep4Δ cells.  
From these experiments, it was concluded that firstly, prolonged stay in the ER has no major 
influence in UPOM of ER-GFP since a version of ER-GFP unrestricted to move along the 
secretory pathway also receives O-glycans in a Pmt1-Pmt2-dependent manner. Secondly, 
although ER-GFP is a stable protein when retained at the ER, the absence of ER-retention 
results in its vacuolar turnover. This point is relevant for the high throughput screen since as 
mentioned, ER-retention efficiency can be compromised in the absence of certain genes and 
the ER-escape of GFP will likely result in protein degradation. 
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Figure 4.8. Cycloheximide chase analysis of non-retained ER-GFP. Wild type (BY4741) and pep4Δ were 
transformed with pJC08 (non-retained ER-GFP) and treated with 200 µg/ml cycloheximide. Equivalent to 10 
OD600 cells was sampled at the indicated time points. Equivalent to 0.2 OD600 of total cell extract was resolved 
on a 12% PAA gel and subjected to Western blot analysis using an anti-GFP antibody. G6PDH served as a 
loading control (n=2, representative results are shown). 
4.2.2 High throughput screen for UPOM factors 
 
In order to get a comprehensive picture of unfolded protein O-mannosylation, a genome-
wide screen was performed using ER-GFP as an O-mannosylation reporter. The screen was 
performed by Lihi Gal in collaboration with the group of Prof. Maya Schuldiner (Weizmann 
Institute of Science, Rehovot, Israel). 
Folding competency of ER-GFP is impeded by O-mannosylation by the Pmt1-Pmt2 complex 
and therefore deletion of PMT1 or PMT2 results in increased fluorescence intensity (Figure 
4.5A). Hypothetically, the deletion of genes involved in UPOM should yield a similar 
fluorescence increase. To analyze the fluorescence of ER-GFP upon the disruption of every 
single gene in yeast the workflow depicted in figure 4.9 (and detailed in 3.3.1) was followed. 
In brief, an automated crossing of a starting wild type strain with ER-GFP genomically 
integrated (JEY06) with two different libraries was carried out: single deletion mutants and 
DAmP (decreased abundance by mRNA perturbation) yeast collections. The DAmP collection 
is a library of hypomorphic alleles for essential genes generated by the fusion of an antibiotic 
resistance marker to the 3’UTR of the target gene, inducing instability and decay of the 
transcript (Breslow et al., 2008).  
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Figure 4.9. Workflow of the ER-GFP screening. In brief, a wild type strain with ER-GFP genomically integrated 
(JEY06) was crossed with both, single-gene deletion (Giaever et al., 2002) and DAmP (Breslow et al., 2008) 
genetic libraries using SGA methodology (see 3.3.1). Haploid yeast strains carrying both genetic modifications 
(ER-GFP integration and single-gene deletion/DAmP allele) were selected. The fluorescence intensity of ER-GFP 
was calculated based on the software analysis of microscopy images as described in (Breker et al., 2013). 
 
Haploids carrying both ER-GFP and the corresponding mutation (deletion or DAmP) were 
selected, fluorescence microscopy was performed, and intensity was quantified (see 3.3.1). 
109 mutants were yielded as positive hits (Table App 1, Figure 4.10A). As an indication of the 
validity of the screen, pmt1Δ and pmt2Δ were found among the positive hits, being pmt2Δ 
the third top hit in the list (Figure 4.10A). Together with PMT mutants GO term enrichment 
showed a low enrichment score (approximately 2) and included very heterogeneous 
categories such as glycosylation, protein metabolic process, proteolysis or chromatic 
organization, indicating no ontologically enriched biological pathway or process influencing 
ER-GFP fluorescence (Figure 4.10B).  
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Figure 4.10. Identification of potential UPOM factors. (A) Distribution of the median fluorescence intensity (y-
axis) displayed by each mutant analyzed in the ER-GFP screening (x-axis) with respect to the median average of 
wild type cells. The threshold for positive hit selection is depicted as a red dashed line. (B) GO term enrichment 
analysis using DAVID (v6.7). GO term enrichment was performed on 100 mutants considered as a hit (Table 
App. 1) using GO ALL terms, an EASE score of 0.1, and the S. cerevisiae reference list. Enrichment scores were 
extracted for the respective GO term clusters and clusters were named by representative terms. Biological 
process (GO_BP), molecular function (GO_MF) and cellular compartment (GO_CC) are shown. 
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 Systematic analysis of the positive mutants 
4.2.2.2
 
Next to O-mannosylation, multiple scenarios resulting from gene deletion might impact on 
the fluorescence of ER-GFP: incorrect ER-targeting, deficient ER-retention (as shown in 
4.2.1.3) or inability to maintain the ER-GFP-induced stress response since the UPR is needed 
to optimize the protein quality control mechanisms. In line with this, it is important to note 
that genes that affect canonical glycosylation would also be potentially found in the 
screening. Although it is also of interest targeting core components of the glycosylation 
pathway, the goal was to find genes that might particularly function in the context of ER-
stress and UPOM. 
A first analysis of the mutants consisted of manual curation of the ER-localization of ER-GFP 
in the ER. Of the 109 positive hits, only spf1Δ (top hit of the screen, figure 4.10A) showed 
partial localization of ER-GFP in the cytosol, which was validated in an independent spf1Δ 
deletion mutant (Figure App.3) and excluded from further analyses. 
In order to restrict the analysis to those mutants involved in UPOM, two parallel strategies 
were developed: In a first strategy, to find genes that affect general O-mannosylation, it was 
taken advantage of the extensively O-mannosylated protein Hsp150. Hsp150 is a cell wall 
protein that is induced and secreted to the medium by heat shock (Russo et al., 1992). When 
analyzing medium containing Hsp150 by SDS-PAGE followed by western blot, deletion of 
either PMT1 or PMT2 results in a shift of the above 150 KDa main fraction to lower 
molecular mass fractions, resulting in a smeary pattern that likely represents 
hypoglycosylated subspecies of Hsp150 (Figure 4.11, indicated with white arrow). The 
medium from 100 heat-shocked positive mutants from the ER-GFP screen was isolated and 
analyzed. None of the mutants resulted in a major shift of the 150 KDa band (Figure 4.11, 
indicated with black arrow), however, 12 of them, clustered as pop2Δ-like mutants, showed 
a smear comparable to what shown by the PMT mutants (Table App. 1). Other positive 
mutants clustered as ost3Δ-like, showed an increased presence of two protein fractions of 
about 70 and 50 KDa, which might correspond to immature forms of Hsp150.  
In conclusion from this first filtering, the 12 mutants that showed the pop2Δ-like phenotype 
are promising candidates to suffer from general O-mannosylation defects whereas mutants 
showing the ost3Δ-like phenotype are likely unrelated to O-mannosylation. 
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Figure 4.11. Systematic western blot analysis of Hsp150 in the ER-screening positive hits. Viable single 
deletion mutants considered a hit in the ER-GFP screening (Figure 4.10, Table App.1) were retrieved from the 
Euroscarf collection and their O-mannosylation capacity was analyzed based on the cell wall component 
Hsp150. (A) As detailed in 3.4.4, mutants were subjected to heat shock to induce secretion of Hsp150, proteins 
of the medium were loaded and resolved on 8% PAA gels and subjected to Western blot analysis using anti-
Hsp150 antibody. To ensure reproducibility, wild type and hsp150Δ-derived medium were included in each PAA 
gel as controls. Hsp150 fully glycosylated and hypoglycosylated protein fractions are indicated with black and 
white arrows, respectively. (B) Hsp150 phenotypes were grouped according to the following criteria: protein 
size shift (pmtΔ-like), presence of lower molecular size smear (pop2Δ-like) and accumulation of Hsp150 
immature species (ost3Δ-like). The number of mutants included in each cluster is shown. 
 
In a second strategy, the aim was to select the positive mutants that might affect UPOM in 
particular. SDS-PAGE followed by western blot was used to evaluate the presence of the 
O-mannosylated fraction of ER-GFP. Although this method denies the quantification of the 
glycosylation state of ER-GFP, it is proven to be qualitatively suitable when PMT1 or PMT2 
are deleted (Figure 4.5 B and C). Five mutants among the positive hits were found presenting 
either absence or strong reduction of the O-mannosylated fraction of ER-GFP (Figure 4.12A 
and B): pmt1Δ, pmt2Δ, bfr1Δ, psa1-DAmP, and pgi1-DAmP.  
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Figure 4.12. Systematic analysis of O-mannosylation of ER-GFP in the positive hits of the ER-GFP screening. 
Selected haploids resulting from SGA crosses and considered a hit in the screening (Figure 4.10A, Table App.1) 
were analyzed with respect to the glycosylation state of ER-GFP. Total cell extracts were prepared according to 
3.4.2 and equivalents to 0.2 OD600 were resolved on a 12% PAA gel and subjected to Western blot analysis 
using anti-GFP antibody. To ensure reproducibility, total cell extracts from wild type expressing ER-GFP (JEY06) 
were included in each PAA gel as controls. (A) ER-GFP phenotypes were clustered with respect to the reduction 
of the presence of the O-mannosylated protein fraction. (B) bfr1Δ, pgi1-DAmP, and psa1-DAmP were identified 
as mutants with deficient UPOM indicated by the reduction of the O-mannosylated protein fraction (white 
arrow). Blots showing pgi1-DAmP and psa1-DAmP were obtained by Dr. Daniela Bausewein. 
 
The mutants bfr1Δ and pgi1-DAmP showed strong hypoglycosylation of ER-GFP whereas the 
effect was milder but still significant for psa1-DAmP (Figure 4.12B, indicated with white 
arrow). In pgi1-DAmP, the fluorescence intensity of ER-GFP, although significantly higher 
than in wild type cells (Table App. 1, Figure 4.10A), was slightly below the threshold. 
Nevertheless, pgi1-DAmP was included in this analysis because of two reasons: First, pgi1-
DAmP has been shown to cause ER-retention defects (Copic et al., 2009) which in turn would 
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lead to lower ER-GFP fluorescence level irrespective of UPOM. Second, the involvement of 
PGI1 in the glycolic pathway in part necessary for the production of GDP-mannose in the 
cytosol (Aguilera & Zimmermann, 1986) suggesting a functional link to PMTs. 
4.2.3 The role of PGI1 in UPOM 
 
PGI1 and PSA1 are essential genes encoding the glycolytic enzymes glucose-6-phosphate 
isomerase and GDP-mannose pyrophosphorylase, respectively.  
Pgi1 catalyzes the isomerization of glucose-6-phosphate into fructose-6-phosphate, a critical 
reaction of the pathway that metabolizes the glucose taken up by the cell (Aguilera & 
Zimmermann, 1986; Green et al., 1988). Psa1 catalyzes the synthesis of GDP-mannose using 
mannose 1-phosphate and GTP as substrates (Hashimoto et al., 1997, Figure 4.13).  
 
Figure 4.13. Representation of the cytosolic pathways 
that result in the production of GDP-mannose. After 
phosphorylation, internalized glucose is isomerized into 
fructose-6-phosphate by Pgi1. Fructose-6-phosphate is 
then converted into mannose-6-phosphate which can also 
be internalized in the cell as mannose and then 
phosphorylated. Mannose-6-phosphate is used as a 
substrate to synthesize GDP-mannose by Sec53 and Psa1. 
GDP-mannose is used as a substrate for the different ER 
glycosylation machinery, including the PMT machinery via 
Dol-P mannose (See 1.2.1 and 1.2.2). 
 
 
 
Both genes have been found to be necessary to ensure proper UPOM of ER-GFP (Figure 
4.12B). In order to validate the results of the screen and to characterize the extent of the 
downregulation of these two genes by the DAmP methodology, both mutants were 
generated de novo and the mRNA levels were quantified to confirm the knockdown. RT-PCR 
yielded about 10 and 5 fold-change reduction for PGI1 and PSA1, respectively in comparison 
to wild type (Figure 4.14) 
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Figure 4.14. Relative mRNA levels of PSA1 and PGI1 in 
wild type, JCY014 (pgi1-DAmP) and JCY015 (psa1-
DAmP). Cell cultures were grown in YPD. cDNA was 
prepared from total mRNA according to 3.2.3 and 
3.2.4 and RT-PCR was performed according to 3.2.9. 
Results show averages of PSA1 and PGI1 mRNA 
abundance ± SD with respect to ACT1. For statistical 
significance, a two-tailed t-Student’s test was applied 
(n=3). 
 
 
 
One logic hypothesis to explain the need of glycolytic enzymes for efficient O-mannosylation 
is given by the fact that both enzymes are involved in the pathway that produces GDP-
mannose in the cytosol, thereby providing Dpm1 (see 1.2.1 and 1.2.2) with the substrate to 
form Dol-P-Man, the sugar donor for N-glycosylation, O-mannosylation, and GPI-anchor 
biosynthesis.  
In humans, mutations in the homolog of PSA1 have been associated with different 
congenital disorders of glycosylation (CDGs) defined as muscular α-dystroglycanopathies 
(Carss et al., 2013; Koehler et al., 2013; Belaya et al., 2015). In contrast, PGI1 deficiency has 
been reported to cause a rare type of hereditary hemolytic anemia sometimes associated 
with neurological disorders (Kanno et al., 1996; Kugler et al., 1998). In particular, for PGI1 
most of the symptoms of its deficiency have been assumed to be the result of impaired 
metabolism of glucose and no effect on protein glycosylation and consequently on ER 
protein quality control has been described so far. The lack of CDGs associated with PGI1 to 
date and the modest reduction of O-mannosylation of ER-GFP found in psa1-DAmP (Figure 
4.12B) were encouraging to put the focus on PGI1 as a link between sugar metabolism and 
ER homeostasis. 
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 UPOM in pgi1-DAmP is mannose-dependent 
4.2.3.1
 
To test that compromised UPOM in pgi1-DAmP is related to GDP-mannose production, the 
glycosylation state of ER-GFP was analyzed in pgi1-DAmP cells grown using glucose, 
mannose or a combination of both as carbon source (Figure 4.15).  
 
 
 
Figure 4.15. Characterization of the requirement of mannose supplementation in pgi1-DAmP for UPOM. 
Yeast strains JEY06 (wild type), JCY011 (pmt2Δ) and pgi1-DAmP ER-GFP (strain resulting from SGA crosses) were 
grown in synthetic medium using 2% of the indicated sugar as carbon source. Total cell extracts were prepared 
according to 3.4.2 and equivalents to 0.2 OD600 of protein were resolved on a 12% PAA gel and blotted with 
anti-GFP antibody. G6PDH served as a loading control. The presence of the O-mannosylated fraction of ER-GFP 
(indicated with a white arrow, see figure 4.5) depends on the presence of mannose as a carbon source. These 
experiments were performed by Dr. Daniela Bausewein in collaboration with the author. 
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Mannose supplementation resulted in the rescue of hypoglycosylation of ER-GFP in pgi1-
DAmP as shown by the presence of the O-mannosylated fraction by western blot (indicated 
with white arrow). A combination of both glucose and mannose resulted in a partial rescue 
likely due to the preference of the cell to take up glucose. No evident effect of the presence 
of mannose on the O-mannosylation of ER-GFP was observed either wild type or pmt2Δ 
when using mannose, indicating that mannose supplementation does not impact severely in 
UPOM when PGI1 remains unaffected. 
To further characterize the functional relationship between PGI1 and the PMT machinery a 
pmt2Δpgi1-DAmP double mutant was generated. In the absence of mannose, pmt2Δpgi1-
DAmP exhibits a very strong growth defect that can be rescued by mannose 
supplementation (Figure 4.16). This indicates that the downregulation of PGI1 and 
O-mannosylation defects have negative additive effects for growth and highlights that the 
mannose-based rescue of ER-GFP glycosylation can be also extended to a functional rescue. 
 
 
Figure 4.16. Characterization of the mannose-dependent negative genetic interaction between PGI1 and 
PMT2. Yeast strains JEY06 (wild type), JCY011 (pmt2Δ) and JCY014 (pgi1-DAmP) were streaked together with 
five independent transformants of JCY033 (pmt2Δpgi1-DAmP) on YP-based plates containing 2% of the 
indicated sugar as carbon source. Plates were imaged after 24h growth at 30 °C. 
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 PGI1 knockdown affects ER-homeostasis 
4.2.3.2
 
The finding of PGI1 as necessary for UPOM adds sugar metabolisms to the requirements for 
ER homeostasis. The idea of cytosolic sugar content influencing the efficiency of protein 
folding in the ER encouraged to characterize this relationship. 
In 4.2.3.1 it is shown how mannose supplementation can rescue the hypoglycosylation 
phenotype of pgi1-DAmP. In order to check whether mannose is also able to influence 
protein folding ER-GFP was expressed in pgi1-DAmP and fluorescence intensity was 
measured by flow cytometry under different carbon source conditions.  
For this specific assay, the non-retained version of ER-GFP (see 4.2.1.3) was used. PGI1 has 
been described as one of the genes that when downregulated, results in the secretion of the 
ER-resident chaperone Kar2 (Copic et al., 2009). By using the non-retained version of ER-GFP 
the ER retention defect in pgi1-DAmP was anticipated and prevented, which in turn would 
have biased the analysis. 
 
 
Figure 4.17. Characterization of the effect of mannose supplementation on ER-GFP folding in pgi1-DAmP. (A) 
Wild type (BY4741) and JCY014 (pgi1-DAmP) cells were transformed with pJC08 (non-retained ER-GFP), grown 
in SD-URA-based medium containing 2% of the indicated sugar as carbon source and imaged under standard 
conditions, scale bar 5µm. (B)The same strains were grown under identical conditions and analyzed by flow 
cytometry. R values indicative of the cell population’s fluorescence intensity (see 3.5.3) are normalized to RWT 
and results are plotted as fold-change. For statistical significance, a one-tail Student’s test was applied (n=3).  
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Under mannose limiting conditions, the fluorescence intensity of ER-GFP in pgi1-DAmP was 
about 2-fold higher than in wild type cells (Figure 4.17). Consistent with the restoration of 
the O-mannosylation state of ER-GFP, mannose supplementation reduced fluorescence of 
pgi1-DAmP to almost wild type levels. No effect in fluorescence could be observed upon 
mannose supplementation in wild type cells (Figure 4.16). In conclusion from these results, 
upon PGI1 knockdown, UPOM is impaired and hence inefficient folding of ER-GFP is not 
prevented.  
 
In 4.1.2 it is shown that the absence of either PMT1 or PMT2 causes UPR activation. As 
discussed in 5.1, a valid explanation is that the Pmt1-Pmt2 complex actively contributes to 
the quality control of aberrant proteins in the ER, as it is shown for ER-GFP (Figure 4.5, C. Xu 
et al., 2013). In pgi1-DAmP, quality control of ER-GFP is also prevented (Figure 4.17) 
suggesting that, by extension, UPR might be also activated to cope with a hypothetical 
increase in the load of unfolded proteins.  
UPR in pgi1-DAmP activation was evaluated by quantitative RT-PCR analysis of UPR-related 
transcripts. This experiment yielded a clear increase in HAC1s and KAR2 levels in pgi1-DamP 
(6 and 3 fold-change, respectively) indicative of constitutive activation of the UPR (Figure 
4.18B). Consistent with this, pgi1-DAmP cells were more sensitive to the ER stress agent 
tunicamycin (Figure 4.18A).  
Given that mannose supplementation is able to restore quality control of ER-GFP (Figure 
4.17), the effect of this rescue was also analyzed with regard to the UPR. Both UPR levels 
and growth sensitivity to tunicamycin in pgi1-DAmP were restored upon mannose 
supplementation making this mutant indistinguishable from wild type (Figure 4.18A and B). 
These results confirm PGI1 as an important contributor to the ER protein quality control, 
expanding the requirements for proper ER homeostasis to the substrate sugar content in the 
cytosol. 
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Figure 4.18. Characterization of the pgi1-DAmP mutant in the context of ER-stress. (A) Spotting assay of wild 
type (BY4741), wild type expressing ER-GFP (JEY06), JCY014 (pgi1-DAmP) and pgi1-DAmP ER-GFP (strain 
resulting from SGA crosses). Serial 10-fold dilutions cells were spotted on solid SD-based medium containing 
2% of the indicated sugar as a carbon source together with no (control) or 0.5 µg/ml tunicamycin. This 
experiment was performed by Sven Klassa under the author’s supervision and included in the bachelor thesis: 
“Phosphoglucose isomerase 1 function in the frame of protein O-mannosylation and ER homeostasis”, 
submitted to the Ruprecht-Karls-University (Heidelberg faculty of Biosciences) in 2017. (B) Fold- change in 
mRNA levels of HAC1
u
, HAC1
s,
 and KAR2 in JCY014 (pgi1-DAmP). Total RNA was extracted (3.2.3) from cells 
grown in YP-based medium containing 2% of the indicated sugar as a carbon source, cDNA was prepared (3.2.4) 
and used as a template for RT-PCR. Fold-change is calculated by averaging Cts with respect to ACT1. Errors bars 
show the confidence interval. For statistical significance one-tailed, t-Student’s test was applied to log (2
-ΔΔCt
), 
n=3. 
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4.2.4 The role of BFR1 in UPOM 
 
The deletion of BFR1 was found to be an enhancer of fluorescence intensity and hence 
folding of the O-mannosylation reporter ER-GFP (Figure 4.19A and B). Western blot analysis 
confirmed the inefficient UPOM of ER-GFP as the cause of improved folding competence 
(4.2.2.1). In order to validate the results of the screen, a BFR1 knockout was de novo 
generated in the parental wild type starting strain of the screen and measured the 
fluorescence of ER-GFP by flow cytometry (Figure App. 4). At this point, it is important to 
note that although the majority of the transformants confirmed by PCR showed the 
expected increase in fluorescence intensity there was significant variability among 
transformants. 
 
 
Figure 4.19. The deletion of BFR1 enhances ER-GFP folding. (A) Flow cytometry of strains JEY06 (wild type 
expressing ER-GFP) and bfr1Δ ER-GFP (strain resulting from SGA crosses) grown in YPD under standard 
conditions. R values indicative of the cell population’s fluorescence intensity (see 3.5.3) are normalized to RWT 
and results are plotted as fold-change (n=3). (B) Microscopy of the same strains grown under identical 
conditions, scale bar 5 µM. 
 
BFR1 encodes a 55 KDa cytosolic protein first identified as a multicopy suppressor of 
brefeldin A-induced lethality (Jackson & Kepes, 1994), suggesting a link of BFR1 to protein 
secretion. Furthermore, this study also pointed out note worth phenotypes associated with 
BFR1 deletion: abnormal cell ploidy described as pseudo haploidy, with polynucleated cells 
and non-nucleated cells found in the same population; and abnormally increased cell size. 
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Later studies showed Bfr1 as part of a ribonucleoprotein complex mainly represented by the 
protein Scp160 and associated with the polyribosome mRNP machinery (Lang et al., 2001). 
Moreover, RNA immunoprecipitation (RIP)-CHIP experiments showed that Bfr1 is capable to 
associate with multiple RNAs (Hogan et al., 2008). Since then, multiple functions related to 
mRNA post-transcriptional regulation have been assigned to Bfr1. On one hand, Bfr1 
mediates the re-localization of certain mRNAs to P-bodies (Simpson et al., 2014), which are 
conserved, complex and dynamic ribonucleoprotein complexes where mRNA de-adenylation 
and decay occurs (reviewed in Luo et al., 2018). In terms of optimizing and adjusting the 
proper mRNA levels next to gene transcription, P-bodies become especially relevant under 
conditions that require attenuating protein translation such as cell starvation or stress. In 
this context, Bfr1 and Scp160 have been shown to prevent the appearance of P-bodies under 
normal conditions (Weidner et al., 2014), suggesting a role as a gate for mRNA from 
polyribosomes to the decay system. 
How can a cytosolic protein work in the context of mRNA transport and metabolism be 
linked to protein O-mannosylation? Insights to answer this question came with the 
publication of the mRNA targets of Bfr1 in a novel in vivo RNA tagging approach (Lapointe et 
al., 2015). Interestingly, Bfr1 binds more than a 1000 mRNAs significantly enriched with 
transcripts that undergo ER-localized translation (Jan et al., 2014), including PMT mRNAs as 
main Bfr1 targets. Therefore, although functionally unclear, the link of Bfr1 to mRNA 
regulation, and in particular along with PMTs being mRNA targets of Bfr1 raised the 
hypothesis of Bfr1 regulating the expression of PMTs and thereby impacting on 
O-mannosylation of ER-GFP. 
 BFR1 deletion impacts negatively on the abundance of Pmt1 and Pmt2 
4.2.4.1
  
To explore whether inefficient UPOM in bfr1Δ is a consequence of abnormal PMT expression 
the steady-state levels of Pmt1 and Pmt2 were quantified by Western blot. Considering the 
ER stress scenario triggered by the expression of ER-GFP, WT, and bfr1Δ without ER-GFP 
expression were included as controls.  
In a no ER-stress scenario, the results of three independent experiments show a significant 
reduction of 2-fold in the protein level for both Pmt1 and Pmt2 when BFR1 is deleted (Figure 
4.20). Interestingly, Pmt1 and Pmt2 showed a reduction of 2-fold and 3.7-fold upon ER-GFP 
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expression, indicating that the upregulation of both PMTs, expected due to ER stress (see 
Figure 4.6), is also absent in bfr1Δ.  
 
Figure 4.20. The deletion of BFR1 affects negatively Pmt1 and Pmt2 protein levels. (A) Total cell extract was 
prepared from yeast strains wild type (BY4741), JEY06 (wild type ER-GFP), bfr1Δ (Euroscarf) and bfr1Δ ER-GFP 
(strain resulting from SGA crosses) grown in YPD under standard conditions. 20 µg of protein were resolved on 
a 12% PAA gel and subjected to Western blot analysis using either anti-Pmt1 or anti-Pmt2 antibody (Pmt2 
signal indicated with black arrow). G6PDH served as a loading control. (B) Western blot signals were quantified 
using Image Studio Lite V.5.2 as a Pmt/G6PDH ratio, normalized to Pmt/G6PDHWT, averaged and plotted as 
fold-change. For statistical significance, a one-tail Student’s test was applied to averaged fold-change values 
(n=3). 
 
As described in the literature, bfr1Δ cells display a very complex and pleiotropic phenotype 
that might impact in ER-GFP intensity at multiple levels. Therefore, in order to confirm that 
decreased protein abundance of PMTs is the reason for inefficient UPOM a functional rescue 
of bfr1Δ was performed by overexpressing PMT2 from a centromeric plasmid. The 
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overexpression of PMT2 results in a significant rescue of the ER-GFP intensity in bfr1Δ 
(Figure 4.21A), whereas no effect was detectable in wild type cells. This observation on wild 
type cells indicates that the rescue in bfr1Δ is due to the restoration of the physiological 
levels of Pmt2 to some extent and rules out that increasing the PMT2 load over physiological 
levels impacts in ER-GFP folding. In line with this, overexpression of PMT2 also restores the 
presence of the hypoglycosylated fraction of ER-GFP in bfr1Δ (Figure 4.21B), confirming that 
decreased PMT protein levels is the cause for increased ER-GFP folding in absence of Bfr1. 
Besides analyzing the rescue of UPOM, PMT2 overexpression conditions were used to 
question whether Pmt2 abundance is also diminished in bfr1Δ when additional PMT2 is 
expressed. These conditions would mimic the scenario of ER-GFP expression, where PMT2 is 
transcriptionally upregulated via the UPR. When comparing Pmt2 steady-state levels under 
PMT2 overexpression conditions bfr1Δ (with or without ER-GFP) fails to fully overexpress 
Pmt2 to the same extent as in wild type cells (Figure 4.21C, compare lanes two and four 
without ER-GFP expression and lanes six and eight with ER-GFP expression). Still, some 
increase in Pmt2 levels can be observed in bfr1Δ, explaining the partiality of the functional 
rescue observed in Figure 4.21A and indicating that Pmt2 expression is just reduced in bfr1Δ 
and not fully impeded. 
One indicator of O-mannosylation capacity is the sensitivity to the general O-mannosylation 
inhibitor R3A-5a (Arroyo et al., 2011). Consistent with the reduction in the levels of Pmt1 
and Pmt2 in absence of Bfr1, a previous study showed bfr1Δ to be significantly more 
sensitive to R3A-5a (Zatorska et al., 2017). In order to confirm the data and to test whether 
PMT2 overexpression is also able to rescue sensitivity to R3A-5a in bfr1Δ a spotting assay 
was performed (Figure 4.22). A mild decrease in cell growth upon R3A-5a could be observed 
for bfr1Δ independently of ER-GFP expression (indicated with black arrows), supporting 
decreased O-mannosylation capacity. However, in this assay, overexpression of PMT2 was 
unable to rescue the R3A-5a sensitivity phenotype in either case, suggesting that although 
PMT2 overexpression is enough to restore UPOM of ER-GFP, the rescue of the general O-
mannosylation capacity likely requires complementation with also PMT1 or even with 
additional PMTs. These results indicate that the reduction in the Pmt1 and Pmt2 levels in 
bfr1Δ compromise the efficiency of O-mannosylation and highlight that the role of Bfr1 is 
not restricted to UPOM, but it also involves O-mannosylation in general. In agreement, bfr1Δ 
was clustered among the pop2Δ-like mutants when analyzing Hsp150 (Figure 4.11) and has 
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been shown to have negative genetic interaction with PMT1 and PMT2 (Schuldiner et al., 
2005) suggesting that they work in parallel pathways. 
 
 
Figure 4.21. (A) PMT2 overexpression partially rescues ER-GFP fluorescence in bfr1Δ. Flow cytometry analyses 
of JEY06 (wild type ER-GFP) and bfr1Δ ER-GFP expressing either pRS41N (empty vector, EV), pJC09 (PMT2) or 
pJC10 (PMT2-3xHA) grown under standard conditions in YPD supplemented with nourseothricin for selection. R 
values indicative of the cell population’s fluorescence intensity (see 3.5.3) are normalized to RWT and results are 
plotted as fold-change. For statistical significance, a one-tail Student’s test was applied (n=3). (B) Total cell 
extract was prepared from the same strains as in A transformed with either pRS41N or pJC09 and grown under 
identical conditions. 20 µg of protein were resolved on a 12% PAA gel and subjected to Western blot analysis 
using anti-GFP antibody. O-mannosylated fraction (indicated with black arrow) is restored by PMT2 
overexpression in bfr1Δ. (C) bfr1Δ cells fail to fully overexpress PMT2. Total cell extracts were prepared from 
wild type (BY4741), bfr1Δ, JEY06 (wild type ER-GFP) and bfr1Δ ER-GFP transformed with either pRS41N or 
pJC09 and grown as in A. 20 µg of protein were resolved on a 12% PAA gel and blotted with anti-Pmt2 
antibody. G6PDH served as a loading control. 
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 Figure 4.22. Spotting assay of wild type (BY4741), bfr1Δ, JEY06 (wild type expressing ER-GFP) and bfr1Δ ER-GFP 
expressing either pRS41N (empty vector, EV) or pJC09 (PMT2). Serial 10-fold dilutions cells were spotted on 
solid YPD medium containing nourseothricin for selection together with no (control) or 5 µM of the PMT 
inhibitor R3A-5a (Arroyo et al., 2011) and grown at 30 °C for 24h. bfr1Δ are slightly more sensitive to R3A-5a 
(indicated with black arrows). 
 
Before addressing how Bfr1 regulates PMT protein expression, the reduction in protein 
levels of other Bfr1 targets was investigated. As shown in Lapointe et al., 2015, Bfr1 
preferentially targets transcripts coding for secretory proteins, some of them functionally 
linked to PMTs. Bfr1 targets representative for different protein classes linked to 
O-mannosylation were selected and analyzed their protein abundance in bfr1Δ. Among the 
Bfr1 targets selected there is Gas1 as representative for GPI-anchored proteins (Nuoffer et 
al., 1991), Kar2 as soluble ER Hsp70 chaperone (Rose et al., 1989), Ost3 and Wbp1 as 
subunits of the OST complex (te Heesen et al., 1992; Karaoglu et al., 1995) and Sec61 as 
main subunit of the translocon complex (Deshaies & Schekman, 1987). Despite the 
previously observed increased values of Kar2 upon ER-GFP expression (Figure 4.6), no 
significant differences were found in the protein abundance of other Bfr1 targets upon BFR1 
deletion (Figure 4.23, Figure App.5), restricting the effect on protein expression to PMTs, so 
far. The specificity observed for PMTs over other Bfr1 transcript targets implies that the 
capacity to interact with Bfr1 does not necessarily result in a change in protein expression. In 
addition to binding, Bfr1 must drive additional events for PMT transcripts that result in 
correct protein expression. 
  
98 
 
Figure 4.23. BFR1 deletion does not affect the steady-state levels of other representative secretory proteins. 
Total cell extract was prepared from yeast strains wild type (BY4741), JEY06 (wild type ER-GFP), bfr1Δ 
(Euroscarf) and bfr1Δ ER-GFP (strain resulting from SGA crosses) grown in YPD under standard conditions. 20 
µg of protein were resolved on a 12% PAA gel and subjected to Western blot analysis using the indicated 
antibodies. G6PDH served as a loading control. Proteins analyzed are described as Bfr1 targets at the mRNA 
level according to (Lapointe et al., 2015). Quantification of the Western blot signals based on three biological 
replicates is shown in Figure App.5. 
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 PMT protein abundance does not correlate with transcript levels 
4.2.4.2
 
Given that BFR1 is suggested in the literature to play a role in mRNA transport and very 
closely linked functionally to mRNA catabolism (Simpson et al., 2014; Weidner et al., 2014), 
whether the decrease in Pmt1 and Pmt2 protein abundance is a consequence of decreased 
transcript level was analyzed by RT-PCR.  
 
Figure 4.24. Relative mRNA levels of PMT1 and PMT2 in wild type (BY4741), JEY06 (wild type ER-GFP), bfr1Δ 
(Euroscarf) and bfr1Δ ER-GFP (strain resulting from SGA crosses) (A); and PMT2 in wild type (BY4741) and bfr1Δ 
(Euroscarf), expressing either pRS41N (empty vector, EV) or pJC09 (PMT2) (B) grown in YPD or YPD 
supplemented with nourseothricin. cDNA was prepared from total mRNA according to 3.2.3 and 3.2.4 and RT-
PCR was performed according to 3.2.9. Results show averages of PMT1 and PMT2 mRNA abundance ± SD with 
respect to TAF10 (A) or ACT1 (B). For statistical significance, a two-tailed t-Student’s test was applied (n=3). 
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When comparing wild type and bfr1Δ, no difference in the transcript level was observed for 
either PMT1 or PMT2. In contrast, upon ER-GFP expression, which results in a 2-fold 
transcriptional upregulation of both PMTs in wild type cells, such an increase in transcript 
level was absent specifically for PMT2 in bfr1Δ (Figure 4.24A). In agreement, a similar 
reduction of the PMT2 transcript level is observed in bfr1Δ in comparison to wild type under 
PMT2 overexpression conditions (Figure 4.24B). 
These data pictures a complex scenario where two conclusions were drawn: First, 
comparable PMT1 and PMT2 transcript levels between wild type and bfr1Δ result in lower 
protein abundance in bfr1Δ. Second, when PMT2 is overexpressed at the mRNA level, either 
mediated the UPR caused by ER-GFP expression or by extra copies of PMT2, bfr1Δ affects 
specifically PMT2 transcript levels.  
Likely the reduction in PMT2 transcript observed in bfr1Δ upon ER-GFP expression 
contributes to the hypoglycosylation of ER-GFP. However, PMT2 transcript decrease occurs 
only upon the excess of PMT2 expression. This suggests that the general role of Bfr1 in PMT 
protein expression is independent of the changes observed at the mRNA level for PMT2. 
Given that Bfr1 is described to function in the context of mRNA processing, further analyses 
were performed to explain the effect observed for PMT2 transcript in bfr1Δ upon stress. 
The inability of bfr1Δ ER-GFP to produce or maintain correct levels of PMT2 transcript upon 
ER stress can be due to transcriptional downregulation as well as enhanced mRNA turnover. 
Since the Bfr1 function is somehow linked to P-body formation, both questions were 
addressed by replacing the PMT2 native promoter by the GAL1 inducible promoter (PGAL1). 
PGAL1 is known to be tightly repressed in cells grown in glucose and to drive a strong 
overexpression in cells grown in galactose. The strain selected included PMT2-HA-tagged 
driven by PGAL1 and an N-terminal UbiR protein degron (Hwang et al., 2010), which works as 
a signal for proteasomal degradation. The reason for using a degradable Pmt2-HA version is 
that a growth defect was detected when overexpressing PMT2-HA in particular in bfr1Δ 
(Figure App. 7, indicated with black arrow) and therefore the potential lethality that could 
result by the strong overexpression driven by PGAL1in bfr1Δ was anticipated. Yet, the reason 
behind why specifically HA-tagged PMT2 is harmful to bfr1Δ cells in contrast to untagged 
PMT2 remains unknown.  
Analysis of Pmt2-HA expression under the control of PGAL1 showed that the deletion of BFR1 
results in lower protein abundance in comparison to wild type (Figure 4.25A). Upon 
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replacement of PMT2 promoter, no difference in PGAL1-PMT2-HA transcript level was 
observed between wild type and bfr1Δ (Figure 4.25B, left panel), and identical results were 
obtained when expressing ER-GFP (Figure 4.25B, right panel) indicating that the reduction in 
native PMT2 transcript level observed in Figure 4.24 is promoter-dependent.  
 
Figure 4.25. The effect of BFR1 deletion on PMT2 transcript level is promoter-dependent. (A) Total cell extract 
was prepared from yeast strains MLY014 (wild type, PMT2-3xHA), MLY098 (wild type, PGAL1-UBI4-R-PMT2) and 
JCY034 (bfr1Δ, PGAL1-UBI4-R-PMT2-HA) grown in YP medium containing 2% of the indicated sugar. Equivalent of 
0.2 OD600 (lanes 1 and 2) or 20 µg protein (lanes 3 and 4) were resolved on a 12% PAA gel and subjected to 
Western blot analysis using anti-Pmt2 antibody. G6PDH served as loading control. (B) Relative PMT2 mRNA 
levels in MLY098 (wild type, PGAL1-UBI4-R-PMT2-HA) and JCY034 (bfr1Δ, PGAL1-UBI4-R-PMT2-HA) (left panel) or 
in the same strains transformed with pJC16 (ER-GFP) (right panel) grown in YP or synthetic medium (left and 
right panel, respectively) containing 2% Galactose as carbon source. Results show averages ± SD with respect to 
or ACT1, (n=3). 
 
In addition, the capacity of PGAL1 to be repressed by glucose was used to perform a 
transcriptional shutdown and the turnover of PGAL1-PMT2-HA transcript was analyzed over 
time. As anticipated by the comparable steady-state mRNA levels (Figure 4.25B), no 
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significant changes were detected in the PGAL1-PMT2-HA mRNA decay with or without ER-
GFP expression (Figure 4.26).  
As a conclusion from these results, the reduction observed in the PMT2 transcript in bfr1Δ is 
uncoupled from the defects in PMT protein expression. Despite the effect at the transcript 
level likely contributes to the hypoglycosylation phenotype in bfr1Δ, it is promoter-
dependent and possibly caused by downstream effects of BFR1 deletion.  
 
 
Figure 4.26. PMT2 mRNA decay is not affected in bfr1Δ. MLY098 (wild type, PGAL1-UBI4-R-PMT2-HA) and 
JCY034 (bfr1Δ, PGAL1-UBI4-R-PMT2-HA) (left panel) or in the same strains transformed with pJC16 (ER-GFP) 
(right panel) were grown in YP or synthetic medium (left and right panel, respectively) containing 2% Galactose 
as carbon source. Glucose was added to the medium at t0 and fold-change in PMT2 transcript abundance is 
calculated by averaged Cts with respect to ACT1 at the indicated time points and normalized to t0. Errors bars 
show the confidence interval.  
 Bfr1 is involved in the translation of PMTs and PMT-related transcripts 
4.2.4.3
 
Decreased PMT protein abundance (Fig 4.20) while unchanged transcript levels in bfr1Δ 
under standard conditions (Fig 4.24) suggested a defect in protein production. Bfr1 has been 
shown to interact with translating ribosomes (Lang et al., 2001) but no functional 
relationship to translation is known to date.  
In order to explore potential defects in PMT mRNA translation in the bfr1Δ mutant, a 
ribosome profiling experiment was carried out for both wild type and bfr1Δ cells in 
collaboration with the group of Prof. Bern Bukau and Dr. Güenter Kramer (Zentrum für 
Molekulare Biologie, Heidelberg, Germany). The experiments were performed by Ilgin Kotan 
and are detailed in methods (see 3.6.1). 
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Ribosome profiling compares the abundance of ribosome-protected mRNA footprints of all 
translating ribosomes allowing to obtain a snapshot of the translatome under desired 
conditions (Figure 4.27A, Becker et al., 2013; Doring et al., 2017). A ratio of transcript 
abundance determined by RNA deep sequencing was obtained between bfr1Δ and wild type 
for every ORF in yeast based on normalized values of sequencing reads (RPKM, Reads Per 
Kilobase per Million) of the respective footprints. The experiment was performed in 
duplicate for both yeast strains wild type and bfr1Δ. In both cases, data sets showed a high 
correlation (coefficient of determination r2 of 0.99 and 0.97 for wild type and bfr1Δ, 
respectively, Figure App.9). When comparing wild type and bfr1Δ translatome high 
correlation was also observed (r2 of 0.97, Figure 4.27B), indicating no major defects on 
general translation. This is consistent with the analysis of polyribosomes of bfr1Δ shown in 
Lang et al., 2001. 
First focusing on PMT1 and PMT2, RNA deep sequencing data showed about 1.7 fold 
reduction in the presence of both PMT1 and PMT2 among the ribosome-protected 
footprints in bfr1Δ (RPKMbfr1Δ/RPKMWT ratios of 0.58 and 0.59, respectively), revealing a 
decrease in the engagement of PMT1 and PMT2 transcripts to ribosomes in absence of BFR1 
(Figure 4.27B, App. Data 1). In addition to PMT1 and PMT2, all other different PMT family 
members (PMT3, 4, 5 and 6) are also found to be downregulated in bfr1Δ with 
RPKMbfr1Δ/RPKMWT ratios below 0.6 in all cases (App. Data 1). Since the underrepresentation 
of PMT1 and PMT2 footprints in bfr1Δ was consistent with the reduction observed at the 
protein level (Figure 4.20) these values were used as a basis to set a threshold to define 
significant changes in footprint distribution of 1.5 fold-change for both –under and 
overrepresented footprints in bfr1Δ. The additional ER proteins analyzed in bfr1Δ showing 
no obvious change in abundance (Figure 4.23) serve as negative controls for the translatome 
data. Based on the 1.5 fold-change threshold, Sec61, Gas1, Ost3, and Wbp1 appear to be 
unchanged whereas similar to PMTs, Kar2 shows approximately 1.7 fold reduction in bfr1Δ 
translatome. The reason behind the inconsistency between ribosome profiling and western 
blot data for Kar2 is unknown. 
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Figure 4.27. Ribosome profiling of bfr1Δ. (A) Workflow of a ribosome profiling approach to obtain a snapshot 
of the translatome (see 3.6). The total ribosome fraction was isolated from wild type (BY4741) and bfr1Δ 
(Euroscarf) in duplicate and digested with RNase I. Ribosome footprints remain protected from digestion and 
represent the mRNA fraction being actively translated in the cell. mRNA footprints were further isolated and 
subjected to deep RNA sequencing, assigned to the corresponding ORF and quantified on reads per million 
(RPM). For translatome comparison RPMs were normalized to the corresponding transcript length (reads per 
kilobase per million, RPKM). (B) Scatter plot illustrating the correlation between wild type and bfr1Δ 
translatome. PMT1 and PMT2 appear as underrepresented footprints in bfr1Δ. Red dashed lines account for 
the 1.5 fold change threshold applied to define translatome changes upon BFR1 deletion, (n=2). (C) Analyses of 
functional categories enriched among ORFS below and/or above the threshold with respect to the total 
translatome. Gene annotation is based on (Lapointe et al., 2015) for Bfr1 targets, (Neubert et al., 2016) for 
O-mannosylated proteins, (Zielinska et al., 2012) for N-glycosylated proteins, (Pittet & Conzelmann, 2007) for 
GPI-anchored proteins and SGD (Saccharomyces genome database) and UniportKB/Compartments databases 
for cell compartment localization. 
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By applying the 1.5 fold-change threshold, about 10% (510) of the measured ORFs were 
considered as underrepresented in bfr1Δ, whereas 5% (258) were overrepresented. 
When mining the available data on Bfr1 transcript targets (Lapointe et al., 2015) a significant 
enrichment of Bfr1 known targets was found among underrepresented ORFs in comparison 
with the entire translatome (45 % versus 26%, respectively) (Figure 4.27C, upper panel; App. 
Data 1). On the contrary, such overlap does not hold true when looking at the 
overrepresented ORF fraction, where only 14% are known targets of Bfr1. This observation, 
together with the higher number of ORFs that are downregulated suggests that BFR1 
positively affects translation of its transcript targets, whereas upregulated ORFs are mainly 
unrelated to Bfr1 function and might respond to a compensatory mechanism for BFR1 loss. 
 
In order to gain insight on the biological relevance of Bfr1 at the translation level, 
downregulated ORFs were clustered based on their annotated cell localization and their 
distribution in the translatome was analyzed (Figure 4.27C, right panel). Interestingly, 
secretory proteins localizing to the ER, Golgi, vacuole, plasma membrane or cell wall were 
enriched among downregulated transcripts when comparing to the total translatome, 
whereas cytosolic and nuclear proteins were dis-enriched. Moreover, similar enrichment 
within downregulated transcripts was observed when looking at the distribution of 
O-mannosylated, N-glycosylated or GPI-anchored proteins. This indicates that together with 
PMTs, mainly other secretory proteins rely on Bfr1 for effective translation. Whether the 
effect on the translatome impacts on the steady-state protein abundance for those 
downregulated ORFs as it is the case for PMTs is still pending of investigation.  
In addition, gene ontology analysis was performed for the genes that rely on Bfr1 for 
translation (ORFs below the 1.5 fold-change, Figure 4.28). The most enriched clusters 
showed terms closely linked to protein O-mannosylation: glycosylation, GPI anchor 
metabolic process or response to endoplasmic reticulum stress. Most ORFs are clustered as 
intrinsic component of membranes and hexosyl transferase, across-membrane transport or 
oxidoreductase activity terms were also highlighted, rendering a functionally and spatially 
interconnected catalog of Bfr1 clients.  
What determines the dependence on Bfr1 for effective translation besides the described 
interaction at the mRNA level for many of them (Lapointe et al., 2015, Figure 4.27C, left-
upper panel) still remains unknown. 
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Figure 4.28. Gene ontology analysis of ORFs underrepresented in the translatome of bfr1Δ. GO term 
enrichment analysis using DAVID (v6.8). GO term enrichment was performed on 504 ORFs considered as 
downregulated in the ribosome profiling experiment (Figure 4.27B, App. Data 1) using GO ALL terms, a very 
stringent EASE score of 0.0001, and the S. cerevisiae reference list. Enrichment scores were extracted for the 
respective GO term clusters and clusters were named by representative terms. Biological process (GO_BP), 
molecular function (GO_MF) and cellular compartment (GO_CC) are shown. 
 
In order to approach the potential molecular mechanism behind Bfr1 function, metagene 
analyses of footprint distribution along the mRNA sequences was performed for the 
downregulated ORFs (see Doring et al., 2017 as an example), revealed a slight trend of 
increased ribosome occupancy in the first 100 codons in bfr1Δ relative to wild type (Figure 
App. 9C), suggestive of defects in translation elongation. However, the weakness of the 
observed effect and the data available are not enough to robustly conclude whether the 
translational speed is certainly affected. 
In conclusion, these data indicate that Bfr1 is required for effective translation of PMT1 and 
PMT2. Furthermore, 510 ORFs whose expression is also hampered by the absence of Bfr1 
were identified. Most ORFs identified as Bfr1-dependent for translation are proteins 
localizing to the different organelles of the secretory pathway and that mainly fulfill 
functions at least partially related to protein O-mannosylation. The molecular mechanism of 
the Bfr1 function is yet to be elucidated since at the time of this current work more 
specialized analysis of the ribosome profiling data is part of the future perspectives. Both the 
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implications of these findings in the context of O-mannosylation and insights on the 
potential molecular mechanisms are outlined in the discussion (see 5.3). 
 PMT mRNA localization to the ER-membrane is Bfr1-independent 
4.2.4.4
 
Bfr1 is required for the translation of PMT1 and PMT2 gene products. One immediate 
question that arises after the ribosome profiling data is whether the function of Bfr1 is 
restricted to translation when the ribosomal subunits have assembled or rather implies 
some sort of RBP-dependent mRNA localization mechanism. Transcript localization in 
eukaryotes is long known to be a source for directed protein synthesis not only providing 
polarity during cell differentiation but also contributing to optimize protein translation and 
translocation into different cell organelles (Beach et al., 1999; Singer-Kruger & Jansen, 2014).  
Previous evidence of ER localization has been already shown for PMT2 transcript in an in vivo 
mRNA localization study (Kraut-Cohen et al., 2013). The well-known model of translation-
dependent protein targeting to the ER via signal recognition particle (SRP) would predict the 
hydrophilic amino acid sequence of transmembrane domains of PMTs to act as a signal for 
ER delivery (reviewed in Aviram & Schuldiner, 2017). There is however emerging evidence of 
protein targeting mechanisms to the ER that rely not on the protein sequence but in signals 
present in the mRNA itself (Kraut-Cohen & Gerst, 2010). 
In this context, one role shown for Bfr1 is mRNA transport to P-bodies upon glucose 
starvation (Simpson et al., 2014). Also, Scp160, which forms a complex with Bfr1 (Lang et al., 
2001) has been described in the context of specific mRNA localization during mating (Guo et 
al., 2003). The fact that most ORFs affected in bfr1Δ are enriched for secretory proteins 
(Figure 4.27C) raised the hypothesis of Bfr1 mediating mRNA transport of specific PMT 
transcripts to the ER, where they are translated (Jan et al., 2014), perhaps as a backup 
mechanism to optimize ER targeting when SRP is inefficient.  
ER localization of PMT transcripts was analyzed by two parallel strategies of subcellular 
fractionation. In a first approach, sucrose step-gradient centrifugation of total cell extracts 
was performed and the fractions containing the interphase between each step were 
selected (Figure 4.29A). In order to track the cellular localization of Bfr1 in the gradient, a 
C-terminal HA-tagged BFR1 shown to keep the functionality of the protein (Fig App. 6) was 
used as a wild type strain. 
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Analysis of the mRNA content of the fractions showed enrichment of ribosomes in two pools 
represented by fractions F2 and F3 (Figure 4.29A and B). As a control the experiment was 
performed under EDTA conditions and both, a shift of the Abs260 peaks to soluble fractions 
and disassembly of the ribosomal subunits were observed (Figure App.7A). Ribosome-rich 
fraction F2 contained residual cytosolic G6PDH whereas Sec61 was exclusively found in F3, 
confirming successful isolation of ER-associated and ER-free ribosomal cell pools in F2 and F3 
fractions, respectively. Bfr1-HA was present in all fractions together with the ribosomal 60S 
subunit protein Rpl5, consistent with the described engagement of Bfr1 protein with the 
translation machinery (Figure 4.29C, Lang et al., 2001). Analysis of the mRNA of F2 and F3 by 
semi-quantitative RT-PCR (Figure 4.25D) yielded strong engagement of PMT1, PMT2 and 
SEC61 transcripts to ER-associated ribosomes (F3) whereas for ACT1 transcript was also 
significantly present at the ER-free ribosome pool (F2). It not surprising to observe ACT1 
transcript, coding for a cytosolic protein, associated with the ER since it is postulated that 
this organelle works as a hub for general translation, including proteins that function at the 
cytosol (Diehn et al., 2000). When analyzing bfr1Δ, no changes were observed in the 
distribution of these transcripts in all cases. 
 
In a second approach, total cell membranes were isolated by ultracentrifugation and the 
presence of specifically PMT2 transcript associated with either the membrane (TM) or the 
soluble fraction (SF) was analyzed. Western blot on soluble and membrane fractions 
confirmed successful isolation of Sec61-containing membranes whereas G6PDH was found 
exclusively in the soluble fraction (Figure 4.30A). Both fractions contained ribosomes (Figure 
App.8). When analyzing the presence of PMT2 mRNA, one of the advantages of this strategy 
is that the simplicity of separating the cell in only two fractions allows relative quantification 
by standard RT-PCR. 
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Figure 4.29. Analysis of PMT1 and PMT2 transcript localization by sucrose gradient cell fractionation. JCY017 
(wild type, BFR1-3xHA) and bfr1Δ (Euroscarf) strains were grown in YPD under standard conditions, harvested, 
lysed and subjected to sucrose step gradient centrifugation as described in 3.5.1.2. (A) Image of a 
representative sucrose step gradient (wild type, strain JCY017). Black, grey and white arrows indicate the 
fractions selected. (B, upper panel) Abs260 at each fraction sampled from the sucrose gradient (JCY017). (B, 
lower panel) The equivalents of each fraction were loaded in an agarose gel and stained with ethidium bromide 
(JCY017). (C) 0.25 OD600 units of total cell extract (TCE) and equivalents of each sucrose fraction (wild type, 
strain JCY017) were resolved on a 12% PAA gel and subjected to Western blot analysis using the indicated 
antibodies. (D) Semi-quantitative PCR performed on cDNA prepared from total RNA extracted from selected 
sucrose fractions. 1:20 cDNA dilution was used as a template in a standard dreamtaq PCR program (see 3.2.7) 
using 23 or 25 cycles for amplification of ACT1 or PMT1, PMT2, and SEC61, respectively. Representative results 
of two independent fractionations are shown. 
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Thus, the relative abundance of PMT2 transcript with respect to ACT1 was quantified in each 
fraction and a ratio between fractions was calculated. In agreement with the results shown 
in Figure 4.29D, PMT2 mRNA was found associated with the membrane fraction to a higher 
extent and no significant difference in PMT2 distribution was observed in bfr1Δ with respect 
to wild type cells (Figure 4.30B, upper panel). 
 
Figure 4.30. Analysis of PMT2 transcript localization by 
one step gradient cell fractionation. Either JCY017 (wild 
type, BFR1-3xHA) and bfr1Δ (Euroscarf) (A; B, upper 
panel) or wild type (BY4741) and bfr1Δ transformed with 
pRS41N (empty vector, EV) or pJC09 (PMT2) (B, lower 
panel) were grown in YPD or YPD supplemented with 
nourseothricin under standard conditions, harvested,  
lysed and subjected to one-step ultracentrifugation as 
described in 3.5.1.2. (A) Western blot analysis of the 
protein content of total cell extract (TCE) soluble fraction 
(SF) and total membrane fraction (TM) prepared from 
JCY017. Equivalents to 0.25 OD600 of each fraction were 
resolved on a 12% PAA gel and subjected to Western 
blot analysis using the indicated antibodies (B) cDNA was 
synthesized from total RNA prepared from TCE, SF, and 
TM fractions and used as a template for quantitative RT-
PCR (3.2.9). Results show the ratio between the relative 
PMT2 abundance normalized to ACT1 in TM with respect 
to SF. Error bars show the confidence interval. For 
statistical significance, a one-tailed t-Student’s test was 
applied to log (2
-ΔΔCt
), n=3. 
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Further, whether increasing the total levels of PMT2 would also increase the need for 
functional Bfr1 was questioned. Perhaps performing these experiments under PMT2 
overexpression conditions could reveal changes in transcript distribution that are 
undetectable under standard conditions. Analysis of mRNA distribution in wild type and 
bfr1Δ overexpressing PMT2 yielded a transcript distribution comparable to standard 
conditions and no significant change was observed in bfr1Δ (Figure 4.30B, lower panel).  
Taken together, the two strategies used to track PMT transcript distribution show that PMT 
transcripts are preferentially associated with the ER membrane and that the reduction in 
PMT protein expression observed in bfr1Δ is not caused by changes in PMT transcript 
mislocalization. The reduction of PMT protein expression in bfr1Δ is therefore restricted to 
translation, suggesting that Bfr1 might be required when the ribosome has already been 
recruited to the ER membrane. 
 Bfr1 functions in the UPR 
4.2.4.5
 
As detailed in the introduction, the Pmt1-Pmt2 complex is specifically integrated in the UPR 
and therefore is upregulated upon ER-GFP expression. The role of Bfr1 in Pmt1-Pmt2 protein 
expression is particularly relevant upon ER-GFP expression, where the expected increase in 
PMT protein abundance upon ER stress is also prevented in the absence of BFR1 (Figure 
4.20). One possible explanation already suggested by transcriptomic data (Travers et al., 
2000) is that BFR1 also functions, together with PMTs, during the UPR.  
This hypothesis was tested by measuring the expression of BFR1 upon DTT treatment in both 
wild type and the UPR-deficient mutant hac1Δ. As shown in Figure 4.31A, DTT causes a 2-
fold upregulation in the BFR1 transcript level and such an effect is absent when HAC1 is 
deleted, confirming that BFR1 is a target of the UPR. These data point out that Bfr1 function 
is particularly important when the ER faces folding stress, which makes sense since among 
the ORFs that require Bfr1 for translation there are key members of the ER quality control 
system such as the Hsp70 chaperone Lhs1, or the central E3-ligase Hrd1 (App. Data 1). 
The deletion of BFR1 was also analyzed for constitutive UPR activation (Figure 4.31B). Like 
what shown for PMT mutants (see 4.1.1), quantification of UPR-related transcripts in bfr1Δ 
yielded a very poor increase in the level of HAC1s (1.5 fold-change) and no change in the 
levels of KAR2, indicating no UPR activation under standard conditions. This suggests that 
the reduction in expression of the mainly secretory proteins showed by the ribosome 
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profiling experiment (Figure 4.27C) is insufficient to cause detectable stress. However, since 
IRE1 is one of the ORFs affected at the translational level in bfr1Δ (App. Data 1), the capacity 
of this mutant to fully activate the UPR should be analyzed in more detail. 
 
 
 
Figure 4.31. Characterization of BFR1 in the context of the UPR. (A) Relative mRNA levels of BFR1 in response 
to DTT in wild type and hac1Δ cells. Wild type (BY4741) and hac1Δ (Euroscarf) cultures were treated with 2.2 
mM DTT for 60 min. (B) Fold- change in mRNA levels of HAC1
u
, HAC1
s,
 and KAR2 upon either deletion of BFR1. 
Total RNA was extracted either from yeast strains wild type (BY4741), JEY06 (wild type ER-GFP), bfr1Δ 
(Euroscarf) and bfr1Δ ER-GFP (strain resulting from SGA crosses) grown in YPD under standard conditions. (A, 
B) cDNA was prepared from total mRNA according to 3.2.3 and 3.2.4 and RT-PCR was performed according to 
3.2.9. (A) Results show averages of mRNA abundance ± SD with respect to ACT1. For statistical significance, a 
two-tailed t-Student’s test was applied (n=3). (B) Fold-change is calculated by averaging Cts with respect to 
TAF10. Errors bars show the confidence interval. For statistical significance, a one-tailed t-Student’s test was 
applied to log (2
-ΔΔCt
), n=3. 
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4.3 Monitoring the role of protein O-mannosylation in protein 
dynamics 
In the context of investigating the role of O-mannosylation in maintaining protein 
homeostasis, the aim was to systematically approach the opposite effects described for 
O-mannosylation in protein stability (see 1.4.2 and 1.4.3). 
In order to get a comprehensive picture of the impact of O-mannosylation on protein 
stability, the first interest was to unravel the complexity of the redundant PMT family by 
looking at the contribution of each major PMT member. Secondly, the spotlight was put on 
those O-mannosylated proteins whose stability is increased upon PMT deletion, seeking for 
endogenous targets for a PMT-dependent quality control mechanism. 
One possibility to account for protein stability in vivo in a high throughput manner is the use 
of tandem protein timers (tFT). This method is based on the C-terminal fusion of the protein 
of interest to two different fluorescent proteins: mCherry and sfGFP; whose fluorophores 
have distinct maturation time (Figure 4.32A, Khmelinskii et al., 2012). While sfGFP is very 
efficiently folded after translation and thereby becomes rapidly fluorescent, mCherry takes 
longer time to fold and fluorescence can only be detected when the fused protein of interest 
was stable long enough to permit mCherry complete maturation. 
By using this system different aspects of protein dynamics can be investigated in vivo. One 
aspect of particular interest for this study is to account for protein stability. On one hand, 
the sfGFP signal allows the quantification of steady-state protein abundance since due to its 
folding kinetics it will become fluorescent independently of the age of the fused protein of 
interest. On the other hand, combining sfGFP and mCherry signals allows measuring 
differences in protein stability since only stable proteins will display mCherry fluorescence 
(Khmelinskii et al., 2012). Hence, conditions that decrease the mCherry/sfGFP ratio are 
indicative of decreased stability whereas increased ratios indicate protein stabilization. 
Besides stability, this system also allows to track protein localization and provides valuable 
information about the physical environment of the tFT. The fluorescence of each fusion 
protein with tTF facing the lumen will be differently affected by conditions that vary 
throughout the secretory pathway such as pH.  
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4.3.1 High throughput screen of dynamics of O-mannosylated proteins by tandem 
fluorescent timers 
 
The recently described yeast O-mannose glycoproteome, which includes 293 
O-mannosylated PMT-target proteins (Neubert et al., 2016) was used to select queries for 
the tFT screening. Fluorescence of a total of 137 tFT fusion proteins was analyzed in pmt1Δ, 
pmt2Δ, and pmt4Δ mutants in vivo (App. Data 2).  
pmt1Δ, pmt2Δ, and pmt4Δ deletions mutants were generated in the selected subset of 
O-mannosylated proteins tFT-fused by automated crossing following synthetic genetic array 
(SGA) methodology (see 3.3.2). Three replicates for each resulting cross as well as untagged 
negative controls were plated onto the corresponding selective medium and fluorescence 
for both sfGFP and mCherry of the resulting colonies was measured after growth at 30 °C for 
24h using a fluorescent plate reader (Figure 4.32B). A Δ-score was calculated based on the 
intensities of both fluorescent proteins for each mutant versus wild type. Δ-score for sfGFP 
accounts for changes in protein abundance upon PMT deletion whereas Δ-score for 
mCherry/sfGFP accounts for protein stability. In line with this, negative mCherry/sfGFP Δ-
score values indicate stabilization, while positive values mean destabilization of the tFT-
fusion protein in the mutant compared to the wild-type. While the deletion of PMTs had no 
major influence on the majority of proteins analyzed (App. Data 3, Figure App. 10), 
significant changes were observed for 39 individual proteins in total in the three pmtΔ 
mutants (Figure 4.33A and B). Among those, the tFT-fusion proteins Pmt3, Tsc3, Kre6, Opy2, 
Vth2, Ted1, Fab1, Lam6, YNL058c, Coy1, Osm1, YCR061w, Sec12, Nis1, and Mnl2 showed the 
most relevant changes in Δ-score (App. Data 3; net Δ-score > 0.5; p-value < 0.1). 
Fluorescence of luminal tFT can be affected by the change in localization induced by PMT 
deletion. This scenario was addressed first in order to narrow down the effects in Δ-score to 
changes in protein abundance and/or stability. 
Based on prediction (TOPCONS, Bernsel et al., 2009) C-terminal tFT of 59% of the identified 
proteins is localized at the cytosol (Figure 4.33C). As a proof of principle, localization of the 
fluorescent signal was analyzed for different representative C-terminally oriented proteins of 
the selected 39 positive fusions (e.g., Axl2, Coy1, Kre6, Mnn11, Osm1, Sec12, Ted1, Tsc3, 
Vrg4 and Wsc2, data not shown). No difference was observed in localization upon PMT 
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deletion (eg. Figure 4.36B), suggesting that the effects on Δ-score are restricted to changes 
in protein abundance and/or stability. 
 
 
Figure 4.32. Tandem fluorescent protein timer (tFT) screening. (A) Representation of a C-terminal tFT-fusion 
protein analyzed. The slow maturing mCherry and the fast maturing sfGFP are fused in tandem to the C-
terminus of O-mannosylated proteins of interest. Figure section designed by Patrick Neubert. (B) Workflow of 
the screening of the selected fusion proteins. In brief, 137 individual tFT fusions of the tFT library established by 
Khmelinskii and coworkers (Khmelinskii et al., 2014) were selected based on the presence of O-mannosyl 
glycans on these proteins (Neubert et al., 2016). The 137 tFT query strains were crossed with pmt1Δ (MLY201), 
pmt2Δ (MLY202), or pmt4Δ (MLY204) mutants using synthetic genetic array methodology (Baryshnikova et al., 
2010). Haploid yeast strains carrying both genetic modifications (tFT-fusion and pmt deletion) were selected. 
mCherry/sfGFP ratio was calculated for each protein and used for comparison between wild-type and mutants. 
Figure published in Castells-Ballester et al., 2018. 
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Figure 4.33. Identification of proteins affected in pmt1Δ, pmt2Δ, and pmt4Δ deletion mutants. (A) Volcano 
plots illustrating changes in tFT-fusion protein stability in the indicated mutant strains in regard to the 
statistical significance of data as inferred from variance analysis. Plots show Δ-scores mCherry/sfGFP for 
changes in protein stability on the x-axis and the negative logarithm of p-values on the y-axis. Data were subset 
for relevance based on thresholds as indicated by red dashed lines (p-value < 0.1 and net Δ-score > 0.2). (B) 
Correlation of Δ-scores mCherry/sfGFP, as a measure of tFT-fusion protein stability and turnover (x-axis), and Δ-
scores sfGFP, as a measure of the change in protein abundance (y-axis). (A, B) Data referring to proteins further 
analyzed or discussed in this study are labeled in red. The example of Vrg4-tFT shows that even minor effects 
could be reproducibly detected. (C) Heatmap with hierarchical clustering of Δ-scores mCherry/sfGFP from a 
subset of data that passes the thresholds of significance in at least one of the indicated mutant strains (p-value 
< 0.1 and net Δ-score > 0.2). Cytosolic and luminal orientation of the tFT reporter is indicated with C and L, 
respectively. Analyses and figure designs made by Patrick Neubert and published in Castells-Ballester et al., 
2018. 
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To further analyze the effect of each PMT deletion Δ-scores of each pmt mutant were 
hierarchically clustered (4.33C). Clustering shows a group of proteins with comparable 
responses to all pmt deletions. For example, Pmt3 and Sec12 are stabilized in all three 
deletions whereas Tsc3 and Wsc2 are destabilized. Consistent with these results, the effect 
of PMT deletion on Pmt3, as well as defects in Wsc2 maturation, has been shown in previous 
studies (Verna et al., 1997; Lodder et al., 1999; Girrbach & Strahl, 2003; Lommel et al., 
2004). On the contrary, other tFT fusions show unique effects upon the combined deletion 
of specific PMTs. This is the case of the destabilization effect is observed for Opy2 in pmt1Δ 
and pmt2Δ but not pmt4Δ or the opposing case for Axl2, which is destabilized only in pmt4Δ. 
The diversity observed among the different PMT deletions likely represents the substrate 
specificity of the Pmt1-Pmt2 and Pmt4-Pmt4 complexes.  
In summary, by a biased (O-mannoprotein directed) high throughput screen 39 tFT-fusion 
proteins were identified as potential candidates for altered protein abundance or stability 
upon deletion of PMTs. Noteworthy, both effects protein stabilization and destabilization 
can be inferred from the changes obtained on the reporters Δ-score. 
4.3.2 O-mannosylation impacts differently on the stability of secretory proteins 
 
As indicated by the Δ-score from the tFT screen, some tFT fusions are likely affected by PMT 
deletion in terms of abundance and/or protein stability. To evaluate the solidity of these 
results the analyses were first focused on the previously shown example of Axl2. Axl2 is a 
type I plasma membrane glycoprotein required for yeast axial budding and shown to require 
Pmt4 for proper maturation (Roemer et al., 1996; Sanders et al., 1999). In the tFT screen, 
Axl2 shows a Δ-score consistent with destabilization upon PMT4 deletion specifically (Figure 
4.33A and C).  
Next, it was of particular interest to address those tFT fusions that showed a Δ-score 
compatible with protein stabilization upon PMT deletion as potential targets of an 
O-mannosylation-directed quality control system. Among the potentially stabilized tFT 
fusions, Kre6, Vrg4, and Ynl058C were selected based on the most relevant Δ-scores 
identified with a p-value < 0.015 in pmt1Δ or pmt2Δ (App. Data 3). To confirm Axl2, Kre6, 
Vrg4, and Ynl058C PMT deletions were generated de novo on the respective parental tFT 
fusion strains and the Δ-scores shown in the screen were confirmed under logarithmic 
growth conditions by flow cytometry (Table 1). 
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Table 1. Fluorescence flow cytometry of selected candidate strains. Fluorescence intensities of sfGFP and 
mCherry were measured by flow cytometry in mutants EZY107 (pmt4Δ, Axl2-tFT), EZY91 (pmt1Δ, Kre6-tFT), 
EZY96 (pmt1Δ, Vrg4-tFT), EZY106 (pmt2Δ, YNL058C-tFT) and the corresponding wild-type strains. Intensity 
ratios were calculated as detailed in 3.3.2. Ratios > 1 and < 1 are indicative for protein destabilization and 
stabilization, respectively. Mean ± SD values of three measurements are shown. Indicated p-values were 
calculated using a two-tailed t-test. The experiment was performed in collaboration with Dr. Ewa Zatorska. 
Table published in Castells-Ballester et al., 2018 
pmtΔ Mutant tFT-Fusion Protein WTmCherry/sfGFP/pmtΔmCherry/sfGFP ± SD p-Value 
pmt4Δ Axl2 1.118 ± 0.033 0.088 
pmt1Δ Kre6 0.842 ± 0.027 0.037 
pmt1Δ Vrg4 0.873 ± 0.040 0.047 
pmt2Δ YNL058C 0.787± 0.042 0.010 
 
Consistent with what previously shown for Axl2, Axl2-tFT was found at the bud site of 
mother cells forming ring-like structures when tracking the sfGFP signal (Figure 4.34A, 
Roemer & Bussey, 1991; Sanders et al., 1999). The mCherry signal, however, was 
predominantly found at the vacuole, suggesting that this is the older fraction of the protein 
that undergoes vacuolar turnover. In contrast to wild type cells, PMT4 deletion results in 
vacuolar localization of the sfGFP signal, indicating that even younger protein undergoes 
turnover in pmt4Δ. When comparing the steady-state abundance of previously shown 
functional Axl2-HA with Axl2-tFT, a similar increase in the presence of degradation products 
was detected (Sanders et al., 1999, Figure 4.34B), indicating decreased stability in pmt4Δ. 
This data on Axl2-tFT is largely in agreement with what previously described and allows to 
further infer changes in protein stability from the Δ-score yielded in the tFT screen.  
Once confident with the solidity of the tFT screening, the effect of PMT deletion on protein 
stabilization was next investigated. In principle, increased protein stability should be also 
reflected in an increase in steady-state abundance. Among the confirmed tFT fusions Kre6, 
Vrg4 and YNL058C, Kre6-tFT was selected for further analyses because the Δ-score of both 
sfGFP and sfGFP/mCherry ratio met both criteria (Figure 4.33B). 
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Figure 4.34. Analyses of Axl2-tFT protein. (A) Wild type and pmt4Δ (EZY107) cells expressing the Axl2-tFT (WT 
Axl2-tFT resulting from SGA crosses, (Khmelinskii et al., 2012); and EZY107 strains) were grown in SD medium 
and imaged under standard conditions. Prior to imaging, cells were stained with the vacuolar vital dye 7-amino-
4-chloromethylcoumarin (CMAC). Scale bar, 5 µm. Figure section designed by Dr. Ewa Zatorska. (B) Membranes 
(equivalent to 1 OD600 units of yeast cells) from wild-type (MGY69) and pmt4Δ (MGY72) cells expressing Axl2-
HA or wild-type (WT Axl2-tFT, strain resulting from SGA crosses, Khmelinskii et al., 2012) and pmt4Δ (EZY107) 
cells expressing Axl2-tFT, were resolved on 8% polyacrylamide gels and subjected to Western blot analysis 
using anti-HA and anti-GFP antibodies, respectively. The full-length form of tagged Axl2 (black arrows) is less 
abundant in pmt4Δ than in corresponding wild-type cells. In the cells lacking Pmt4, C-terminal proteolytic 
fragments of the protein (white arrows) are detected. Differences in the apparent molecular masses of the full-
length forms and proteolytic fragments observed for Axl2-HA and Axl2-tFT, respectively, correspond to the 
calculated mass difference (−60 kDa) of the tags. Asterisks indicate an unrelated cross-reactive band, present 
also in the membranes isolated from wild-type cells without tFT-fusion protein (YMaM330). Sec61 served as a 
loading control. Experiments have been replicated three times; representative results are shown. Figure 
published in Castells-Ballester et al., 2018. 
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Kre6 is a type II transmembrane protein that functions in the synthesis of β-1,6-glucan that is 
deposited in the yeast cell wall (Roemer & Bussey, 1991). According to previous studies, 
Kre6 localizes to the ER and to a lesser extent to the plasma membrane at sites of cell wall 
remodeling (Kurita et al., 2012). Kre6-tFT showed partial ER localization from the sfGFP 
signal, however, the majority of the protein was found at the vacuole in both sfGFP and 
mCherry signals (Figure 4.35A). This result indicates that the addition of a large C-terminal 
tag might affect the stability or the localization of Kre6 itself, which likely undergoes 
vacuolar turnover. When analyzing Kre6-tFT in pmt1Δ (Figure 4.35A), an overall increase for 
both sfGFP and mCherry signals was observed. A stronger presence of ER localization could 
be observed from the sfGFP signal, which would be in agreement with the longer persistence 
of Kre6-tFT at the secretory pathway. Nevertheless, the overall increase in total fluorescence 
signal complicates drawing definitive conclusions. Still, although largely consistent with 
protein stabilization in pmt1Δ, Kre6-tFT shows unexpected vacuolar localization regardless of 
the genetic background.  
Kre6 has been described to require interaction with a set of chaperones for proper function 
(Takahashi et al., 2001; Kurita et al., 2012) and therefore it is possible that the tFT tag, which 
faces the lumen, might be hampering this interaction and thereby causing folding defects 
that trigger vacuolar turnover. To rule out that tFT induces general mislocalization of the 
type II proteins, correct localization of the Golgi mannosyltransferase Mnn11-tFTwas 
confirmed (Figure 4.36A and B). In order to test the increased stability of Kre6-tFT upon 
PMT1 deletion, Western blot was performed to address increased protein abundance, and 
cycloheximide chase followed by Western blot to address changes in protein stability. In 
agreement with the Δ-score yielded at the screen, pmt1Δ results in an increased abundance 
of Kre6-tFT (Figure 4.34B, left panel). Increased Kre6-tFT turnover was observed in wild type 
cells in comparison with pmt1Δ, where Kre6-tFT remains even after 3h after the addition of 
cycloheximide (Figure 4.35B, right panel). 
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Figure 4.35. Analyses of Kre6-tFT protein. (A) Localization of Kre6-tFT protein. Wild-type and pmt1Δ cells 
expressing the Kre6-tFT (strains WT Kre6-tFT and EZY91, respectively) were grown in SD and imaged under 
standard conditions. Prior to imaging, cells were stained with the vacuolar vital dye CMAC. In wild-type and 
pmt1Δ cells Kre6-tFT is present in the ER, but mainly in the vacuole. Scale bar, 5 µm. Figure section designed by 
Dr. Ewa Zatorska (B, C) Cell lysates from wild-type (WT Kre6-tFT) and pmt1Δ (EZY91) cells expressing Kre6-tFT 
were resolved on 8% polyacrylamide gels and subjected to Western blot analysis using anti-GFP antibodies. 
Pgk1 served as a loading control. (B) Steady-state levels of Kre6-tFT. Cell lysates equivalent to 0.2 OD600 units of 
yeast cells were analyzed. (C) Cycloheximide chase analysis. Cell lysates equivalent to 0.2 OD600 units (1x; 
pmt1Δ) and 0.4 OD600 units (2x; WT) of yeast cells were analyzed, to allow for better comparability. (B, C) Three 
forms of Kre6-tFT were detected as previously demonstrated for the native protein (Takeuchi et al., 2008). The 
major band is more abundant at steady state (B) and slower degraded (C) in mutant pmt1Δ. Experiments have 
been replicated at least two times; representative results are shown. Figure published in Castells-Ballester et 
al., 2018. 
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Figure 4.36. (A)Topology model of Axl2, Kre6 and Mnn11 depicting the orientation of the tFT timer for type I 
and type II transmembrane proteins. Figure section designed by Patrick Neubert. (B) Localization of another 
type II transmembrane protein, Mnn11-tFT, to the Golgi is not affected by the C-terminal tFT reporter. Lower 
abundance of old Mnn11-tFT (mCherry) in pmt4Δ cells when compared to wild-type strain confirms the 
destabilization of this protein observed upon decreased O-mannosylation. Prior to imaging, cells were stained 
with the vacuolar vital dye CMAC. Scale bar, 5 µm. Figure section (B) designed by Dr. Ewa Zatorska. Figure 
published in Castells-Ballester et al., 2018. 
 
In summary, these results show the suitability of using in vivo fluorescent timers to monitor 
the influence of O-mannosylation on protein stability. 137 secretory O-mannoproteins were 
analyzed upon the deletion of the major members of the PMT family and confirmed previous 
data on the requirements of this post-translational modification for protein maturation. 
More interestingly, O-mannosylation is likely required for the turnover of a set of 
endogenous secretory proteins. Putting the spotlight on Kre6, vacuolar mislocalization was 
observed for Kre6-tFT, where PMT1 becomes necessary for efficient turnover. Therefore, it 
was concluded that O-mannosylation is an important contributor for protein stability and 
that whether the influence of O-glycans is positive or negative largely depends on the nature 
of the substrate. 
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5 DISCUSSION 
5.1 The function of PMTs during protein folding stress 
 
As a start point of this current work, the relationship between protein O-mannosylation and 
ER stress via the UPR was investigated. Under conditions where the ER lumen faces an 
unbalance between an increased load of unfolded polypeptides and the folding machinery, 
the activation of the UPR becomes vital to restore ER homeostasis (reviewed in Thibault et 
al., 2011).  
Previous studies pointed out the requirement of the UPR when O-mannosylation is 
compromised. PMT1, PMT2 and PMT4 show synthetic lethality with HAC1 (Arroyo et al., 
2011), also identified by high throughput methods as negative genetic interaction (Ernst, 
2013; Costanzo et al., 2016). The sensitivity of the hac1Δ mutant to the general PMT 
inhibitor R3A-5a has been shown (Zatorska et al., 2017). One hypothesis to explain these 
observations would be that abrogating O-mannosylation would result in the accumulation of 
immature unfolded or misfolded forms of secretory proteins that would be eventually 
recognized by Ire1. Supporting this hypothesis there is the assumption that O-glycans confer 
solubility to secretory proteins and therefore prevent protein aggregation in the ER lumen 
(Harty et al., 2001; Vashist et al., 2001; Nakatsukasa et al., 2004; Hirayama et al., 2008; 
Murakami-Sekimata, Sato, Takashima, et al., 2009). 
In this study, a specific and bidirectional relationship within the redundant PMT family is 
shown between the Pmt1-Pmt2 complex and the activation of the UPR. First, only the Pmt1-
Pmt2 complex prevents the activation of the UPR under standard conditions (Figure 4.2). 
Specifically, for pmt1Δ mutant comparable upregulation of KAR2 transcript and protein 
levels were reported in the course of this current work (Cui et al., 2015). Second, PMT1 and 
PMT2, in contrast to PMT4, are specific targets of the UPR (Figure 4.1). Moreover, during the 
characterization of ER-GFP as a UPOM substrate, a high correlation was observed between 
the spliced version of HAC1 mRNA and increased protein abundance of Pmt1 and Pmt2 but 
not Pmt4 (Figure 4.4).  
These data argue against that O-mannosylation, in general, prevents UPR, since even the 
combination of multiple PMT deletions (Figure 4.2, see pmt4356), is insufficient to produce 
detectable stress as it is the case when deleting PMT1 or PMT2. Is then UPR activation a 
  
124 
consequence of a specific function of the Pmt1-Pmt2 complex during protein quality 
control? 
One common feature of the ER quality control system is that malfunction caused by the 
absence of key components results in UPR activation as it is, for instance, reported for 
proteins working on ERAD or affecting vacuolar function (Jonikas et al., 2009; Promlek et al., 
2011). Likewise, as reviewed in the introduction and showed for the specific example of ER-
GFP, UPOM has been so far restricted to the function of the Pmt1-Pmt2 (1.4.2, 4.2.1.1). 
Furthermore, Pmt1 is shown as necessary for the correct degradation of mislocalized Kre6 
(See 4.3.3), which suggests that UPOM might be a relevant pathway to facilitate degradation 
for certain endogenous secretory proteins (discussed in 5.3). Although not analyzed further, 
also pmt2Δ mutant displayed a phenotype compatible with the stabilization of Kre6-tFT 
(Figure 4.35) supporting the idea of the Pmt1-Pmt2 complex working in concert with ER 
protein quality control mechanisms.  
However, the pieces of evidence supporting a specific quality control-related function of the 
Pmt1-Pmt2 complex do not completely rule out that insufficient O-mannosylation of bona 
fide substrates may be also a cause of ER stress. It is still possible, that the Pmt1-Pmt2 
complex has a broader range of protein targets in comparison with other PMTs. The absence 
of PMTs that are minor contributors to the overall O-mannose glycoproteome may be 
insufficient to activate the UPR. Although the Pmt1-Pmt2 complex has been considered as 
the major PMT machinery (Gentzsch & Tanner, 1996), this statement is only supported by 
the severity of the phenotype manifested by the multiple mutants: In contrast to PMT4, 
deletion of PMT2 is lethal in combination with the minor PMT3, PMT5, and PMT6 (Martin 
Loibl, unpublished). Moreover, the determinants that define substrate specificity among 
PMTs remain unknown. Only the Pmt4-Pmt4 complex has been linked to O-mannosylation of 
Serine/threonine rich regions in the vicinity of membrane-anchoring sequences (Hutzler et 
al., 2007). It is therefore not possible to answer the question of which PMT complex has a 
stronger contribution to the overall O-mannose glycoproteome with the data available so 
far. 
Furthermore, the specificity of the Pmt1-Pmt2 complex being integrated in the UPR could be 
the consequence of the malfunction of specific downstream effects of the PMT1 or PMT2 
deletion. Multiple key members of the folding and quality control machinery have been 
revealed to be O-mannosylated (Neubert et al., 2016). In a hypothetical scenario of Pmt1-
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Pmt2 complex being specific for one or more of these key quality control factors, 
hypoglycosylation of those could be the reason behind UPR activation in pmt1Δ or pmt2Δ.  
Taken together, by dissecting the PMT family and analyzing the relationship between each 
major PMT member with the UPR, the relevance of the Pmt1-Pmt2 complex in maintaining 
ER homeostasis is highlighted. One likely reason is the role described for this particular 
protein complex as a contributor to the quality control of aberrant proteins. Considering the 
example of ER-GFP, UPR activation in pmt1Δ and pmt2Δ could be the cost of abnormally 
prolonged folding attempts for proteins that would otherwise be discarded by UPOM. Still, it 
would not be valid to consider a role in protein quality control as the only explanation 
behind the concert between UPR and the Pmt1-Pmt2 complex, since dissecting the 
O-mannose glycoproteome into each single PMT member’s contribution is still a future 
challenge.  
5.2 ER-GFP drives the hunt for UPOM components 
 
Being aware of the obstacles of targeting the complex mechanism of UPOM, it was taken 
advantage of ER-GFP as a reporter to perform a high throughput screen searching for UPOM 
components. The initial characterization of ER-GFP confirmed previous data showing that it 
is indeed a specific target of the Pmt1-Pmt2 and not the Pmt4-Pmt4 complex (Figure 4.5). 
Contrary to ER-GFPf, expression of ER-GFP causes ER folding stress, triggers the activation of 
the UPR and thereby the transcriptional upregulation of PMT1 and PMT2 (Figure 4.6). 
Increased levels of the Pmt1-Pmt2 complex likely favor the efficiency of UPOM and 
therefore factors monitoring ER-stress (E.g. Ire1) and/or driving the upregulation of the 
Pmt1-Pmt2 complex (E.g. Hac1) could be potentially found in the screening. In the case of 
ire1Δ and hac1Δ, haploids resulting from crosses with wild type expressing ER-GFP were 
inviable (data not shown). Probably the overexpression of ER-GFP when the UPR is impaired 
results in cell lethality as previously shown for other misfolded protein models (Spear & Ng, 
2003).  
 
Moreover, the relevance of the HDEL signal included in the ER-GFP construct was analyzed. 
As hypothesized in (Harty et al., 2001), UPOM could be favored by the prolonged stay of 
UPOM targets in the ER lumen. In the case of non-retained ER-GFP, UPOM works 
independently of ER-retention and contributes to the folding state of non-retained ER-GFP 
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(Figure 4.7A and C). When qualitatively comparing the extent of UPOM received by ER-GFP 
with and without HDEL signal, no major difference was observed in the presence of the 
O-mannosylated fraction by Western blot (Figure 4.7B). This implies that ER retention is not 
crucial for UPOM since this type of O-mannosylation seems to precede the recruitment of 
cargos for ER-Golgi transport, at least in the case of ER-GFP. Supporting this idea, expression 
of both retained and non-retained ER-GFP cause comparable UPR activation (Figure App 8). 
If it is assumed that the degree of UPR activation largely depends on the extent of unfolded 
regions being recognized by chaperones and by Ire1 itself; and that UPOM disengages 
chaperones from unfolded segments (Nakatsukasa et al., 2004; Pincus et al., 2010; C. Xu et 
al., 2013), it is deduced that both versions of ER-GFP interact with chaperones during a 
comparable time window until UPOM takes place. In general, it is accepted that immature 
proteins, meaning those still interacting with chaperones, are prevented to be packaged into 
COPII vesicles (reviewed in Geva & Schuldiner, 2014).  
 
In addition, during the characterization of non-retained ER-GFP, it was noticed that ER-GFP is 
eventually targeted to the vacuole, where it undergoes degradation in a Pep4-dependent 
manner (Figure 4.7 and 4.8). It is important to note that ER-GFP fluorescence is significantly 
lower in the vacuole, likely because of both the ongoing protein degradation as well as the 
acidic environment of the vacuolar lumen. This fact gains importance in the context of a high 
throughput screen, where efficiency of UPOM was about to be inferred from the 
fluorescence intensity of ER-GFP in deletion mutant libraries. As described by Copic and 
colleagues (2009), there are several deletions that interfere with the function of Erd2, the 
main cargo receptor for proteins bearing HDEL retention signals. These deletions would 
result in the release of ER-GFP from the ER, vacuolar degradation and thereby decrease of 
fluorescence intensity, biasing the interpretation of the results of the ER-GFP screening. 
Precisely, one mutant described at (Copic et al., 2009) is pgi1-DAmP, which was found 
affecting UPOM (Figure 4.12). With these considerations, the non-retained version of ER-GFP 
was used to anticipate misinterpretations when analyzing the fluorescence intensity of ER-
GFP in pgi1-DAmP (Figure 4.17)  
 
The screening yielded 107 mutants for genes potentially involved in UPOM. The fraction of 
mutants considered positive corresponds to about 5% of the total number of mutants tested 
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and indicates that fluorescence of ER-GFP is not affected upon the deletion of the majority 
of non-essential genes. The suitability of ER-GFP to report defects in UPOM was proven by 
the presence of pmt1Δ and pmt2Δ among the positive hits of the screen. The diversity of GO 
term categories and the low enrichment score pointed out the absence of a clear biological 
pathway affecting UPOM. This is consistent with the fact that UPOM is not a preceding step 
for any quality control pathway but rather works independently, sometimes facilitating 
degradation depending on the nature of each the UPOM target (see 5.3). In parallel to this 
work, a conceptually similar study was conducted by the group of Davis Ng and focused on 
finding factors that diminish the folding capacity of ER-GFPf (Zhang et al., 2017). Although the 
purpose of their study largely differed from this current work, the functional heterogeneity 
in the mutants found in both screenings is comparable. This indicates that despite not so 
many mutations interfere in ER-GFP intensity, the deletions that do so cause malfunction in 
many diverse cell machinery, many of which are unconnected to the quality control of 
secretory proteins. 
Given the high noise within the 107 positive mutants, different filters were applied to 
discriminate those mutants that are directly linked to O-mannosylation and UPOM.  
First of all, ER localization of the GFP signal was manually curated for the 107 positive 
mutants and was confirmed for all of them except for spf1Δ (Figure App 3). Spf1 is a P-type 
ATPase that works at the ER membrane as an ion transporter maintaining the homeostasis 
of Ca2+ (Cronin et al., 2002). In the context of this work, deletion of SPF1 results in partial 
cytosolic folding of ER-GFP where, due to the folding environment and the absence of 
O-mannosylation (Jain et al., 2001; D. G. Huang & Shusta, 2006), it displays the highest 
fluorescence intensity of all mutants tested (Figure 4.10). Literature highlighting the 
importance of Spf1 for ER homeostasis is abundant (Cronin et al., 2002, Y. Chen et al., 2005, 
Cohen et al., 2013) and although an ER import defect has not been described so far, it is 
possible that this is a consequence of the strong overexpression conditions of ER-GFP used 
in the screen in a scenario of already compromised homeostasis. 
Qualitative evaluation of the O-mannosylation state of the cell wall protein Hsp150 by 
western blot was used to track general changes in glycosylation and yielded 12 mutants that 
display Hsp150 phenotype compatible with hypoglycosylation. Among those, one of the 
most prominent is pop2Δ, in which a major subunit of the Ccr4-Not complex is deleted. This 
complex mediates 3' to 5' mRNA de-adenylation prior to mRNA decay. Although the pop2Δ 
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mutant did not show a clear reduction of O-mannosylation of ER-GFP (Figure 4.12), it would 
be interesting to question whether the post-transcriptional regulation of PMT expression 
could also include mRNA decay mechanisms. Particularly after the link shown between PMT 
expression and protein translation efficiency (See 4.2.4) 
Unexpected connections of UPOM to N-glycosylation were found among the 109 positive 
mutants such as cwh41Δ and ost3Δ. CWH41 encodes the α-glucosidase I in charge of 
trimming N-glycans during glycoprotein folding cycles (See 1.4.1). As it works in mammals 
with the calnexin-calreticulin cycle (Trombetta & Helenius, 2000), glucose removal sets up a 
time window for glycoprotein folding before Mns1 and Htm1 mannosidases are recruited 
and generate a signal recognized by Yos9 for ERAD (Benitez et al., 2011). Interestingly, as it is 
shown for O-mannosylation (see 1.4.2), CWH41 has been involved in the degradation of 
misfolded proteins (Hitt & Wolf, 2004). Ost3 is a subunit of the OST complex described to 
determine the substrate specificity of OST (Schwarz et al., 2005). Ost3 was recently reported 
to be necessary for Pmt2 N-glycosylation although no direct evidence of decreased 
O-mannosylation was observed in ost3Δ (Zatorska et al., 2017). However, the formation of 
ER-GFP oligomers as a consequence of ER-GFP misfolding (C. Xu et al., 2013) was 
significantly reduced in ost3Δ (Ewa Zatorska, 2017, unpublished) indicating that ER-GFP 
indeed folds more efficiently in the absence of OST3. Both CWH41 and OST3 do not seem to 
intrinsically modulate UPOM, but their influence in the quality control of secretory proteins 
is an attractive scenario to investigate. 
Next, the efficiency of UPOM was analyzed in the positive mutants by the presence of the 
O-mannosylated fraction of ER-GFP. Analysis of 97 mutants revealed that UPOM was 
affected in four of them: bfr1Δ, pgi1-DAmP, and Psa1-DAmP, which showed clear UPOM 
reduction. At this point, it is relevant to mention that although judging the efficiency of 
UPOM by the presence of O-mannosylated ER-GFP by Western blot was done in a qualitative 
manner, very stringent criteria were used in terms of only selecting those mutants that 
showed clear hypoglycosylation of ER-GFP. Therefore, it is still possible that milder but still 
significant reduction of UPOM in other mutants might have been unnoticed. 
5.2.1 A link between sugar metabolism and ER protein folding stress 
 
Among the mutants found in the screening, the deficient UPOM of ER-GFP was confirmed by 
western blot for both psa1-DAmP and pgi1-DAmP mutants (Figure 4.12). Both genes PSA1 
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and PGI1 are involved in the cytosolic reaction cascade that converts glucose-6-phosphate 
into GDP-mannose, which will be subsequently used as a substrate to generate the sugar 
donor for both N- and O- glycosylation machinery as well as for the formation of the GPI 
anchor.  
Two reasons encouraged to put the focus on characterizing PGI1: First, the pgi1-DAmP 
mutant displayed a more severe hypoglycosylation of ER-GFP (Figure 4.12B). Second, unlike 
for PSA1, no CDGs have been associated with PGI1 defects in humans, which indicates that 
the impact of PGI1 on protein glycosylation has not been characterized in detail.  
The O-mannosylation state of ER-GFP in pgi1-DAmP strongly relies on the availability of free 
mannose (Figure 4.15), suggesting that limiting the cytosolic substrate of the PMT machinery 
has a strong impact on the efficiency of UPOM. Recombinant overexpression of MPG1, the 
homolog of Trichoderma reesei, was shown to cause an increase in the intracellular levels of 
GDP-Man, an increase in the expression of Dpm1 and an overall increase in 
mannosyltransferase activity (Zakrzewska et al., 2003) Accordingly, the opposite effect could 
be expected when limiting the accessibility of fructose-6-phosphate (see figure 4.13). 
In fact, there is a functional relationship between PMT2 and PGI1 since the deletion of PMT2 
on top of the pgi1-DAmP knockdown results in a severe growth defect. Although either 
pmt2Δ or pgi1-DAmP alone does not impair growth, both O-mannosylation and the 
isomerization of glucose-6-phosphate into fructose-6-phosphate are vital processes and 
therefore it is not surprising that both mutations have additive negative effects when 
combined (Figure 4.15, upper panel). Together with PMTs, the potential depletion of GDP-
mannose would also impact the efficiency of the N-glycosylation as well as the synthesis of 
the GPI anchor. Since these two processes are also functionally linked to O-mannosylation 
(Ecker et al., 2003; G. Huang et al., 2003), it is likely that their malfunction also contributes 
to the phenotype of pmt2Δpgi1-DAmP double mutant. 
UPOM of ER-GFP in pgi1-DAmP can be rescued by including mannose as the carbon source in 
the medium, so presumably, fructose-6-phosphate is no longer a necessary intermediate to 
synthesize mannose-6-phosphate. Under these conditions, both UPOM in pgi1-DAmP and 
growth in pmt2Δpgi1-DAmP are restored (Figure 4.15 and 4.16).  
Furthermore, the impact of mannose supplementation in pgi1-DAmP in regard to ER-GFP 
folding was investigated. Upon mannose supplementation, folding of ER-GFP in the pgi1-
DAmP mutant is prevented similar to wild type (Figure 4.17), confirming that the availability 
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of mannose contributes to the folding competency of secretory proteins. In agreement, 
pgi1-DAmP cells display constitutive activation of the UPR and increased sensitivity to the ER 
stress agent tunicamycin (Figure 4.18 A and B). Both phenotypes can be rescued when 
supplementing pgi1-DAmP cells with mannose, indicating that the activation of the UPR 
occurring at the ER can be tuned by the availability of sugars at the cytosol. This is 
particularly relevant since there is increasing literature that links the UPR with spatially 
unconnected processes occurring at the cytosol (Ishiwata-Kimata et al., 2013; Schmidt et al., 
2019) or mitochondria (Knupp et al., 2019).  
Isomerization of glucose-6-phosphate into fructose-6-phosphate by PGI1 is a key reaction of 
glycolysis. Mutations in GPI1, the human homolog of PGI1 have been associated with a rare 
hereditary hemolytic anemia sometimes accompanied by neurological impairment (W. M. 
Xu & Beutler, 1994; Kanno et al., 1996). Most of the symptoms of GPI1 deficiency have been 
assumed to be caused by impaired metabolism of glucose or explained by the potential 
neurotrophic properties of GPI1 (Kugler et al., 1998). No effect on protein glycosylation 
neither in yeast and humans has been described for PGI1 mutants so far. Given the high 
degree of conservation of glycolytic enzymes in eukaryotes it is expected that besides 
defects in glycolytic metabolism, GPI1 malfunction also results in hypoglycosylation of 
secretory proteins that could have well been unnoticed.  
In yeast, most of the hypoglycosylation-associated phenotypes of pgi1-DAmP can be relieved 
by bypassing the need for endogenous synthesis of mannose-6-phosphate. It would be 
relevant to explore whether these observations translatable to human patients of hemolytic 
anemia. Interestingly, mannose supplementation has been proven to be suitable for patients 
suffering from CDG associated genes that act downstream of PGI1 in the pathway such as 
the mannosephosphate isomerase MPI and the phosphomannomutase PMM2 (homolog to 
the yeast PMI40 and SEC53, and associated with CDG-Ib and CGD-Ia, respectively) 
(Grunewald et al., 2002; Thiel et al., 2012; Witters et al., 2017). In the case of GPI1, It is 
feasible that its role in glycolysis complicates the use of mannose-based nutritional therapies 
to cope with the expected CDG due to the existing unbalance in sugar metabolism. 
Nevertheless, mannose-based therapies can cause osmotic diarrhea among other undesired 
side effects on CDG-Ib patients (Alton et al., 1997; Freeze & Aebi, 1999). Yet, whether 
mannose supplementation could be applied to hemolytic anemia patients to alleviate some 
of the symptoms is an attractive hypothesis that could be explored in the future. Baker’s 
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yeast is a suitable platform to investigate defects in protein glycosylation that are possibly 
linked to hemolytic anemia as well as to analyze to which extent mannose-based nutritional 
therapies are a realistic option. 
Overall, the data shown in this current work indicate that PGI1 is a key contributor for ER 
homeostasis and UPOM and provides a direct link between the UPR and sugar metabolism.  
5.2.2 Local protein translation control as a contributor to ER homeostasis 
 
In the frame of the ER-GFP screening, BFR1 was found as necessary for efficient UPOM 
(Figure 4.12 and 4.13). Clues on how Bfr1 could influence O-mannosylation appeared when 
looking at the mRNAs previously shown to interact with Bfr1. Among the mainly secretome-
related transcripts, there was PMT1 and PMT2 (Lapointe et al., 2015), leading to the 
hypothesis of Bfr1 modulating PMT expression.  
The steady-state protein abundance of Pmt1 and Pmt2 is certainly dependent on Bfr1 
(Figure 4.20). Further, it was confirmed that the effect of BFR1 deletion on PMTs is the 
reason behind ER-GFP hypoglycosylation since PMT2 overexpression is partially able to 
restore ER-GFP folding and glycosylation (Figure 4.21A and B). Although previously published 
data strongly supported a role for Bfr1 in regulating PMT expression, a cycloheximide chase 
experiment was performed to address potential changes in protein stability. The preliminary 
results showed that the PMT proteins are very stable, and no changes were detected in 
bfr1Δ (data not shown). 
In order to find out at which level Bfr1 regulates PMT expression, whether the decrease in 
PMT protein levels was the result of transcriptional downregulation was first questioned. RT-
PCR analyses showed that the effect at the protein level is not coupled to decreased 
transcript abundance under normal conditions (Figure 4.24A). Significant reduction of 
transcript levels was nevertheless observed for PMT2 both upon ER stress (Figure 4.24A), 
where PMT1 and PMT2 undergo upregulation via the UPR, or when mirroring such 
upregulation by PMT2 overexpression (Figure 4.24B). By promoter replacement it was 
clarified that the observed specific effect of BFR1 deletion on PMT2 transcript level is 
promoter-dependent (Figure 4.25B) and uncoupled to the effect at the protein level (Figure 
4.25A), which is constant under all conditions tested (Figures 4.20, 4.21C and 4.25A). 
The involvement of Bfr1 in post-transcriptional mRNA processing events (Simpson et al., 
2014) led to the hypothesis that Bfr1 could perhaps play a protective role for its client 
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transcripts in addition to its role at the protein level. This idea was also supported by the 
increase of mRNA decay nodes when Bfr1 and/or its cognate partner Scp160 are deleted 
(Weidner et al., 2014). By performing the transcriptional shutdown of PMT2 no link of Bfr1 
to altered mRNA decay was observed to explain the above-mentioned particular effect on 
PMT2 transcript (Figure 4.26). At this stage of the project, what underlies PMT2 transcript 
reduction under certain conditions remains unanswered. One option supported by the 
dependence of this effect on the gene promoter is that PMT2 simply undergoes 
transcriptional downregulation as the sum of downstream effects of BFR1 deletion and ER-
stress. Alternatively, modifications on galactose-induced PMT2, which additionally contains a 
degron and a C-terminal HA tag, might interfere with the transcript decay, burying potential 
changes that would be only effective for PMT2 native transcript. This second explanation 
considers that the mRNA determinants that recruit Bfr1 are unknown. Whether specific 
transcript recognition by Bfr1 is based on a consensus sequence or perhaps on secondary 
structures has not been addressed so far. Notably, the interaction between P-body 
components and mRNAs based on conformational cues has been shown for the RNA helicase 
Dhh1 (Jungfleisch et al., 2017).  
 
Given that under standard conditions mRNA level of both PMT1 and PMT2 remained 
unchanged in bfr1Δ (Figure 4.24A), efforts were focused on characterizing a potential role of 
Bfr1 on PMT translation. Analysis of ribosome-protected mRNA footprints revealed a 
decrease in ribosome occupancy of a set of transcripts in the absence of BFR1 (App. Data 2). 
Among those, PMT1 and PMT2 transcripts were approximately 1.7 fold-change 
underrepresented in bfr1Δ translatome (Figure 4.27), confirming that Bfr1 regulates UPOM 
by affecting the translational state of PMT transcripts. Noteworthy, known Bfr1 targets were 
enriched among those ORFs that are underrepresented in bfr1Δ translatome, which 
indicates that Bfr1 likely functions as a translational enhancer rather than as a repressor 
(Figure 4.27C).  
Although described as part of ribosome-associated mRNP complexes, no previous study 
pointed out Bfr1 to act at the translational level. The first intriguing question is how Bfr1 
could modulate the translational state of its client transcripts. The fact that in absence of 
BFR1 fewer ribosomes sit on transcripts together with the decreased steady-state protein 
amounts observed at least for Pmt1 and Pmt2 suggests that Bfr1 might work as a translation 
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control factor facilitating the recruitment of its client transcripts with the ribosome at the 
initial stages of translation.  
 
However, metagene analysis of footprint distribution revealed a slight accumulation of 
footprints in the first 100 codons in bfr1Δ (Figure App. 9B), suggestive of defects in 
translation elongation similar to what previously observed by comparable methods when 
inducing ribosome stalling or translational slow-down (Gerashchenko & Gladyshev, 2014, 
Subramaniam et al., 2014, Schuller et al., 2017). Notably, defects in translation elongation 
coupled to decreased protein production have been linked to the absence of Scp160 
(Hirschmann et al., 2014), an RNA-binding protein (RBP) that forms a stable complex with 
Bfr1 (Lang et al., 2001). The link between Scp160 and translation is based on the analysis of 
the codon composition of Scp160 mRNA targets and the ribosomal occupancy of tRNAs upon 
Scp160 loss (Hogan et al., 2008). It is proposed that the absence of Scp160 results in loss of 
synonym-rich tRNAs by causing either tRNA diffusion or facilitating tRNA recycling, thereby 
affecting translation efficiency. A similar function could be conceived for Bfr1, however 
slowing down translational elongation would conceptually result in prolonged engagement 
with ribosomes and thereby increased ribosome occupancy which is in evident contradiction 
with the ribosome profiling data. A potential explanation for this discrepancy could rely on 
the interaction between Bfr1 and Scp160. Despite the fact that deletion of either BFR1 or 
SCP160 causes a very similar phenotype in terms of cells morphology and both proteins have 
been shown to have partially overlapping functions in different contexts (Lang et al., 2001; 
Baum et al., 2004; Sezen et al., 2009), the functional relationship between these two RBPs is 
far from being clear. One interesting observation is the dependence of Scp160 on Bfr1 for 
interaction with polyribosomes (Lang et al., 2001) which might imply that Scp160 is 
prevented to function in optimizing translation efficiency in the absence of BFR1. Therefore, 
the slight accumulation of footprint in the first 100 codons of Bfr1 target ORFs might 
represent the loss of Scp160 function, independent of the more probable role of Bfr1 in 
facilitating translation initiation for its cognate transcripts.  
 
In order to gain insight into the molecular mechanism of Bfr1, the localization of PMT 
transcripts to the ER membrane was investigated. No difference was found in transcript 
localization to the ER membrane in bfr1Δ (Figures 4.29 and 4.30), indicating that co-
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translational targeting of ribosomes to the ER membrane occurs independently of Bfr1. Both 
the SRP-dependent or the more recently described SRP-independent (SND) targeting 
pathways rely on the emergence of hydrophobic polypeptide chains (transmembrane 
domain or signal peptide)(Aviram et al., 2016; reviewed in Aviram & Schuldiner, 2017), an 
event that occurs sequentially after the assembly of the translation initiation complex where 
Bfr1 function might be integrated. Supporting the independence of Bfr1 to ribosome-to-ER 
targeting pathways, there is no preferential enrichment of SRP –dependent or independent 
proteins among the ORFs affected in bfr1Δ, indicating that the secretory proteins are 
generally affected (Figure App. 9B). 
Co-localization of Bfr1 with the ER membrane seems to correlate fairly well with the 
presence of ribosomes (Figures 4.29C and App.9D), suggesting that Bfr1 is directly recruited 
to ribosomes that would eventually carry it to the ER membrane. Supporting this model, the 
interaction of Bfr1 with the ER membrane is shown to be abolished after RNase treatment 
(Lang et al., 2001). One interesting factor that could function recruiting Bfr1 to ribosomes is 
the conserved core component of the 40S ribosomal subunit RACK1/Asc1 (Inada et al., 
2002). Asc1 is thought to function as a scaffold protein for multiple kinases and membrane 
receptors (McCahill et al., 2002; Ben-Shem et al., 2010), integrating inputs from different 
signaling pathways (Melamed et al., 2010; Schmitt et al., 2017). Furthermore, Asc1 has been 
directly linked to translation initiation (M. K. Thompson et al., 2016; Gerbasi et al., 2018), as 
it seems to interact with eIF4G and eIF3b initiation factors (Gavin et al., 2002) and other 
RBPs such as Sro9p and Gis2p, thought to feed the ribosome with nuclear transcripts (Opitz 
et al., 2017). Asc1 is also associated with other processes in the context of the ribosome 
such as ribosome quality control (Brandman et al., 2012; Wolf & Grayhack, 2015; Ikeuchi & 
Inada, 2016) or translation control of specific mRNAs (Shor et al., 2003). Interestingly Asc1 is 
associated with Bfr1 and Scp160 in an RNA-dependent manner (Sezen et al., 2009; Opitz et 
al., 2017) and seems to play a role in local translation control events at the nuclear envelope 
(Sezen et al., 2009). Interaction of Scp160 with polysomes is also Asc1-dependent (Baum et 
al., 2004), suggesting that Asc1 could work as a platform to recruit Scp160 and also Bfr1 to 
the ribosome. Taking all these observations together, a hypothetical model could be that 
Bfr1 is recruited to the 40S subunit of the ribosome by Asc1 and captures its target 
transcripts by the time translation initiation occurs. Perhaps Bfr1 is loosely interacting with 
ribosomes by default and this interaction is stabilized by the presence of a Bfr1 target 
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transcript. This however does not answer the question of how Bfr1 recognizes and 
discriminates between its client transcripts. Ribosome profiling of bfr1Δ revealed 510 ORFs 
being at least 1.5 fold-change underrespresented in the translatome (Figure 4.27, App. Data 
2). Bfr1-dependent proteins highly correlate with Bfr1 mRNA targets (Lapointe et al., 2015) 
and are significantly enriched for secretory proteins (Figures 4.27 and App.9), suggesting 
that Bfr1 represents a novel mechanism of local translation control at the ER membrane, 
where most of these proteins are actively translated (Jan et al., 2014). Although it is far too 
early from being able to propose a mechanism behind the specificity shown by Bfr1 towards 
secretory proteins, one possibility is that the interaction with its target transcripts is 
achieved by specific determinants on the mRNA sequence that could be recognized and 
stabilized by Bfr1 on the ribosome. As mentioned above, determinants of client transcripts 
may consist of both specific sequons and/or secondary structures that would recruit Bfr1. 
The question of how Bfr1 interacts with mRNA was already raised in previous studies (Hogan 
et al., 2008; Lapointe et al., 2015). Based on domain prediction Bfr1 protein structure lacks 
any classical RNA-interacting domains while having three independent coiled-coil domains, 
regions previously showed to crosslink with mRNA (Kramer et al., 2014) indicating that they 
most likely represent the effector domains for RNA binding. In line with this, multiple RBPs 
have been shown in the last years to carry non-canonical RNA-binding domains (Baltz et al., 
2012; Beckmann et al., 2015; Hentze et al., 2018). In-depth scrutiny of the ribosome profiling 
metadata and/or directed mutagenesis of Bfr1 targets are potential approaches to solve the 
riddle. 
 
5.2.3 At both, sugar donor and enzyme abundance levels: How to fine-tune UPOM 
 
Putting together the findings from the ER-GFP screening, PGI1 and BFR1 were confirmed and 
further characterized to be necessary for efficient O-mannosylation of ER-GFP. 
First, it is shown that PGI1 regulates UPOM most likely by defining the availability of GDP-
mannose to generate Dol-P Man, the sugar donor of the protein glycosylation machinery at 
the ER. The data also revealed the RBP Bfr1 to modulate the translational state of PMTs, 
bringing the first evidence of its potential role as a local translation factor for secretory 
proteins. Taken together, in the hunt for UPOM components genes involved in the 
regulation of this process at both substrate and enzyme levels were found. This raises the 
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question of why PMTs would require such a meticulous tuning of their abundance and 
enzymatic activity? 
The answer might rely on the promiscuity shown by the O-mannosylation machinery, which 
seems to have a very broad and flexible catalog of potential substrates. As recently shown, 
O-mannosylation in baker’s yeast is more abundant than initially expected. The O-mannose 
glycoproteome revealed 293 secretory proteins including more than 1900 unique sites that 
undergo O-mannosylation (Neubert et al., 2016). Although features such as the presence of 
unstructured regions and β-strands seem to favor O-mannosylation, no sequon has been 
identified yet. Along with this, PMTs have shown their capacity to O-mannosylate different 
acceptor peptides in a cell-free microsomal system as long as they emerge long enough into 
the lumen (Loibl et al., 2014; Zatorska et al., 2017, Ewa Zatorska, unpublished). Moreover, as 
shown in this and previous studies, the PMT complex is also able to target unfolded protein 
segments of multiple misfolded protein models (C. Xu & Ng, 2015) and even be the 
predominant type of glycosylation for proteins recombinantly expressed in yeast (Murakami-
Sekimata, Sato, Sato, et al., 2009). 
All in all, O-mannosylation is pictured as a post-translational modification that, in contrast to 
N-glycosylation, is versatile and seems to target any protein substrate that contains 
accessible serine/threonine residues. Given that the PMT activity is not limited by a defined 
consensus sequence, it is possible that the cell regulates the extent of O-mannosylation by 
adapting the abundance of PMTs and the abundance of the PMT sugar donor Dol-P-Man to 
the existing demand. Thus, optimization of the correct PMT function is accomplished by 
multiple coordinated regulatory layers: First by transcription, as it is the case of the PMT 
upregulation upon cell wall damage via activation of the CWI pathway (Arroyo et al., 2011); 
or as it is shown for the PMT1 and PMT2, during UPOM when the ER faces protein folding 
stress. Second, PMTs are regulated at the level of protein translation by the RBP Bfr1, which 
ensures the correct expression of the PMT transcripts. Finally, the efficiency of 
O-mannosylation relies on the availability of cytosolic GDP-mannose via PSA1 and PGI1, 
whose function likely determines the availability of Dol-P-mannose.  
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Figure 5. Model of the function of Pgi1 and Bfr1 in the context of UPOM. Model summarizing the highlights of 
the high throughput screening for UPOM.  (left) PGI1 ensures the efficiency of UPOM by deriving primary 
metabolites (Fructose-6-phosphate) for the synthesis of GDP-mannose and the sugar donor Dol-P-Man. The 
downregulation of the PGI1 function results in hypoglycosylation and UPR activation. (right) BFR1 works in the 
frame of translation ensuring the expression of a subset of transcripts mainly functioning across the secretory 
pathway; including PMT1 and PMT2. The expression of both the Pmt1-Pmt2 complex and Bfr1 is coordinated 
by the UPR. The mechanism underlying the Bfr1 function remains unknown and it is likely involving additional 
factors. 
As it is for PMT1 and PMT2, both genes PGI1 and BFR1 are connected to ER folding stress 
(Figures 4.18 and 4.31, respectively). What happens during ER stress is a very figurative 
example of how UPOM, in particular, could be fine-tuned (Figure 5): Expression of the slow 
folding protein ER-GFP compromises ER homeostasis and the cell responds activating the 
UPR and therefore increasing the transcript level of PMT1 and PMT2. At this point two 
conditions determine the efficiency of UPOM: First Dol-P-Man content must be sufficient to 
ensure effective O-mannosylation, resulting in additional ER stress when depleted. Second, 
BFR1, which is also upregulated by the UPR, will ensure efficient translation of PMT 
transcripts. 
An existing question derived from the hypothesis of the PMT promiscuity is whether 
meticulous regulation of the enzymatic function is also present for other O-glycosylation 
types that lack a consensus sequence. In yeast, O-mannosylation is the only type of 
O-glycosylation and it is fairly abundant along the secretory pathway (Neubert et al., 2016). 
In mammals, however, O-mannosylation is so far only present in a few cell surface proteins 
such as α-dystroglycan, KIAA1549, members of the cadherin and plexin superfamilies and 
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lecticans (Moore & Hewitt, 2009; Pacharra et al., 2013; Vester-Christensen et al., 2013). 
Furthermore, O-mannosylation in mammals coexists with other types of O-glycosylation, 
being the mucin-type O-GalNAc glycosylation the most common modification (Steentoft et 
al., 2013). Interestingly, O-GalNAc also lacks a general consensus sequence and shares a set 
of substrates with O-mannosylation orthologs in yeast, based on glycoproteomic data 
(Neubert et al., 2016). Perhaps in analogy to PMTs, the expression of GalNAc-transferases 
also undergoes post-transcriptional regulation to cope with the absence of specificity at the 
sequence level of target proteins. 
The genes BFR1 and PGI1 found in the screen to be necessary for UPOM represent the high 
heterogeneity among the requirements of O-mannosylation during ER stress. Especially 
regarding the function of Bfr1, it is proposed that the existence of manifold regulatory levels 
of PMT protein abundance serves as a mechanism to adapt the O-mannosylation activity at 
the enzymatic level to the cellular needs, thus compensating for the high versatility of PMTs 
in finding potential protein substrates.  
5.3 O-Mannosylation, quality control, and protein fate: substrate’s nature 
matters 
 
In the third part of the study the question of how O-mannosylation impacts protein 
dynamics was approached. The goal of this part was to shed light on the heterogeneity 
shown by PMT target proteins when it comes to the influence of O-glycans on protein 
turnover. As developed in 1.4.2, the fate of several misfolded protein models that become 
UPOM targets is to undergo degradation either by ERAD or by vacuolar turnover as the final 
step of their quality control. Strikingly, O-mannosylation is not always a determinant for 
protein degradation since in the absence of UPOM several misfolded model proteins are 
nevertheless degraded (C. Xu & Ng, 2015). Else ways, the effect of O-mannosylation on 
protein stability is not restricted to UPOM function. It is long known that O-mannosylation is 
necessary for the complete maturation of a set of secretory proteins. The absence of major 
members of the PMT family reduces the stability of the plasma membrane proteins Wsc1, 
Wsc2, Mid2, and Mtl1 (Lommel et al., 2004; Petkova et al., 2012). 
It was a goal to confirm the coexisting opposing effects of O-mannosylation on protein 
stability and to overcome the obstacle of redundancy within the PMT family by dissecting 
the contribution of each major PMT member. In the hope that high throughput 
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methodologies are suitable to address such complex scenarios, it was taken advantage of 
tandem fluorescent protein timers to estimate the lifetime of a set of proteins described to 
be O-mannosylated (Neubert et al., 2016) upon deletion of each of the major components of 
the PMT machinery: PMT1, PMT2 and PMT4. 
O-mannosylation-dependent changes in protein stability were inferred from Δ-scores 
obtained by subtracting the ratio mCherry/sfGFP of 137 tFT C-terminal fusion proteins in 
wild type versus pmtΔ mutant. Under the applied conditions, the great majority of tFT 
fusions did not exhibit severe changes in Δ-score suggesting that O-mannosylation might not 
influence the protein’s lifetime (App. Data 2, Figure App.10). However, a total of 39 
individual proteins were found clearly affected (Figure 4.32A and C). Δ-scores suggested the 
presence of both effects, protein stabilization and destabilization upon deletion of individual 
PMTs. Among the 39 tFT fusions potentially destabilized Wsc2 and Axl2 were found, which 
were previously described to have maturation defects upon PMT deletion (Sanders et al., 
1999; Lommel et al., 2004).  
As a proof of principle, the known example of Axl2 was used to validate the findings from 
the tFT screening. Fluorescence microscopy confirmed the localization of Axl2-tFT to the bud 
neck in the sfGFP channel whereas additional vacuolar localization was found for the older 
pool of the protein at the mCherry channel, indicating most likely protein turnover in this 
organelle. In a de novo generated pmt4Δ mutant changes in the mCherry/sfGFP intensity 
ratio were confirmed and in agreement with the destabilization of the protein, vacuolar 
localization of Axl2-tFT was observed already in the sfGFP channel (Figure 4.33A). Moreover, 
the running behavior of Axl2-tFT in an SDS-PAGE (Figure 4.33B) was compared with a 
previously described Axl2 C-terminally HA-tagged (Sanders et al., 1999). A similar 
degradation pattern was observed upon PMT4 deletion, confirming what previously shown 
for Axl2.  
Mining the data on tFT fusions destabilized upon PMT deletion yields Tsc3, which appears to 
be affected in a similar manner in all three pmtΔ (Figure 4.33C). Tsc3 is a subunit of the 
serine palmitoyltransferase involved in the biosynthesis of sphingolipids (Gable et al., 2000). 
Sphingolipids are particularly relevant for the formation of membrane rafts involved in the 
ER trafficking of GPI-anchored proteins (Helms & Zurzolo, 2004). GPI-anchored proteins are 
major targets of PMTs (Neubert et al., 2016) and O-mannosylation appears to be necessary 
for correct ER export of the GPI-anchored protein Gas1 (Goder & Melero, 2011). 
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Additionally, Ted1, a protein involved in remodeling of GPI glycan moieties, was found 
destabilized in pmt1Δ and pmt4Δ. Ted1 is described to act in concert with the members of 
the p24 family Emp24 and Erv25 promoting cargo exit from the endoplasmic reticulum 
(Haass et al., 2007). Besides being a target of O-mannosylation, Ted1 is, together with 
Emp24 and Erv25 a physical interactor of the Pmt1-Pmt2 complex (Goder & Melero, 2011). 
Furthermore, it was recently shown that the deletion of PMT1 on top of ted1Δ suppresses 
the shortened replicative lifespan of the single deletion (Cui et al., 2018). The fact that the 
stability of Tsc3 and Ted1 relies on PMT function suggests that O-mannosylation might work 
in concert with sphingolipid biosynthesis and GPI-anchor remodeling enzymes to ensure the 
correct export of GPI anchored proteins out of the ER. Based on these findings, the 
functional connection between O-mannosylation and the GPI anchor remodeling machinery 
is indeed an intriguing scenario to be explored in the future. 
Next, the focus was put on tFT fusions showing a Δ-score indicative for protein stabilization. 
This perhaps was the most interesting subset of affected tFT fusions because the role of 
PMTs in assisting protein turnover has been so far only described for artificial misfolded 
model proteins in the frame of UPOM. Therefore, finding endogenous proteins that undergo 
degradation in a PMT-dependent manner is fundamental to understand whether UPOM is a 
physiologically relevant mechanism. Among the tFT fusions validated by flow cytometry 
using de novo generated pmtΔ mutants Kre6-tFT was characterized. Kre6 is a type II integral 
membrane protein; required for beta-1,6 glucan biosynthesis. Kre6 was described to cycle 
between the ER and the Golgi to be released to the plasma membrane at sites of polarized 
growth (Takeuchi et al., 2008; Kurita et al., 2011). The data on Kre6-tFT localization show 
that a C-terminal tFT-tag interferes with the localization of Kre6, indicated by the presence 
of the fusion protein largely at the vacuole in both wild type and pmt1Δ. Although the 
potential misfolding or Kre6-tFT and neither the influence of the tFT-tag on the protein 
function were investigated in this work, the interaction between the C-terminal domain of 
Kre6 with a set of chaperones and chaperone-like proteins such as Kar2, Rot1, and Keg1 has 
been described. Under the absence of Keg1 or Rot1, Kre6 is destabilized and degraded in a 
Pep4 and Ubc7-dependent manner indicating that both ERAD and the vacuole are involved 
in the turnover of misfolded Kre6 (Takeuchi et al., 2008; Kurita et al., 2012). Based on these 
observations, it is proposed that an intact C-terminal domain is required for the correct 
localization of Kre6. Likely the addition of the tFT-tag hampers the interaction of Kre6 with 
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the above-mentioned proteins causing misfolding defects that direct the protein for vacuolar 
turnover.  
Under conditions that mislocalize Kre6, O-mannosylation by Pmt1 becomes a requirement 
for correct turnover (Figure 4.34A and B). Also, Pmt2 was shown in the tFT screening to 
contribute to Kre6-tFT stability in a similar manner as Pmt1 (Figure 4.32C), indicating that 
the effect on the turnover of Kre6-tFT is caused by the Pmt1-Pmt2 complex. The fact that 
Kre6-tFT was observed at the vacuole suggests that turnover is mainly taking place in this 
organelle. This, however, does not exclude ERAD as a contributor to Kre6-tFT degradation as 
previously indicated (Kurita et al., 2012). At this point, there are different scenarios that 
could explain how the presence of O-glycans would enhance Kre6-tFT turnover. One 
attractive possibility is that O-glycans on misfolded proteins might modify the protein 
structure and enhance the accessibility of vacuolar proteases to cleaving sites that could 
remain hidden in the non-glycosylated counterparts. This hypothesis is supported by the 
enhanced sensitivity of ER-GFP to proteases in vitro when comparing to ER-GFPf (C. Xu et al., 
2013) and could be an additional contributor to the increased fluorescence intensity of non-
retained ER-GFP at the vacuole observed in pmt1Δ and pmt2Δ (Figure 4.7). It is also possible, 
that protease activity is modulated by O-mannosylation itself since several vacuolar 
proteases are found to be O-mannosylated, including proteinase A (Pep4), proteinase B 
(Prb1), aminopeptidase Y (Ape3) and carboxypeptidase S (Cps1) (Neubert et al., 2016). In 
general, protein glycosylation is considered a contributor to protease activity, and both 
enhancing and inhibiting effects have been described (Goettig, 2016). With these 
considerations, it is proposed that given the many requirements for proper Kre6 maturation, 
the dependence of Kre6-tFT stability on the Pmt1-Pmt2 complex might indicate that 
O-mannosylation is a relevant mechanism to facilitate protein disposal under the many 
conditions that induce Kre6 misfolding. 
Other ER stabilized tFT fusions that were not further analyzed include the Pmt2 paralog 
Pmt3 which shows a very significant Δ-score in all three pmt1Δ, pmt2Δ and pmt4Δ mutants 
(Figure 4.33C). Pmt3 together with Pmt5 are members of the PMT family considered minor 
contributors to the overall PMT activity and are described to form redundant complexes 
with both Pmt1 and Pmt2 (Girrbach & Strahl, 2003). Previous unpublished data from the 
Strahl lab already pointed out the increase in Pmt3 protein abundance in the absence of the 
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Pmt1-Pmt2 complex. Another interesting protein is Sec12-tFT involved in COPII vesicle 
formation and found to be also strongly affected in all three pmtΔ mutants. Although some 
tFT fusions are affected similarly in pmt1Δ and pmt2Δ, this not always the case. A good 
example to illustrate this observation is Ire1-tFT, which seems to be stabilized in pmt2Δ 
whereas no effect was notified in pmt1Δ (Figure 4.33C). The different effects of each of the 
three PMT deletions on protein stability might be indicative of the substrate specificity of 
the different PMT complexes. Therefore, the data provided by the tFT screen could be taken 
to start dissecting the O-mannose glycoproteome into each PMT’s contribution while waiting 
for more robust proteomic data. 
Overall, the tFT screen is the first high throughput attempt to clarify the role of O-glycans in 
protein stability. Valuable data with strong potential to infer O-mannosylation-dependent 
changes in protein stability is provided for 137 tFT fusions. Results are in agreement with 
previous indications of the double-edged sword effect of O-mannosylation which on one 
hand assists protein maturation and on the other actively contributes to protein turnover. 
The prevalence of either effect seems to be greatly dependent on the nature of the 
substrate. One ideal explanation for this would arise from classifying proteins with 
shortened lifetime upon O-mannosylation defects as bona fide targets that require this 
modification for their maturation, whereas proteins with increased stability could be 
considered as targets of an O-mannosylation-dependent quality control pathway. Thus, the 
requirement of the Pmt1-Pmt2 complex for efficient vacuolar turnover of mislocalized and 
probably misfolded Kre6 were characterized. Whether what these observations are 
translatable to native Kre6 is pending for investigation. Still, Kre6-tFT could be considered a 
suitable protein model to characterize in detail the role of O-glycans in the efficiency of 
vacuolar degradation of misfolded proteins. 
5.4 Final remarks: Defining UPOM, is it really happening? 
 
Although the term UPOM has not been used until very recently (C. Xu et al., 2013; C. Xu & 
Ng, 2015), the addition of O-glycans on misfolded proteins was described already almost two 
decades ago (Harty et al., 2001). Throughout this current work it was aimed to i) clarify the 
relationship between ER stress and O-mannosylation; ii), to unravel mechanistically the 
UPOM machinery in a high throughput screen and iii), to explore the effects of 
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O-mannosylation on protein stability, mainly aiming to explore the physiological relevance of 
UPOM. 
With a birds-eye-view of all three different parts, it can certainly be stated that 
O-mannosylation and in particular the Pmt1-Pmt2 complex is a key contributor to ER 
homeostasis in Saccharomyces cerevisiae (see 5.1). However, the high throughput screening 
was unable to find mechanistic differences, in terms of specific factors that define and 
differentiate UPOM from canonical O-mannosylation. On the contrary, evidence was found 
for O-mannosylation being a process that is tightly regulated at multiple layers, perhaps 
balancing the lack of specificity shown by the PMT machinery (see 5.3). Evidence of 
O-mannosylation being a determinant for protein stability was provided, together with a 
large number of proteins that likely follow an O-mannosylation dependent degradation 
pathway. However, it is too early to state that UPOM is a process mechanistically different 
from O-mannosylation as it has been recently defined (C. Xu & Ng, 2015). The basis of PMT 
substrate recognition rather suggests that O-mannosylation targets proteins based on 
confirmation cues, implying a competition mechanism between protein folding and 
glycosylation during, and likely also after translocation. Who wins the game perhaps 
depends on each polypeptide’s folding intermediates and the accessibility of Ser and Thr 
residues during its journey to the final native state. 
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6 APPENDIX 
 
Figure App 1. Analysis of transcription factors associated with PMT1, 
PMT2 and PMT4 in the Yeastract database (Teixeira et al., 2018). 
Results show the number of transcription factors associated with 
each gene based on bibliographic references. 
 
 
 
 
 
 
 
 
Figure App 2. Cycloheximide chase analysis of ER-GFP. Wild type (BY4741) cells were transformed with plasmid 
pWXB206 (ER-GFP) and treated with 200 µg/ml cycloheximide. Equivalent to 10 OD600 cells was sampled at the 
indicated time points. The equivalents to 0.2 OD600 of total cell extract were resolved on a 12% PAA gel 
subjected to Western blot analysis using anti-GFP antibody. Consistent with (C. Xu et al., 2013), ER-GFP is stable 
when retained in the ER. This experiment was performed by Dr. Ewa Zatorska in collaboration with the author. 
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Figure App 3. Analyses of ER-GFP in spf1Δ. (A) Wild type (BY4741) and spf1Δ (Euroscarf) cells were 
transformed with pWXB206 (ER-GFP), grown in SD-Uracil and imaged under standard conditions. The deletion 
of SPF1 causes partial cytosolic localization of ER-GFP. This experiment was performed by Karen Schriever 
under the author’s supervision and included in the bachelor thesis: “Assessing a possible role of unfolded 
protein O-mannosylation as a complementary Endoplasmic Reticulum quality control mechanism in 
Saccharomyces cerevisiae”, submitted to the Ruprecht-Karls-University (Heidelberg faculty of Biosciences) in 
2015. (B) Total cell extracts were prepared from the strains shown in (A) and analyzed by western blot. 
Equivalents of 0.2 OD600 of protein were resolved on a 12% PAA gel and blotted with anti-GFP antibody. SPF1 
deletion causes a reduction in the presence of the O-mannosylated fraction of ER-GFP (indicated with white 
arrow). 
 
 
Figure App 4. Flow cytometry analysis of bfr1Δ knockout transformants. BFR1 was knocked out in JEY06 (wild 
type ER-GFP) by homologous recombination. A knockout cassette containing up and downstream BFR1 
homologous regions and KanMX6 was generated via PCR (oligos 2810-2811) from pUG6 and transformed 
according to 3.2.12. After selection, KanMX6 insertion was verified by PCR and eight independent 
transformants (t1-t8) were grown in YPD and analyzed by flow cytometry. R values indicative of the cell 
population’s fluorescence intensity (see 3.5.3) are normalized to RWT and results are plotted as fold-change. 
Results show heterogeneity in the expected increase of ER-GFP fluorescence. 
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Figure App 5. Quantification of the western blot of representative targets of Bfr1 at the mRNA level (figure 
4.23). Western blot signals were quantified using Image Studio Lite V.5.2 as a Pmt/G6PDH ratio, normalized to 
PmtWT/G6PDHWT averaged and plotted as fold-change. For statistical significance, a one-tail Student’s test was 
applied to averaged fold-change values (n=3). 
 
 
 
Figure App 6. Evaluation of functionality of Bfr1-3xHA. A yeast strain including a genomic 3xHA c-terminal tag 
of BFR1(JCY017) was generated by homologous recombination. A tagging cassette containing sequences 
homologous of BFR1 3’, 3xHA and KanMX6 was generated via PCR (oligos 2885-2886) from pJH24 and 
transformed into wild type cells (BY4741) according to 3.2.12. After selection, KanMX6 insertion was verified by 
PCR. A validated transformant was grown together with wild type (BY4741) and bfr1Δ in YPD and imaged under 
standard conditions, scale bar 5 µm. Results show no phenotypic effect of the 3xHA C-terminal tag. 
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Figure App 7. Analyses of protein and RNA content of 
EDTA-treated cell lysates after fractionation by sucrose 
gradient. As a control for what shown in Figure 4.27B, 
total cell extracts prepared from wild type (BFR1-HA, 
strain JCY017) were supplemented with 30 mM EDTA 
prior load in a sucrose gradient. (A, Upper panel) Abs260 
of each fraction sampled from the sucrose gradient. 
(Lower panel) The equivalents of each fraction were 
resolved ion an agarose gel and stained with ethidium 
bromide. Addition of EDTA causes both, disengagement 
of ribosomes from the membrane containing sucrose 
fraction (F3) and disassembly of the ribosomal subunits 
at the sucrose fractions where they accumulate (F2 and 
F3).(B) 0.25 OD600 units of total cell extract and 
equivalents of each sucrose fraction were resolved on a 
12% PAA gel and analyzed by Western blot using the 
indicated antibodies. In comparison to Figure 4.29C, 
EDTA treatment results in decreased prevalence of Rpl5 
and Bfr1-HA at F2 and F3 fractions. 
 
 
 
 
 
 
 
Figure App 8.Analysis of RNA content after cell 
fractionation by 1-step ultracentrifugation. 400 ng of 
total mRNA extracted from total cell extract (TCE) 
soluble fraction (SF) and total membrane fraction (TM) 
prepared from wild type (BFR1-HA, strain JCY017) were 
resolved in triplicate in an agarose gel and stained with 
ethidium bromide. Results show the distribution of 
ribosomal subunits in each fraction. 
  
  
149 
Figure App 7. Spotting assay of wild type (BY4741), bfr1Δ 
(Euroscarf), JEY06 (wild type expressing ER-GFP) and bfr1Δ 
ER-GFP (strain resulting from SGA crosses) expressing 
either pRS41N (empty vector, EV) or pJC10 (PMT2-3xHA). 
Serial 10-fold dilutions cells were spotted on solid YPD 
medium containing nourseothricin for selection and 
grown at 30 °C for 24h. In contrast to the native protein, 
overexpression of C-terminally tagged Pmt2 in bfr1Δ cells 
results in a modest growth defect (indicated with black 
arrow). 
 
 
 
Figure App 8. Fold-change in mRNA levels of HAC1u, HAC1s, and KAR2 upon expression of retained or non-
retained ER-GFP. Wild type cells (BY4741) were transformed with either pWXB206 (ER-GFP) or pJC07 (non-
retained ER-GFP). Total RNA was extracted either from cells grown in SD (wild type) or SD-Uracil (transformed 
wild type). cDNA was prepared from total mRNA according to 3.2.3 and 3.2.4 and RT-PCR was performed 
according to 3.2.9. Fold-change is calculated by averaging Cts with respect to ACT1. Errors bars show the 
confidence interval. For statistical significance, a two-tailed t-Student’s test was applied to log (2
-ΔΔCt
), n=3. 
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 Figure App 9. (A) Scatter plot illustrating the correlation between the two replicates for the translatome of 
wild type and bfr1Δ in the ribosome profiling experiment (Figure 4.27). Figure section adapted from Ilgin Kotan 
(B) Metagene analysis of ORF underrepresented in bfr1Δ translatome vs the remaining ORFs according to 1.5 
fold-change threshold (below or above 0.66 RPKMbfr1Δ/RPKMWT, lower and panel, respectively) in the two 
replicates for WT and bfr1Δ used for ribosome profiling (Figure 4.27). Ribosome protected footprints of 
underrepresented ORFs show a modest tendency to accumulate in the first 100 codons of averaged ORF sizes. 
Analyses performed by Ilgin Kotan. (C) Analyses of functional categories enriched among ORFS below the 
threshold with respect to the total translatome. Gene annotation for secretome, SRP-dependent, SRP-
independent and unpredicted is based on Ast et al., 2013. 
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ORF Gene 
Median 
Intensity Gfp 
Error 
Hsp150 
phenotype 
Decreased ER-
GFP O-
mannosylation 
YEL031W SPF1 363 34 pop2Δ-like YES 
YDR123C INO2 299 28 ost3Δ-like NO 
YAL023C PMT2 295 21 WT YES 
YPR049C ATG11 270 32 WT NO 
YDR195W REF2 246 31 WT n.d 
YOR198C BFR1 245 34 pop2Δ-like YES 
YNL064C YDJ1 236 27 WT NO 
YJL006C CTK2 234 0 pop2Δ-like n.d 
YNR052C POP2 231 29 pop2Δ-like NO 
YIL147C SLN1 230 28 n.d NO 
YEL043W YEL043W 220 34 ost3Δ-like NO 
YGR135W PRE9 219 33 ost3Δ-like NO 
YJL088W ARG3 219 40 ost3Δ-like NO 
YLR087C CSF1 215 37 WT NO 
YNL208W YNL208W 212 41 ost3Δ-like NO 
YDR025W RPS11A 211 33 WT NO 
YNL099C OCA1 209 35 ost3Δ-like NO 
YOR085W OST3 208 40 ost3Δ-like NO 
YDL077C VAM6 208 31 ost3Δ-like NO 
YLR079W SIC1 207 32 ost3Δ-like NO 
YDR207C UME6 207 30 WT NO 
YOL008W COQ10 207 44 ost3Δ-like n.d 
YNL079C TPM1 205 35 WT NO 
YIL103W DPH1 205 34 WT NO 
YMR247C RKR1 204 39 WT NO 
YGL003C CDH1 202 37 ost3Δ-like NO 
YPL238C YPL238C 202 37 n.d NO 
YDR369C XRS2 200 33 pop2Δ-like NO 
Table App 1. ER-GFP results are shown. Median intensity of ER-GFP intensity of each mutant and median 
error (MAD) associated. Hsp150 phenotypes according to Figure 4.11. ER-GFP O-mannosylation reduction 
according to figure 4.12. Mutants below the threshold but with ER-GFP intensities above the wild-type 
controls are highlighted in grey. N.d – not determined. Experiment performed performed by Lihi Gal in 
collaboration with the group of Prof. Maya Schuldiner (Weizmann Institute of Science, Rehovot, Israel). 
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YER151C UBP3 200 38 ost3Δ-like NO 
YML112W CTK3 199 25 WT n.d 
YDL097C RPN6 199 32 n.d NO 
YMR306W FKS3 198 38 WT NO 
YNL198C YNL198C 197 50 WT NO 
YGL016W KAP122 197 34 WT NO 
YNL097C PHO23 197 34 WT NO 
YBR003W COQ1 197 35 WT NO 
YIL110W HPM1 197 0 WT NO 
YDL095W PMT1 197 24 WT YES 
YLR039C RIC1 196 29 WT NO 
YPR017C DSS4 196 41 WT NO 
YKR100C SKG1 196 28 WT NO 
YJL064W YJL064W 196 43 WT NO 
YNL056W OCA2 196 29 ost3Δ-like NO 
YBR150C TBS1 196 39 WT NO 
YDL055C PSA1 196 35 n.d NO 
YKR104W YKR104W 195 49 WT NO 
YPL094C SEC62 195 34 n.d NO 
YPL143W RPL33A 195 33 n.d NO 
YNL199C GCR2 194 50 WT NO 
YKR048C NAP1 194 35 WT NO 
YJL065C DLS1 194 37 WT NO 
YBR131W CCZ1 194 42 ost3Δ-like NO 
YBR001C NTH2 194 27 WT NO 
YNL120C YNL120C 194 30 WT NO 
YER161C SPT2 194 24 WT NO 
YLR140W YLR140W 194 37 n.d NO 
YHR178W STB5 194 37 WT NO 
YDR363W-
A 
SEM1 193 36 WT NO 
YDR250C YDR250C 193 40 WT NO 
YMR142C RPL13B 193 28 WT n.d 
YJL063C MRPL8 193 35 WT n.d 
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YBR009C HHF1 193 37 pop2Δ-like NO 
YBR272C HSM3 193 34 WT NO 
YJL068C YJL068C 192 37 WT NO 
YNL054W VAC7 192 30 WT NO 
YBR008C FLR1 192 30 WT NO 
YBR012C YBR012C 192 32 WT NO 
YNL115C YNL115C 192 29 WT NO 
YPR043W RPL43A 192 36 WT NO 
YER122C GLO3 192 43 pop2Δ-like NO 
YLL039C UBI4 192 27 WT NO 
YJL115W ASF1 191 45 pop2Δ-like NO 
YPR014C YPR014C 191 34 WT NO 
YBR005W RCR1 191 33 WT NO 
YNL104C LEU4 191 39 WT NO 
YLL038C ENT4 191 35 WT NO 
YGL028C SCW11 190 37 WT NO 
YGL027C CWH41 190 59 pop2Δ-like NO 
YMR089C YTA12 190 42 WT n.d 
YKR103W NFT1 190 44 ost3Δ-like NO 
YNL069C RPL16B 190 28 ost3Δ-like n.d 
YNL100W MIC27 190 46 ost3Δ-like NO 
YDR525W API2 190 31 ost3Δ-like NO 
YDR349C YPS7 190 42 WT NO 
YCL005W LDB16 190 38 ost3Δ-like n.d 
YDR225W HTA1 190 36 ost3Δ-like NO 
YNL196C SLZ1 189 44 WT NO 
YIL044C AGE2 189 46 ost3Δ-like NO 
YIL053W GPP1 189 42 ost3Δ-like NO 
YMR125W STO1 189 40 WT NO 
YKR093W PTR2 189 41 ost3Δ-like NO 
YNL078W NIS1 189 39 ost3Δ-like NO 
YBR276C PPS1 189 33 pop2Δ-like NO 
YDL006W PTC1 189 32 ost3Δ-like NO 
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YGL011C SCL1 189 32 n.d NO 
YGL048C RPT6 189 31 n.d NO 
YPR135W CTF4 188 36 pop2Δ-like NO 
YGR237C YGR237C 188 37 WT NO 
YJL073W JEM1 188 68 WT NO 
YMR311C GLC8 188 43 WT NO 
YPR020W ATP20 188 39 WT NO 
YKR098C UBP11 188 43 WT NO 
YBL099W ATP1 188 30 WT n.d 
YBR083W TEC1 188 39 WT NO 
YNL083W SAL1 188 33 WT NO 
YBR287W YBR287W 188 31 ost3Δ-like NO 
YGL105W ARC1 188 44 pop2Δ-like NO 
YLL024C SSA2 188 34 WT NO 
YKL048C ELM1 188 34 ost3Δ-like NO 
YNL219C ALG9 187 28 n.d NO 
YPL158C AIM44 187 44 n.d NO 
YIL045W PIG2 187 39 n.d NO 
YMR312W ELP6 187 50 n.d NO 
YJL057C IKS1 187 42 n.d NO 
YDL104C QRI7 187 28 n.d NO 
YJR087W YJR087W 187 37 n.d NO 
YKR046C PET10 187 33 n.d NO 
YIL100W YIL100W 187 27 n.d NO 
YBR270C BIT2 187 34 n.d NO 
YFL001W DEG1 187 35 n.d NO 
YBR196C PGI1 187 30 n.d YES 
YFR050C PRE4 187 26 n.d NO 
YMR025W CSI1 187 32 n.d NO 
YGL007W BRP1 186 40 n.d NO 
YJL099W CHS6 186 37 n.d NO 
YMR271C URA10 186 42 n.d NO 
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YBL107C MIX23 186 30 n.d NO 
YNL106C INP52 186 26 n.d NO 
YNL105W RRT16 186 36 n.d NO 
YKL172W EBP2 186 33 n.d NO 
YDL098C SNU23 186 48 n.d NO 
YOR103C OST2 186 16 n.d NO 
YML013W UBX2 186 36 n.d NO 
YOR069W VPS5 186 37 n.d NO 
YNL211C YNL211C 185 34 n.d NO 
YNL190W YNL190W 185 47 n.d NO 
YNL191W DUG3 185 42 n.d NO 
YJR110W YMR1 185 30 n.d NO 
YMR279C YMR279C 185 38 n.d NO 
YPR027C YPR027C 185 50 n.d NO 
YKR105C VBA5 185 30 n.d NO 
YJL029C VPS53 185 36 n.d NO 
YBR006W UGA2 185 34 n.d NO 
YBR288C APM3 185 44 n.d NO 
YER169W RPH1 185 32 n.d NO 
YBR075W YBR075W 185 30 n.d NO 
YFR052W RPN12 185 32 n.d NO 
YPL228W CET1 185 35 n.d NO 
YPL144W POC4 185 35 n.d NO 
YOL011W PLB3 185 0 n.d NO 
YNL227C JJJ1 184 47 n.d NO 
YNL226W YNL226W 184 41 n.d NO 
YNL192W CHS1 184 23 n.d NO 
YNL193W YNL193W 184 38 n.d NO 
YPR069C SPE3 184 26 n.d NO 
YMR126C DLT1 184 40 n.d NO 
YLL018C-A COX19 184 49 n.d NO 
YJL058C BIT61 184 28 n.d NO 
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YJL060W BNA3 184 49 n.d NO 
YDL096C OPI6 184 20 n.d NO 
YGR063C SPT4 184 24 n.d NO 
YNL085W MKT1 184 34 n.d NO 
YIL099W SGA1 184 35 n.d NO 
YNL119W NCS2 184 38 n.d NO 
YDL076C RXT3 184 36 n.d NO 
YER162C RAD4 184 27 n.d NO 
YER163C GCG1 184 35 n.d NO 
YFL033C RIM15 184 0 n.d NO 
YPL175W SPT14 184 38 n.d NO 
YJR112W NNF1 184 32 n.d NO 
YDL060W TSR1 184 28 n.d NO 
YJR065C ARP3 184 31 n.d NO 
YBR200W BEM1 184 24 n.d NO 
YEL054C RPL12A 184 36 n.d NO 
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